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ABSTRACT 
 
CELLULAR MECHANOTRANSDUCTION IN THE PATHOGENESIS AND 
TREATMENT OF CARDIAC FIBROSIS 
 
 By  
 
Peter Adam Galie 
 
Chair:  Dr. Jan Philip Stegemann 
 
Cardiac fibrosis occurs after myocardial infarction, and contributes to both systolic and diastolic 
heart failure. Activation of cardiac fibroblasts to a myofibroblast phenotype is essential for 
fibrotic scar development. The present dissertation focuses on this phenotypic transition, 
specifically on the effects of mechanical stress and interactions with mesenchymal stem cells 
(MSC). The experimental platform used was a flexible 3D culture well that allowed 
simultaneous application of fluid flow and cyclic strain to collagen type I hydrogels seeded with 
primary rat neonatal cardiac fibroblasts. The results indicated that fibroblasts transitioned to 
myofibroblasts in static culture in the absence of exogenous biochemical or mechanical 
stimulation. Interstitial fluid flow significantly stimulated the myofibroblast transition, while 
cyclic strain had an opposing effect. Using chemical antagonists and lentivirally-delivered 
shRNA, it was found that the acute response to flow was mediated by angiotensin II receptor 
type I (AT1R) and transforming growth factor β (TGF-β). Cyclic strain also influenced the TGF-
β pathway by attenuating the phosphorylation of smad2, a downstream effector of this signaling 
pathway. The experimental results were augmented with a poroelastic model of flow and gel 
displacement within the collagen hydrogels, which indicated that cyclic strain produced 
substantial interstitial fluid flow in the absence of applied cross flow. The results of the analytical 
model, combined with the experimental findings, suggested that cyclic strain decreased 
fibroblast activation even in the presence of interstitial flow. Finally, GFP-labeled MSC were 
injected into the cell-seeded collagen hydrogels to examine their effect on the cardiac fibroblast 
response. The presence of MSC significantly attenuated cardiac fibroblast activation under both 
static conditions and during biochemical and mechanical stimulation. Hypoxia, not mechanical 
stress, induced the highest levels of MSC migration, as well as the highest release of the 
paracrine factor, VEGF. The data suggest that AT1R can be targeted to prevent the 
myofibroblast transition, due to its role in fluid shear-induced fibroblast activation. Additionally, 
the observed beneficial effects of cyclic strain may have implications for therapies that unload 
the myocardium, including the use of ventricular assist devices (VADs). Finally, the effects of 
MSC on fibroblast activation may illuminate the mechanisms of MSC-based therapies. 
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Chapter I 
 
Introduction 
 
 The field of mechanobiology has gained increasing importance and clinical relevance in 
the last few decades as researchers and clinicians have continued to find evidence that cells 
convert exogenous mechanical stimuli into specific biochemical responses. The goal of the field 
is to discern these mechanically-sensitive signaling pathways in cells, so that interventions can 
be made to attenuate harmful cell responses to altered mechanics. Such mechanotransduction is 
clinically relevant because of the multitude of pathologies that are characterized by a change in 
the mechanical microenvironment. Certainly, one of the reasons for the accelerated growth of 
this field is its applicability to nearly every tissue in the body. For example, understanding the 
response of chondrocytes to compressive strain may yield insight into osteoarthritis. The same 
can be said for pulmonary epithelial cells response to fluid shear stress for emphysema, even 
cancer cells are influenced by the mechanical microenvironment of a tumor. But perhaps no 
tissue in the body is more mechanically relevant than the heart with its constant, cyclic 
deformation during systole and diastole. Though the comparison is made infrequently, there are 
more similarities than differences between a cardiac pressure-volume loop and an Otto cycle of 
the internal combustion engine. Due to its mechanical nature, it is intuitive that the cells within 
the heart are sensitive to changes in solid and fluid phase stress. 
 The research described in this dissertation mostly focuses on the mechanobiology of 
cardiac fibroblasts. Though cardiomyocytes take up the most volume of any cell type in the 
myocardium, there are actually more fibroblasts by number in the heart. Moreover, the crucial 
role of fibroblasts in cardiac architecture and physiology is increasingly being elucidated. Under 
2 
 
specific circumstances, fibroblasts in the myocardium transition to a myofibroblast phenotype 
that is characterized by increased contractility, extracellular matrix secretion, and the expression 
of prominent stress fibers within the cytoskeleton. Myocardial injury leads to activation of 
cardiac fibroblasts which causes scar formation and subsequent systolic or diastolic dysfunction 
in heart failure. Therefore, cells within the fibrotic myocardium are exposed to an altered 
mechanical environment, which may contribute to the growth of the fibrotic scar and eventual 
heart failure. The goal of the present dissertation is to study the response and mechanism of 
cardiac fibroblasts stimulated by fluid-induced and solid stress, so that treatments can be 
developed to attenuate the fibroblast activation that leads to scar development in the heart. 
 The approach of this research involved seeding cardiac fibroblasts within collagen 
hydrogels, which mimic the three-dimensionality of in vivo tissue. The cell-seeded gels were 
studied in conventional culture wells, as well as within a polydimethylsiloxane (PDMS) well 
designed to apply interstitial fluid flow, or cyclic strain, or a combination of both stimuli. To 
predict fluid flow, pressure, and the strain environment, the empirical research was supplemented 
with a numerical poroelastic model. Throughout these studies, the myofibroblast transition was 
quantified using a combination of contractility assays, message level analysis, 
immunofluorescence, and immunoblotting. The mechanisms for the cell response were discerned 
using several blocking agents, including a shRNA construct targeting a specific mechano-
sensitive G-protein coupled receptor. Once the effect of culturing conditions and 
mechanical/biochemical stimulation on fibroblast activation was elucidated, the cell-seeded gel 
was used as an in vitro model of fibrosis to study the addition of mesenchymal stem cells to the 
fibrotic myocardium. MSCs were injected into the cell-seeded hydrogel to study the effect of 
mechanical stimulation on MSC paracrine release and its effect on surrounding fibroblasts.  
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 The following chapters begin with pertinent background information for the research 
presented in later chapters. This background describes the current impact of heart disease, as well 
as a description of the current treatments for patients suffering from this affliction, including 
clinical trials involving stem cell injection. A short introduction of the physiology underlying 
fibrosis in the myocardium is also presented, along with a full explanation of the fibroblast to 
myofibroblast transition. This is followed by a description of the mechanical environment within 
the myocardium, both in healthy and fibrotic tissue. The background section concludes with a 
survey of previously published research conducted on the fibroblast and MSC response to 
mechanical stimuli. Then, a detailed methods section describes the culturing conditions of the 
cell-seeded gels in static culture as well as in the mechanically-stimulated PDMS wells. Assays 
to assess cell response and function are subsequently described. The results of the experiments 
are presented in graphical form with descriptive text, and the interpretation and analysis of the 
results and their significance is provided in the Discussion section.  
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Chapter II 
 
Background 
 
2.1 Heart failure: definition, epidemiology and treatment options  
 Heart failure is the end result for a broad range of different pathologies, and includes 
abnormalities in either cardiac structure, rhythm, or a combination of both. Heart failure is 
generally characterized into two categories: systolic and diastolic. Though both diseases result in 
reduced cardiac output, the structural differences and disease progression are distinctly different. 
In systolic dysfunction, an acute or chronic affliction decreases the contractility of the 
myocardium, as indicated by a reduction in the slope of the Frank-Starling curve. To maintain 
cardiac output, the volume of the left ventricle is increased by remodeling of the myocardium. 
Systolic dysfunction is characterized by an increase in myocyte length, which leads to eccentric 
hypertrophy. This compensatory mechanism eventually breaks down, and the cardiac output falls 
below acceptable levels. In diastolic dysfunction, the left ventricle is unable to sufficiently fill 
with blood. After the constant volume stage of diastole, complete filling relies on the ability of 
the myocardium to distend. If the wall is too stiff, the filling is inadequate and stroke volume 
decreases even though ejection fraction increases. Diastolic dysfunction is associated with an 
increase in myocyte width, which leads to concentric hypertrophy. 
 Differentiating between systolic and diastolic heart failure is further complicated by the 
fact that nearly a third of patients experience simultaneous systolic and diastolic dysfunction 
[McMurray, 2005]. Because ejection fraction can be preserved in diastolic dysfunction, it is 
much more difficult to diagnose clinically than systolic dysfunction. There is increasing evidence 
that the current understanding of systolic and diastolic dysfunction as distinct afflictions is 
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misleading; patients may transition between states of systolic and diastolic dysfunction prior to 
end-stage failure. However, one common factor in both systolic and diastolic dysfunction is the 
presence of fibrosis in the myocardium, as indicated by a study showing elevated levels of 
procollagens I and III in patients suffering from both types of heart failure [Barasch, 2009]. 
Hence, understanding the formation and growth of fibrotic scars is crucial to developing new 
treatments for heart failure. 
 The epidemiology of the disease is well documented, most likely due to its prevalence in 
both developed and developing countries. Nearly 2% of the adult population suffers from heart 
failure [McMurray and Pfeffer, 2005], and the incidence increases with age. Approximately 5.8 
million people in the United States have been diagnosed with heart failure, with nearly 670,000 
being added to that list per year [Lloyd-Jones, 2010]. What is perhaps most striking is the 
mortality associated with heart failure, with rates higher than many cancers for people admitted 
to the hospital [Baker, 2003]. A person in their forties has a 20% chance of being diagnosed with 
heart failure, and a 33% chance of dying within a year of that diagnosis [McMurray and Pfeffer, 
2005]. The impact of heart failure on human life is tremendous and is motivation in itself for 
studying the disease, but its financial burden cannot be ignored. Nearly 2% of all health-care 
spending in a developed country like the U.K. is attributed to heart failure [Stewart, 2002]. In 
2010, heart failure cost the U.S. $39.2 billion in health care services, medication, and lost 
productivity [Lloyd-Jones, 2010]. In 2007, the American Heart Association had a $700 million 
budget for research, public education, community programs, and advocacy. One can assume that 
these costs will only rise as the mean age of developed countries continues to rise in the next 10 
to 20 years, considering that the incidence of heart failure for people over the age of 65 can 
increase by a factor of 5 [McMurray and Pfeffer, 2005].  
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 Despite these grim statistics, treatments for all stages of NYHA-designated heart failure 
are continuing to increase in efficacy and availability. Traditionally, pharmaceutical intervention 
with inhibitors of the renin angiotensin system and β-adrenergic receptors have been effective for 
slowing the progression of heart failure and providing palliative relief for patients. The standard 
treatment for non-end stage heart failure currently involves some combination of beta-blockers, 
digoxin, diuretics, and inhibitors for the renin-angiotensin system, including ACE inhibition 
[Desai, 2011]. A recent argument has been made for inclusion of aldosterone receptor 
antagonists as well [Nappi and Sieg, 2011]. For patients in end-stage heart failure, ventricular 
assist devices are proving to be valuable and increasingly practical solutions [Gregory, 2011]. In 
addition, the use of adult stem cells holds great potential for treatment of heart failure, though the 
efficacy, mechanism, and delivery of this treatment are controversial subjects [Boudolas, 2009]. 
The following paragraphs will provide a brief review of current and future treatments: their 
advantages and caveats as well as their effect on fibrotic scarring in the myocardium.  
 Beta blockers act directly on β-adrenergic receptors, reducing both the chronotropic and 
positive inotropic effects of receptor activation. Originally, due to the decrease in contractility, 
these drugs were considered inappropriate for treatment of systolic dysfunction. However, they 
also act on β1 receptors in the kidney to reduce renin secretion, which provides an added benefit 
for patients of heart failure suffering from hypertension. Moreover, blocking β-adrenergic 
receptors also has anti-apoptotic effects [Liang, 2008; Amin, 2011]. Previous work has also 
indicated that beta-blockers normalize the turnover of beta adrenergic receptors, which is 
attenuated in heart failure. In this manner, beta-blockers can improve the beta adrenergic 
response of cardiomyocytes [Leosco, 2007]. Initial clinical trials featuring bisoprolol and 
metoprolol, selective β1 blockers without sympathetic activation or vasodilating properties, did 
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not find any significant improvement in reducing mortality [CIBIS II, MDI, 1999]. Nonetheless, 
the benefit of beta blockers is well established [Bangalore, 2007]. The only beta blocker 
designated by the FDA for treatment of heart failure is carvedilol, which has been shown to 
significantly reduce the progression of the disease [Packer, 1996]. More recent clinical trials 
have also established the benefit of beta blockers for treating various stages of heart failure 
[Klapholz, 2009]. Overall, the consensus seems to be that beta blockers are effective at 
interrupting the neurohormonal chain of events involved in disease progression, but not with any 
immediate symptomatic improvement. A recent study showed that spironolactone, an 
aldosterone antagonish, used together with a beta blocker significantly reduced cardiac collagen 
turnover in heart failure patients, indicating that these agents may also have anti-fibrotic effects 
in the myocardium [Cavallari, 2007]. Carvedilol also has been shown to reduce cardiac fibrosis 
up to 67% in rat models [Barone, 1998]. The mechanism for this benefit has yet to be elucidated. 
 Digoxin has been used for the treatment of heart failure for over 200 years. Though its 
exact mechanism is still unknown, it is theorized that by deactivating sodium/potassium ion 
channels, the intracellular concentration of sodium in cardiomyocytes is increased. Then through 
the calcium-sodium exchange channel, intracellular calcium concentration subsequently 
increases. This increase in calcium causes a highly positive inotropic effect on the heart, 
augmenting contractility of the myocardium and negating the need for left ventricular 
enlargement during systolic dysfunction. However, the drug is not without severe side effects, 
including toxic and mood-altering consequences at high concentrations.  For example, a recent 
study has shown that dronedarone, a common antiarrhythmic medication, can increase digoxin 
concentrations in the blood when the two are taken in combination [Vallakati, 2011]. A 
genotyping study showed that females may actually be more susceptible to digoxin intoxication 
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[Neuvonen, 2011]. Moreover, one may assume that if it can change calcium concentrations in 
cardiomyocytes, it could do the same in cardiac fibroblasts. The role of increased intracellular 
calcium concentrations in cardiac fibroblast activation has been well-studied [Chen, 2010], and it 
is possible that digoxin could lead to augmented cardiac fibroblast activation and subsequent 
fibrosis. Due to its dangerous effects, the use of digoxin is currently being phased out of the 
clinical setting [McMurray and Pfeffer, 2005].  
 Drugs targeting the renin angiotensin system have been used progressively more in the 
past ten to twenty years to treat patients suffering from heart failure and in the aftermath of 
myocardial infarction. Their primary mode of operation is to reduce blood pressure, both by 
reducing total blood volume (preload) and preventing constriction of vasculature (afterload). 
They are often used in conjunction with antagonists for angiotensin II receptor blockers (ARBs), 
though in recent years there has been a debate to the effectiveness of ―single‖ (without ARBs) 
versus ―dual‖ (with ARBs) use [Messerli, 2009; McMurray, 2009]. The concern with using 
ARBs in conjunction with ACE inhibitors include renal dysfunction, hyperkalemia, and 
hypotension. However, the argument for dual use is based on two clinical trials and the 
recommendation that symptoms for the aforementioned side effects be monitored during 
treatment [McMurray, 2009]. In the past few years, the anti-fibrotic effect of ARBs has been 
increasingly elucidated. A recent study showed that telmisartan, a common ARB, significantly 
reduced fibrosis in rat models of chronic heart failure [Sukumaran, 2010]. Valsartan, another 
ARB, was found to reduce remodeling in the myocardium of hypertensive rats [Okada, 2006]. 
Yet, the mechanism by which these antagonists facilitate this anti-fibrotic effect is unknown. 
 If pharmaceutical intervention can be deemed ―the first line of defense‖ against heart 
failure, then ventricular assist devices (VADs) would be the last line. The device does the work 
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of the ventricle by creating a pressure gradient to drive blood into the circulatory system. Blood 
can be propelled by pulsatile, axial, or centrifugal means [Scolletta, 2011; Moscato, 2009; Wu, 
2010]. Though much progress has been made in the development and use of these devices, there 
are still substantial challenges facing the field. Issues with biocompatibility and thrombosis from 
platelet rupture persist [Alemo, 2010]. Moreover, there are also issues with right heart failure and 
the risk of kidney failure. The effect of VAD implantation on fibrosis is controversial. A recent 
study using a rat model found that unloading of the heart, by abdominal heterotopic heart 
transplantation, resulted in attenuated fibrotic scarring in the unloaded myocardium [Zhou, 
2011]. However, a study involving human hearts unloaded by an LVAD found that 
microvascular density and fibrosis significantly increased [Drakos, 2010]. This study suggests 
that mechanical stress can modulate the fibrotic response in the myocardium. 
 Though the benefit of adult stem cell implantation in the myocardium has been 
established for some time, the mechanism and duration of this improvement is more 
controversial. In recent years, mesenchymal stem cells (MSCs) have been implanted into patients 
suffering from various myocardium-related pathologies including dilated cardiomyopathy, 
concentric hypertrophy, and myocardial infarction [Novotny 2008; Wang, 2010; Meluzin, 2009].  
It has been hypothesized that the implanted cells regenerate tissue through paracrine effects 
[Gnecchi, 2008], cell fusion with damaged cells [Avitabile, 2011], as well as through 
differentiation into cardiomyocytes [Lu, 2010]. However, the extent to which damaged 
myocardium uses stem cell homing from the circulation as a repair mechanism is unclear, 
bringing into question the appropriateness of cell implantation. Moreover, there is a great deal of 
variability in the effectiveness of cell therapies. This could arise from the fact that patients 
receiving stem cell transplants from their own bone marrow may have comorbidity with diabetes, 
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high blood pressure, or another affliction that could affect the beneficial properties of the 
implanted stem cells.  Nonetheless, studies have indicated that injected MSCs attenuate fibrosis 
in the response to myocardial infarction, by altering MMP and collagen production by cardiac 
fibroblasts [Mias, 2009].  
  Not only is the mechanism a source of debate, but the optimal mode of delivery has also 
yet to be identified. The two primary locations of MSC injection in the heart are directly into the 
myocardium (intramyocardial) and into the coronary artery (intracoronary). Both injection 
methods have demonstrated positive results, despite the common obstacle of cell engraftment 
within the fibrotic myocardium. An advantage of injection into the vasculature is distribution of 
any paracrine factors released by the stem cells to perfused tissue [Barallobre-Barreiro, 2011; 
Gyöngyösi, 2010]. Fibrotic regions of the myocardium may suffer from reduced blood flow 
when the occluded artery remains blocked [Germain, 2001], and a recent study has demonstrated 
intracoronary injection is associated with reduced blood flow following the treatment 
[Gyöngyösi, 2010]. The primary advantage of intramyocardial injection is the ability to localize 
the treatment directly to the fibrotic region. Cells injected in this manner often improve cardiac 
function through formation of new vasculature [Hu, 2008], and have even been associated with 
reduction of arrhythmias [Wang, 2010]. Using a rat model of IDC, it was found that 
intramyocardially injected MSC induced angiogenesis and myogenesis through direct 
differentiation into both vascular-associated cells and cardiomyocytes, as well as through the 
production of angiogenic, antiapoptotic, and mitogenic factors including VEGF, hepatocyte 
growth factor, adrenomedullin, and IGF-1 [Nagaya, 2005]. 
 In addition to direct MSC injection, other methods of cell delivery to the heart have been 
investigated.  For example, monolayers of cultured MSC without exogenous matrix support have 
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been grafted onto the surface of scar tissue in the myocardium [Miyahara, 2006].  The cells 
produced significant amounts of extracellular matrix components while in culture, and the 
implanted cell sheet produced a substantial amount of new tissue with evidence of angiogenesis.  
It was hypothesized that a major benefit of this extra tissue was to decrease overall wall stress on 
the damaged myocardium, but in other respects the monolayer technique produced similar 
effects as an injection method used for a similar injury model [Perin, 2003].  Both studies 
suggested that paracrine effects of the implanted MSC outweighed the benefit of direct 
differentiation into cardiomyocytes. 
 The concept of a cardiac patch seeded with MSC applied directly to the epicardium also has 
shown promise.  The principle behind this technique is to deliver cells while they are seeded into 
the type of matrix they will encounter in the native environment of the heart. For example, a 
study using a Type I collagen patch populated with MSC found a significant improvement in 
heart function in rat infarction models [Simpson, 2007] without signs of rejection.  However, the 
authors did not find any significant improvement in wall thinning.  Another study used a 
polyethylene glycol-modified fibrin, a degradable material that allows the gradual release of 
MSC into the affected area [Zhang, 2008].  Using a murine post-infarct model, this patch was 
able to significantly improve the hemodynamic function of the heart, especially ejection fraction.  
A recent study used a portion of decellularized swine myocardium as a scaffold for a cellular 
patch seeded with bone marrow mononuclear cells [Wang, 2010]. Such patches attempt to 
reconstitute certain key aspects of the extracellular environment, but the effects of mechanical 
stresses on such materials have not been fully investigated. Moreover, how a patch would change 
electrical conduction and potentially contribute to arrhythmias are issues that must be addressed. 
2.2 Introduction to the fibrotic myocardium  
12 
 
Fibroblasts in the myocardium are similar in structure and function to fibroblasts in other 
parts of the body; they produce vital components of the extracellular matrix, and by doing so 
maintain tissue structure and integrity. These cells also are able to take on a contractile, smooth 
muscle-like phenotype. In the adult heart, this transition occurs primarily during pathology and 
often facilitates the progression to heart failure. In a healthy adult myocardium, the ratio of 
myofibroblasts to fibroblasts is very low. Nonetheless, the distinction between these two 
phenotypes is not entirely clear.  Though increased extracellular matrix (ECM) production and 
expression of smooth muscle alpha-actin are often utilized as markers of the transition (Figure 
1), cardiac fibroblast phenotype comprises a continuous spectrum of states. Myofibroblasts 
exhibit a hybrid of smooth muscle cell and fibroblast properties, rather than being a completely 
distinguishable cell type. Studies have shown that both mechanical and biochemical stimuli can 
influence the location of the cell in this spectrum, and the pathways by which these cells 
transduce mechanical signals into biological changes have been extensively studied. 
 
 
 
 
 
 
 
 
 
Figure 2.1 - Fibroblast activation in the myocardium: Fibroblasts transition to a 
myofibroblast phenotype and secrete a thick extracellular matrix and increase contractility. 
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 The presence of a fibrotic scar, characterized myofibroblasts and a thick extracellular 
matrix, can be identified through several means. Traditionally, biopsies of myocardial tissue 
were taken to determine the extent of fibrosis. In the past 10-15 years, non-invasive approaches 
have been developed and refined, including measuring the presence of pro-fibrotic peptides in 
blood serum. Markers for collagen I and III production and degradation have shown to be useful 
in this approach [Díez, 2000]. Gadolinium-enhanced magnetic resonance imaging (GE-MRI) 
also provides a non-invasive assessment of the presence of fibrosis in the myocardium [Walcher, 
2010]. Studies using this technique have correlated increased left atrial diameter and septum 
thickness with increased fibrosis [Prinz, 2011]. In patients suffering from dilated 
cardiomyopathy, the presence of fibrosis as quantified by GE-MRI correlated with decreased 
ejection fraction and increased deceleration time [Nanjo, 2009]. In a pig model of myocardial 
infarction, PET scans also revealed a decrease in ejection fraction and increases in both end-
systolic and end-diastolic LV volumes [Teramoto, 2011].  
 Multiple pathologies can stimulate the formation of fibrosis in the myocardium. Fibrosis 
can arise from an acute event like a myocardial infarction, as well as from chronic pathologies 
including hypertrophic and dilated cardiomyopathies and myocarditis arising from infectious or 
toxic causes. As mentioned, studies have shown evidence that fibrosis exists in both systolic and 
diastolic heart failure. The pathogenesis of cardiac fibrosis for many of these pathologies is not 
fully understood, and there is evidence that it can be quite complicated. For example, in a study 
focused on a hypertensive animal model, the development of fibrotic lesions appeared to occur in 
two distinct phases: the first phase is a generalized process that includes the septum, and the 
second phase limited to localized areas in the myocardium [Herrmann, 1995]. Another study 
suggested that aldosterone and mineralocorticoid receptor, important factors in metabolic 
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dysfunction including hypertension and obesity, can mediate the presence of cardiac fibrosis 
[Essick, 2011]. The ubiquity of fibrosis in all of these different pathologies provides motivation 
for studying the cellular and molecular mechanisms underlying scar formation and homeostasis. 
Studying cardiac fibroblasts in vitro provides a platform to elucidate these mechanisms, 
though their behavior in vitro can be quite different than in vivo, and depend upon culturing 
conditions. For example, cardiac fibroblasts isolated from tissue typically begin to spontaneously 
differentiate to a myofibroblast phenotype. Studies have shown that this transition may be related 
to increased activation of protein kinase A through the G protein coupled receptor – adenylyl 
cyclase – cAMP pathway [Swaney, 2005].  Moreover, fibroblasts appear to be sensitive to the 
concentration of serum used in the culture medium.  Serum deprivation has been shown to not 
only affect the expression of SMA [Swaney, 2005], but also the viability and ECM production of 
cardiac fibroblasts [Leicht, 2001; Leicht, 2003].  Another recent study observed that the response 
of cardiac fibroblasts to cyclic mechanical loading depended upon the serum concentration of the 
culture media [Butt, 1997].  The data indicated that the cell response to cyclic loading was 
negligible when cultured in 1% FBS, but became significant in the presence of 10% serum.  In 
this case, the cellular response was characterized by the amount of procollagen produced by the 
cells, as well as labeled thymidine incorporation as a measure of cell proliferation [Butt, 1997].  
As these results indicate, understanding the relationship between mechanical transduction 
and the action of biochemical factors is vital to understanding the phenotype response of cardiac 
fibroblasts. Serum contains a host of growth factors that affect the cardiac fibroblast, so 
modifying serum concentrations does not indicate specifically what factors influence phenotype.  
Nonetheless, other studies have investigated how several growth factors, especially those 
associated with fibrosis, affect the response of cardiac fibroblasts to mechanical loading.  For 
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example, angiotensin II is an important peptide in heart disease, since elevated levels are 
associated with fibrosis and heart failure [Fujita, 2008; Olson, 2008; Kawano, 2000; Thibault, 
2001].  Studies have shown that not only are angiotensin II and other components of the RAAS  
system present in the myocardium, but also that static 20% strain initially reduces the expression 
of angiotensinogen, a key RAS substrate [Lal, 2008].  Hence, these results indicate that static 
stretch diminishes the presence of the myofibroblast phenotype, since angiotensin II is an 
important factor in this fibroblast myofibroblast transition.  Moreover, it provides a clear 
example by which mechanical stimuli influences the biochemical environment.  
Another important biochemical factor that affects the phenotype of cardiac fibroblasts is 
the oxygen concentration of the environment surrounding the cells.  The change in oxygen 
concentration has been speculated as the impetus for the transition from fibroblasts to 
myofibroblasts in culture, since oxygen concentrations in surrounding tissue (~14%) are 
significantly less than the atmospheric conditions encountered once isolated (~21%).  Moreover, 
hypoxic conditions can reduce oxygen concentrations to as low as 3% [Roy, 2003].  Cardiac 
fibroblasts respond to surrounding hyperoxic conditions through a specific signaling pathway 
involving induced p21, cyclin D1, cyclin D2, cyclin G1, Fos-related antigen-2, and TGF-beta 
[Roy, 2003].  This finding is non-intuitive because it indicates the myofibroblast transition is 
initiated by both hypoxia and hyperoxia.  The authors of this study speculate that cardiac 
fibroblasts are able to reset their normoxic oxygen concentration to much lower levels in hypoxic 
conditions, so that a return to the 14% concentration is sensed not as a return to normoxia, but 
rather a hyperoxic condition.  Hence, as the heart is reperfused, this triggers the myofibroblast 
transition. Further research by the group indicated that blocking this p21 associated pathway 
attenuates the expression of SMA, effectively maintaining a fibroblast phenotype even in the 
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presence of hyperoxic conditions [Roy, 2007].  Others have postulated that reactive oxygen 
species also play a central role in producing the myofibroblast phenotype.  There is evidence that 
NADPH oxidase 4 is significantly upregulated in cardiac fibroblasts stimulated with TGF-beta, a 
growth factor known for its pro-fibrotic properties.  Using si-RNA, the results suggest that 
production of reactive oxygen species by NADPH oxidase 4 is required for the fibroblast to 
myofibroblast transition [Cucoranu, 2005].    
The importance of TGF-beta in the production of fibrosis in the heart as well as other 
tissues has been well documented; the following references [Brown, 2002; Liu, 2003; Wipff, 
2007; Merryman, 2007] provide a cursory snapshot of the many studies conducted on this topic.  
In general, the growth factor works in various tissues to increase matrix production, stimulate the 
proliferation of myofibroblasts, and initiate other processes associated with fibrosis.  Cardiac 
fibroblasts stimulated by TGF-beta have been shown to augment contraction of the gels 
compared to controls, with and without the presence of cardiotrophin-1 [Drobic, 2007].  This 
response is consistent with the ability of TGF-beta to promote the contractile myofibroblast 
phenotype, and shows that the effect of the growth factor is resilient to the presence of opposing 
factors.  The augmented gel contraction has been repeated in another study, which showed that 
the extent of contraction was TGF-beta dose-dependent [Lijnen, 2003].  This study also showed 
that TGF-beta stimulated an increase in protein production by the cells, while the DNA content 
of cells was unchanged by TGF-beta [Lijnen, 2003]. However, another study utilized TUNEL 
staining to show that myofibroblasts stimulated by TGF-beta have increased DNA fragmentation 
and an inhibition of telomerase activity that halts cell proliferation, though the cells are non-
apoptotic [Petrov, 2008].  Moreover, the effect of TGF-beta has shown crosstalk with the 
response of cells to angiotensin II [Chen, 2004].  Hence, the biochemical environment that 
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stimulates the transition from fibroblasts to myofibroblasts is complex - relying on multiple, 
related factors in addition to mechanical stimuli.  These effects must be understood in order to 
evaluate the cell‘s response to mechanical loading. 
 An important component of both the biochemical and mechanical environments in tissue 
is the extracellular matrix (ECM), which also directly affects the fibroblast/myofibroblast 
phenotype.  Studies have shown that specific elements of the ECM facilitate a transition to 
myofibroblasts.  Though complex, the orientation of cardiac fibroblasts in the surrounding ECM 
is ordered and well-defined [Goldsmith, 2004].  The interaction between fibroblasts and the 
surrounding ECM is potentially as important as the relationship between fibroblasts and 
myocytes [Banerjee, 2006].  A study by Naugle et al showed that one component of the ECM, 
collagen type VI, is over-expressed in vivo after myocardial infarction.  This protein attenuated 
cell proliferation in the presence of angiotensin II compared to collagens type I and III [Naugle, 
2006].  The authors hypothesized that collagen VI produced this effect by stimulating a transition 
of fibroblasts to myofibroblasts, which are relatively non-proliferative.  Not only does the matrix 
environment affect the cell biology, but the inverse is also true.  Increased matrix production by 
the myofibroblast phenotype alters the structural and mechanical properties of the matrix.  A 
recent study found that not only is the quantity of matrix production augmented in hypertensive 
heart failure, but the quality of this production is also affected.  An imbalance in matrix 
metalloproteinases and tissue inhibitors of these enzymes were found in these tissues, indicating 
that pathology alters the pattern of collagen deposition [Lopez, 2006]. 
 Several in vivo studies utilizing animal models have been conducted to further investigate 
the cardiac fibroblast to myofibroblast transition.  As will be discussed in the following chapter, 
the mechanical environment in the heart is complex and varies both spatially and temporally. 
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Thus, although in vitro studies provide insight into the effects of specific stimuli on cell function, 
they cannot fully mimic the in vivo microenvironment as effectively as an animal model. One 
study in particular combined both in vivo and in vitro approaches. To assess the cell behavior of 
the myofibroblast phenotype, cells were isolated from pig models of left ventricular failure and 
cultured to assess their adhesion, migration, and release of fibrillar collagens and matrix 
metalloproteinase-2 [Flack, 2006]. Results of multiple animal studies have given insight into the 
mechanisms underlying the myofibroblast transition through knockout and transgenic models. 
For example, a tumor necrosis factor-alpha (TNF-α) null mouse model presented reduced cardiac 
fibrosis in a pressure overload model [Sun, 2007], indicating the role of this cytokine in the 
fibrotic response. The role of TGF-β has also been confirmed with an animal model; a transgenic 
mouse overexpressing the growth factor responded differently to β-adrenergic signaling 
[Rosenkranz, 2002]. These studies are just a select few examples of animal models that provide 
insight into the fibroblast to myofibroblast transition. 
2.3 The mechanical microenvironment of the myocardium 
 In order to understand the role of mechanics in the myofibroblast transition, it is necessary to 
first characterize the mechanical environment in the in vivo myocardium, and how these 
mechanics are affected by fibrosis. Despite the health of the myocardium, cardiac fibroblasts are 
exposed to a complex mechanical environment that includes tensile, compressive, and shear 
stresses. These stresses are exerted by the contraction of surrounding cardiomyocytes, interaction 
with the microstructure of the extracellular environment, as well as interstitial fluid flow from 
perfusing vasculature.  Due to the anisotropy and dynamic nature of the heart, these stresses vary 
both spatially and temporally, and are coupled with one another. Due to the complexity of the 
mechanical milieu in the heart, computational and analytical modeling is an important tool in 
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studying both the cell and tissue behavior of the myocardium. Experimental approaches to 
measuring strains in the heart have also been developed [LeGrice, 1995], though such 
experiments are technically challenging. 
 Nonetheless, a substantial amount of work has studied the complex structure of the 
myocardium, which is one of the primary determinants of the stress state.   The structure of 
mammalian heart tissue is largely anisotropic, yet highly ordered.  The wall consists of repeating 
laminar sheets, each approximately four myocytes thick [LeGrice, 1995]. The myocytes within 
each lamina are connected through intercalated disks, which contain both gap junctions and 
desmosomes to link adjacent cells electrically and mechanically.  These branching muscle fibers 
are surrounded by fibrillar extracellular matrix proteins like collagen I and III, as well as 
fibroblasts and the endothelial cells of capillaries.  The myocytes branch between lamina, but 
these connections are less frequent.  This affects the mechanics of the heart in addition to how 
the wall is electrically depolarized.  The existence of discrete lamina causes significant shear to 
adjacent layers, and causes the conduction velocity to be two to three greater along the plane of 
the lamina compared to the transverse plane [LeGrice, 1995]. Collagen fibers also connect 
adjacent layers, though these fibers are often thin and uncoiled, allowing for shear strain 
[Harrington, 2005; Arts, 2001].   
  The overall architecture of the lamina is also ordered. The myocardium exhibits subtle 
differences between fiber orientation within the sheets and the orientation of the sheets 
themselves with respect to an orthogonal coordinate system. Fiber angles vary from –60 degrees 
at the endocardium to +60 degrees at the epicardium, creating a helical pattern to the radial 
direction of the wall [Harrington, 2005]. However, the sheet angles of the lamina are restricted to 
either -45 or +45 degrees, and alternate depending upon the location of the sheet in the 
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myocardium [Harrington, 2005].  Because the sheet orientations are alternating, the lamina slide 
along one another in different directions even though the magnitude of the shear deformation is 
uniform across the wall. This leads to thickening of the wall in systole. Interestingly, research 
has indicated the orientation of these sheets aligns with planes of maximum shear strain [Arts, 
2001]. During systole the healthy heart produces ejection fractions of 60-70%, which is 
accompanied by radial thickening of the heart wall of around 40%. However, the maximum 
contraction of an individual myocyte is limited to approximately 15% [Harrington, 2005].  
Unfortunately, there has not yet been a study to determine the approximate strain on a cardiac 
fibroblast. The discrepancy in dimensional changes is thought to be a result of the shear exerted 
by slip between lamina in the myocardium, which contributes the orientation of the cells within 
the sheets. 
 Fibroblasts in the myocardium are also exposed to substantial fluid stresses from interstitial 
fluid flow [Lorenzen-Schmidt, 2006; Dvir Tal, 2007; Sinay, 1989; Ashikaga, 2008]. Because of 
the large deformation of the heart wall during the cardiac cycle, the interstitial fluid undergoes 
substantial flux and consequently exerts a pressure and shear force on cells within the 
myocardium. The fluid balance within the myocardium is controlled by the perfusion of the 
coronary artery and corresponding microcirculation as well as by lymphatic drainage that 
transports the products of cell metabolism [Mehlhom, 2001]. The factors that control fluid 
balance are strongly dependent on one another. For example, the pressure of the interstitial fluid 
is a regulator of the rate of perfusion.  This effect is manifested during systole, when perfusion in 
the coronary capillaries is impeded due to the high pressure existing in the contracting 
myocardium.  In addition, the myocardium separates two different bodies of fluid:  the 
endocardium surrounds the blood-filled lumen, and the pericardial fluid surrounds the 
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epicardium.  Consequently, there is a pressure gradient in the radial direction of the myocardium 
that may influence interstitial fluid flow [Lee, 2004]. 
 The cardiac mechanical environment is strongly affected by, and may be contributing factor 
to, the damaging effects of various pathologies.  Many of the pathologies affecting the heart, 
including acute infarction, dilated cardiomyopathy, and others are associated with changes in the 
extracellular matrix. These conditions affect the interaction between the sheets of 
cardiomyocytes and consequently the stresses exerted on resident cells like fibroblasts.  In the 
case of acute myocardial infarction, the heart progresses through ischemic, necrotic, fibrotic, and 
remodeling phases that are each characterized by different mechanical properties [Holmes, 
2005].  The necrotic phase is characterized by edema, which affects transport of the interstitial 
fluid within the myocardium.  During the fibrotic phase, the mechanics are influenced by excess 
collagen, the cross-linking of which changes the mechanical environment during remodeling 
[Holmes, 2005]. In a canine model of infarction, researchers found that the twisting motion of 
the heart during systole was significantly reduced by fibrosis, indicating a substantial change in 
cardiac mechanics [Wang, 2009].  Other studies have found that the wall stress increases with 
the size of a remodeling left ventricle, indicating that excess collagen increases the stress on cells 
in the myocardium [Aikawa, 2001]. The studies in the present dissertation determine the extent 
to which cardiac fibroblasts respond to mechanical stress, in order to ascertain whether the 
changes in the mechanical microenvironment during pathology affect fibroblast phenotype.  
 Recent studies have focused on computational modeling of the mechanical environment 
experienced by cells in the myocardial wall.  However, similarly to the experimental approach, 
modeling is made difficult by the complex microstructure of the tissue.  Hence, validation of 
these computational models is also a substantial obstacle, though some empirical data is 
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available [Arts, 2001].  Moreover, the tissue undergoes finite, time-dependent deformation that 
depends upon interaction between the fluid mechanics of blood in the lumen as well as 
interstitial flow within the tissue and the structural mechanics of the heart wall.  Nonetheless, 
useful models have been constructed for elucidating the stresses applied to cells in the heart wall.  
For example, one recent model utilizes an arbitrary Lagrangian-Eulerian reference frame to 
model the fluid-structure interaction present in the heart.  Using finite element analysis, this 
study estimated the stress in the left ventricle wall, and confirmed the thickening of the wall 
during systole [Watanabe, 2004].  In another study, a model was created to predict the planes of 
maximum shear strain in the heart lamina [LeGrice, 1995].  Although complex, such modeling is 
necessary to complement empirical studies to discern the exact mechanical environment 
surrounding cardiac fibroblasts in the heart, and how these mechanics change with pathology. 
2.4 Fibroblast response to mechanical stress 
As with many biological systems, a feedback loop exists in the cardiac fibroblast 
response to loading.  Mechanical stress affects the cell phenotype, which in turn alters the 
surrounding ECM, modifying the applied mechanical stress. This feedback is amplified in 
pathologies like fibrosis; a pathological stimulus causes fibroblasts to transition to 
myofibroblasts, these cells deposit greater amounts of ECM, and the ECM enlarges and stiffens.  
This change in the ECM further increases the stresses exerted on the cells. Understanding how 
cardiac fibroblasts respond to loading can affect the development of treatments for these 
diseases. Furthermore, understanding how to prevent this positive feedback can enable 
physicians to impede or prevent heart failure.  This section will address key results from these 
recent studies which involve in vitro mechanical testing of isolated cardiac fibroblasts, with an 
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emphasis on studies that elucidate how cardiac fibroblasts respond to stress, and how these 
responses are relevant for the treatment of cardiac pathologies. 
Early studies on the mechanobiology of cardiac fibroblasts utilized various flexure units 
able to apply axial or biaxial strain to cells attached to a 2D substrate.  One such study applied 10 
and 20% static strain to cardiac fibroblasts isolated from adult rats, which were cultured in 10% 
serum media.  The cells were plated on a 2D silicone substrate coated with fibronectin.  2D 
biaxial strain of these substrates was associated with early activation of G proteins in the cardiac 
fibroblasts, and the rate of activation was dependent upon the strain rate utilized to stimulate the 
sample [Gudi, 1998]. Although this result does not point to a specific signaling pathway, it 
demonstrates the ability of the cardiac fibroblasts to transduce mechanical stimuli into specific 
biological responses.  In a related study using similar mechanical stimulation, the authors found 
that static, biaxial strain increased levels of TGF-beta produced by the cells [Lee, 1999], 
suggesting a shift toward the myofibroblast state.  Other modes of 2D stimulation have been 
used, including magnetic beads coated with collagen to apply static stresses of 0.65 pN/µm2 to 
determine α-SMA expression [Wang, 2000]. Studies have indicated that static and cyclic strain 
produce different responses. For example, cyclic stress produced significant amounts of IGF-1, 
another pro-fibrotic growth factor, while static stress did not have this effect on cultured cardiac 
fibroblasts [Hu, 2007].Several recent studies have investigated the effect of ECM composition on 
the cellular response of cardiac fibroblasts to mechanical loading. For example, one study 
applied 2D static strain to cardiac fibroblasts isolated from neonatal rats and cultured in 15% 
serum on laminin substrates, and found that cytoskeletal arrangement was significantly affected 
[Fuseler, 2007].  In a related study, mechanical stretch increased activation of MAP kinase when 
cells were plated on collagen and fibronectin compared to cells plated on aligned collagen and 
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laminin [Atance, 2004].  The results also indicated a difference in collagen type I deposition 
depending on the ECM component utilized.  Although the authors of the study did not directly 
evaluate whether the static stretch promoted a transition to myofibroblasts, they did find that 
strain reduced proliferation rates, a characteristic of myofibroblasts.  These results underscore the 
importance of the ECM on cardiac fibroblast response to mechanical loading, and vice versa. For 
example, a recent study showed that cyclic loading affected the type of ECM produced by the 
cells. 2D cyclic strain was applied to cardiac fibroblasts isolated from adult rats cultured in 
varying serum conditions. The authors found that both serum concentration and magnitude of 
strain affected the amount of collagen type I and III expressed by the cells [Husse, 2007]. 
Several studies have begun to focus on specific signaling pathways associated with 
cardiac fibroblast mechanotransduction.  In a study utilizing magnetic beads to apply strain to 
cells, authors investigated the role of a Rho-Rho kinase pathway in increasing expression of α-
SMA in stretched cardiac fibroblasts [Zhao, 2007].  Other studies have found that mechanical 
stretch is involved with specific changes in gene transcription, and activation of several protein 
kinases [Liang, 2000; Prante, 2007; Wang, 2005].  Moreover, other studies have elucidated the 
role of ion exchange and ion channels in the response of cardiac fibroblasts to mechanical 
loading [Raizman, 2007; Chilton, 2005].  This body of work contributes to our understanding of 
the specific mechanisms by which cardiac fibroblasts transduce mechanical stimuli into 
biological changes.  However, most of this work was performed in two-dimensional culture 
systems that do not fully recreate the three dimensional nature of the loading experienced by 
cells in vivo. 
Though fewer in number, there have been several studies focused on the effects of 3D 
mechanical loading on cardiac fibroblasts.  A study analyzing the response of cardiac fibroblasts 
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to static stretch in a 3D environment supported the results of earlier studies that found attenuated 
myofibroblast transition [Poobalarahi, 2006]. Static 3D stretch reverted myofibroblasts to 
fibroblasts, reducing the expression of SMA and attenuating collagen and fibronectin production, 
two hallmarks of the myofibroblast phenotype.  Hence, static strain is an example of a stimulus 
that is not affected by dimensionality. Other studies have examined how cardiac fibroblasts 
compact three-dimensional hydrogels, finding that the morphology of the cells depends on 
whether the gels are free to compact or restrained [Baxter, 2008].  Another method of recreating 
the 3D environment is to use trabecula isolated directly from heart tissue.  One study utilized this 
method and found that cyclic loading increased the size of the trabecula compared to control, 
which can be interpreted as a model of cardiac hypertrophy [Bupha-Intr, 2007].  However, the 
specific behavior of the fibroblasts in this testing setup is not clear. 
The majority of studies investigating cardiac fibroblast mechanobiology focus on normal 
stress, but shear stress is also a crucial component of the mechanical environment in the 
myocardium.  The lamina of the myocardium experience significant sliding, which generates 
shear stress on the cells contained within these layers.  Moreover, interstitial fluid flow also 
imparts shear stress on the cells in the myocardium. In conditions of ischemia following 
myocardial infarction, interstitial fluid flow in the scar environment is most likely substantially 
different than healthy myocardium, though this change has never been quantified. Shear stress 
has been shown to affect fibroblasts isolated from skin [Ahamed, 2008] through the release of 
TGF-beta.  While there is not a similar study published using cardiac fibroblasts, bioreactors 
have begun to provide a platform for studying the effects of perfusion on tissue engineered 
cardiac constructs [Brown, 2008].  To address this gap in mechanobiology knowledge, studies in 
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this dissertation characterize the influence of fluid flow on fibroblast differentiation in a 3D 
environment.   
 
2.5 Mesenchymal stem cell response to mechanical stress 
For the purposes of cell therapy, it is also necessary to understand how mesenchymal 
stem cells respond to the mechanics of the healthy and fibrotic myocardium. However, the 
question of how MSC will respond to the mechanical environment when implanted into the 
myocardium depends strongly on the mode, location, and timing of delivery, as well as on the 
pathology being treated.  Because of the complexity of the in vivo environment of the heart, most 
studies of mechanical stimulation of MSC to date have relied on in vitro culture models, which 
provide a more controllable setting for studying specific stimuli. Nonetheless, valuable and 
insightful information can be obtained by studying the effects of specific loading modes on MSC 
phenotype. The effects that have been studied include changes in cell phenotype and 
proliferation, as well as the secretion of antiapoptotic, angiogenic, mitogenic, and other factors. 
As mentioned, the current consensus is that MSC secrete paracrine factors once implanted in the 
myocardium. By understanding how the mechanics of the environment affect this paracrine 
release, the variables involved with MSC injection (location, timing, etc) can be optimized. 
Similar to cardiac fibroblasts, two-dimensional culture of MSC on deformable substrates 
has provided insight into how these cells are affected by mechanical signals.  Cyclic tension has 
been found to have a strong effect on several aspects of MSC phenotype.  Exposure to 10% 
cyclical, uniaxial tension at 1 Hz for 7 days causes the actin cytoskeleton of bone marrow 
progenitor cells to align, impedes proliferation, and increases expression of α-SMA and calponin 
[Hamilton, 2004]. These results suggest differentiation into a smooth muscle cell (SMC) 
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phenotype rather than a cardiomyocyte lineage.  Such experiments have been repeated on both 
collagen and elastin substrates, and it was shown that exposure of MSC to two-dimensional 
uniaxial strain increases the production of α-SMA and other SMC-type markers [Park, 2004]. In 
another study, equibiaxial strain caused an increase in proliferation of MSC [Song, 2007].  These 
varying responses suggest that MSC phenotype is dependent upon the type of mechanical 
loading. The observed differentiation toward the SMC phenotype in a subset of these studies 
suggest that the primary benefit of implanted MSC may be formation of new vasculature, as 
confirmed by multiple in vivo studies.  
Three-dimensional cultures of MSC embedded in protein matrices also have been used to 
study mechanical effects on cell phenotype.  In particular, MSC embedded in 3D collagen Type I 
matrices have been subjected to both uniaxial or biaxial strains. One study found that MSCs 
formed multicellular units in response to cyclic strain [Doyle, 2009]. In another study, a 
construct seeded with MSC was exposed to either 10% or 12% strain at 1 Hz for four hours a day 
for a week and the cells produced significant levels of bone markers such as bone morphogenetic 
protein 2 [Sumanasinghe, 2006].  An osteogenic response was also observed in another study 
using a similar type of construct for a wider range of strain values [Farng, 2008], and also in a 
study in which MSC were seeded on a synthetic polymer scaffold and exposed to cyclic 
compression [Duty, 2007]. These studies did not assess markers of the cardiomyocyte or smooth 
muscle cell phenotype, but their results are aligned with the observed presence of bone markers 
in an in vivo study of implanted MSC [Breitbach, 2007]. These studies imply that 3D culture in 
collagen matrices under mechanical loading can promote osteogenic differentiation in MSC.  
However since the majority of in vivo studies indicate a beneficial effect, more research is 
needed to determine the difference in these 3D in vitro models and the in vivo myocardium.   
28 
 
The effect of fluid stresses on MSC in 3D environments has not been extensively studied, 
but is an important area of investigation if these cells are to be transplanted to the heart.  Studies 
of embryonic stem cells exposed to fluid shear showed that these cells differentiate to endothelial 
cell types, as evidenced by the expression of von Willebrand factor [Wang, 2005].  In a study 
focused on MSC, cells were plated on two-dimensional surfaces and exposed to pressure 
dominant, shear dominant, and combined constant, fluid stresses.  It was found that fluid shear 
and compressive stress individually and in combination led to the expression of smooth muscle 
cell-like markers, including α-SMA and smooth muscle myosin heavy chain [Kobayashi, 2004].  
This study did not examine the presence of any cardiac specific markers, though the resulting 
cell morphology resembled the smooth muscle phenotype. A recent study did analyze the effects 
of perfusion in a 3D scaffold, and found that flow affected MSC morphology and cell 
interactions [Zhao, 2009].  
The effects of combined fluid shear stress and cyclical tension on MSC phenotype also 
have been investigated.  In a study aimed at developing engineered heart valves using MSC 
seeded in a three-dimensional polymeric scaffold, it was found that cell response was dependent 
upon the type of loading:  flexure, fluid shear, or combined loading.  Under combined loading, 
MSC were responsible for a 75% increase in collagen deposition on the polymeric substrate.  
Moreover, the cells tested positive for such endothelial markers as CD31, laminin, and von 
Willebrand factor [Englemayr, 2006].  In another example of combined loading, MSCs were 
seeded on the lumen of a silicone tube and exposed to both 5% radial distention and a shear 
stress of 1 Pa at a frequency of 1 Hz.  The MSC on the silicone tubes aligned in the direction of 
the flow as endothelial cells would, though they expressed SMC markers including α-SMA and 
calponin [O‘Cearbhaill, 2008]. 
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The mechanical properties of individual MSC also have been examined.  Using a 
micropipette aspiration technique, it was found that these cells are inherently viscoelastic, and 
that the mechanical properties are strongly dependent upon the organization of the actin 
cytoskeleton.  These properties were fit to a linear viscoelasticity model of the cells, which can 
be used for future modeling studies [Tan, 2008].  The study, which used temperature to modulate 
cell mechanical properties, provides motivation to examine how the mechanics of the cells 
changes with other factors relevant to implantation into the myocardium.  For example, 
understanding how mechanics changes in the presence of different biochemicals as well as 
attenuated oxygen concentrations would be useful for cardiac applications.  Research has shown 
that MSCs exposed to hypoxic conditions have been more successful in implantation [Hu, 2011], 
but the mechanism behind this phenomenon is not clear.  The studies of the present dissertation 
test the relationship between oxygen concentration and cell mechanics to determine whether the 
success of cell transplantation is dependent on cell mechanics.  
2.6  Hypothesis and Specific Aims  
 This dissertation focuses on the effects of mechanics on cells within fibrotic tissue, 
specifically fibroblasts and MSCs injected into the myocardium for cell therapies. The overall 
motivation of this work is to understand both the cell response, as well as the mechanisms by 
which the cells respond, in order to direct treatment strategies for attenuating fibrotic scar growth 
and eventual heart failure.  
 There are two distinct hypotheses for this work. First, mechanical strain and interstitial 
flow modulate the myofibroblast transition through a mechanism involving TGF-β signaling. 
Second, the presence of MSC dictates the myofibroblast transition through release of 
cardioprotective and angiogenic paracrine factors. It has been clearly demonstrated that cells are 
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affected by mechanical stress, but the significance of the present work is determining the 
underlying mechanism of this response using a system able to apply both fluid and solid stress to 
the cells in a three-dimensional environment. Although the in vitro system used in this work does 
not fully mimic the in vivo scar microenvironment, it provides a platform to study cell responses 
to specific elements of exogenous mechanical and biochemical stimuli. By understanding the 
mechanism of this response, treatments can be designed to block or stimulate these molecular 
actions to inhibit excessive myofibroblast transition and stimulate MSC paracrine release. 
 
The specific aims are the following: 
 
SA1:  Characterize the response of cardiac fibroblasts to the stiffness environment of static 
collagen hydrogels, determining if the phenotype shift in 2D described in literature is repeated in 
3D.  
 
SA2: Design and construct an apparatus capable of simultaneously applying cyclic strain and 
interstitial fluid flow through the cell-seeded collagen hydrogel. 
 
SA3:  Identify the mechanisms responsible for the fibroblast response to the stimuli stated in 
SA2 using specific agonists and antagonists as well as lentivirally-delivered shRNA constructs. 
 
SA4: Supplement the experimental results with an analytical model to predict relative fluid 
velocities and pressures within the hydrogel during operation, in order to explain cell responses 
to applied mechanical loading. 
 
SA5:  Inject mesenchymal stem cells into mechanically stimulated cardiac fibroblast-seeded gels, 
and determine the response of both the mesenchymal stem cells using tests for stem markers, cell 
motility, and paracrine release as well as the fibroblasts, using immunofluorescence and 
quantitative RT-PCR. 
 
The results of these studies, which were performed in the order presented above, are summarized 
in the following chapters. Each subchapter in the Results and Discussion chapters are devoted to 
a specific aim. Chapter III details the materials and methods used for each of the studies, again in 
the order provided by the specific aims. Chapter IV presents and describes the results of these 
experiments, while Chapter V provides a discussion of how these results conform to the stated 
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hypothesis. The Appendices list specific protocols that can be used to repeat the experiments, a 
manuscript detailing a related project focusing on the adult cardiomyocyte response to stiffness, 
and detailed statistical analysis of the results. 
 A graphical description of the dissertation organization is provided below in Figure 2.2. 
The document begins with preliminary work to understand the effect of serum and stiffness on 
the transition of cardiac fibroblasts to a myofibroblast phenotype. After learning the correct 
culture conditions for stimulating the transition in static culture, the PDMS well was used to 
study the transition in dynamic, mechanically-stimulated culture. The poroelastic model provided 
insight into why cells responded differently to disparate modes of mechanical stimulation. 
Finally, MSCs were injected into the gel to study the effect of this coculture on the fibroblast 
transition. 
 
Figure 2.2 – Dissertation roadmap: The project is organized chronologically (from top to 
bottom) into the five specific aims previously described.  Specific aims 3 and 4 were investigated 
simultaneously. 
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Chapter III 
 
Materials and Methods 
 
3.1  Experimental Methods 
 
3.1.1 Cell Isolation and Culture 
 
 Cardiac fibroblasts were isolated from the ventricles of 2-3 day old Sprague-Dawley rats 
using a previously described enzymatic digestion protocol [Zlochiver, 2008]. This procedure is 
approved by the Institutional Animal Use and Care Committee at the University of Michigan and 
is in compliance with the Guide for the Care and Use of Laboratory Animals published by the 
National Institutes of Health. Briefly, minced ventricles were digested in 0.125% trypsin and 
0.15% pancreatin (Sigma-Aldrich, St. Louis, MO) at 37 °C in consecutive 15-minute steps. 
Fibroblasts were separated from myocytes in a pre-plating step. After one day of culture in M199 
supplemented with 10% FBS, fibroblasts were trypsinized and transferred and cultured in either 
low serum (5% FBS) or high serum (10% FBS) M199 or DMEM culture medium. Cells were 
cultured for one week with media changes every two days prior to use in experiments. The cells 
were then trypsinized and seeded in collagen constructs. For experiments involving both 
mechanical stimulation and MSC paracrine analysis, cells were cultured in 5% FBS. 
3.1.2 Fabrication of Collagen Hydrogels 
 Collagen hydrogels were created in different molds and volumes depending on the 
specific experiments. For example, to study the effect of substrate compliance on cardiac 
fibroblasts in culture, released and constrained collagen gels were prepared in 24-well plates. 
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Both acellular and cellular gels were prepared in PDMS molds for mechanical testing. 
Regardless of the application, the fabrication and formulation of these gels were kept constant. 
Cardiac fibroblasts were seeded at a concentration of 5 × 10
5
 cells/ml in a gel composed of 2.0 
mg/mL acid solubilized bovine collagen type I (MP Biomedicals, Solon, OH), 10 % FBS, 
DMEM, and 0.1 M NaOH at physiological pH. Gels were incubated at 37 °C in a humidified 5% 
CO2 incubator to initiate polymerization, before culture medium was added to the polymerized 
gels. 
3.1.3 Gel Compaction Assay 
 For the released and constrained gels, individual 1.0 ml gel aliquots seeded with cells 
were poured into a 24-well plate, and gels were cultured in either low or high serum. Released 
gels were removed from the sides and bottom of the well plate with a thin spatula at the end of 
the 1 h polymerization step. Culture dishes were incubated at 37
o
C in a humidified incubator 
with 5% CO2. Samples were taken at 6, 24, 48, and 120 hour time points. The gels for the 120 
hour time points were given new media at 48 hours.   To measure compaction, released gels were 
removed from their well plates at the prescribed time points, and transferred to a sterile platform. 
The cylindrical constructs and an adjacent optical scale were photographed from transverse and 
longitudinal angles. These images were imported into ImageJ software, where volume 
calculations were computed. The same gels used for the compaction assay were then 
homogenized for quantitation of message RNA levels by qRT-PCR . 
3.1.4 Mechanical testing of released collagen gels 
Released gels removed from the 24 well plate at the prescribed time points were 
transferred to a compression platen. A uniaxial mechanical testing system (Test Resources, 
Shakopee MN) was used to measure stress and strain at room temperature. All samples were pre-
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stressed to 10% strain at a rate of 30% strain/s and then relaxed prior to data acquisition. A strain 
rate of 30%/s to 30% strain was used to evaluate the static elastic properties of each gel. For the 
dynamic mechanical analysis, a 10% strain magnitude of 1.0 Hz frequency was used to 
determine the phase angle shift between applied strain and measured stress on the hydrogel. Data 
was then analyzed using MATLAB software to determine phase angles. 
3.1.5 Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) 
To isolate mRNA from the cells, a guanidium thiocyanate-phenol-chloroform extraction 
protocol (TRIzol, Invitrogen Inc.) was used. Briefly, 1 mL gels seeded with fibroblasts were 
homogenized in 200 μL of TRIzol, followed by the addition of another 800 μL of TRIzol to 
completely dissolve the constructs. mRNA was further purified with chloroform, precipitated 
and washed with isopropanol, washed with ethanol, and dissolved in RNAse free water. Reverse 
transcription of mRNA was carried out with a high-capacity cDNA Archive kit (Applied 
Biosystems, Foster City, CA) in combination with a C-1000 Thermocycler (Bio-Rad, Hercules, 
CA). Quantitative PCR was then performed using TaqMan gene expression assay kits (Applied 
Biosystems, Foster City CA), using two pre-designed primers (Table 1) and one probe each for 
collagen type I and III, TGF-β, and α-SMA, and the housekeeping gene GAPDH using a 7500 
Fast Sequence Detection system (Applied Biosystems, Foster City CA). Collagen type 1 and 
type III were targeted because they are the most prevalent extracellular matrix proteins in the 
myocardium [Baudino, 2006]. TGF-β is a known pro-fibrotic growth factor, and has been shown 
to mediate the transition to myofibroblast phenotype in response to interstitial flow [Ng, 2005]. 
α-SMA is a commonly used as a marker for the myofibroblast phenotype that plays a role in the 
contractile apparatus of cells. Data is expressed in fold change relative to GAPDH, and was 
calculated by taking the difference in cycles to threshold between the target gene and GAPDH 
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(ΔCT), subtracting the difference from the ΔCT of an initial data set to create a double 
normalization (ΔΔCT). The fold change was calculated from this parameter as FC = 2
-ΔΔCT
. 
Duplicates of each sample were analyzed. 
3.1.6 Immunocytochemistry 
A parallel group of released and constrained gels seeded with fibroblasts were analyzed 
to assess the transition to myofibroblasts by immunocytochemistry. These gels were fixed in 
3.7% paraformaldehyde (Sigma-Aldrich) for 10 min at room temp, washed with PBS, and 
permeabilized in 0.2% Triton X-100 (Sigma-Aldrich) for 10 min. Gels were then incubated in 
PBS containing 1% goat serum (Invitrogen, Carlsbad, CA) , fluorescent DAPI (1:50), phalloidin 
conjugated to Texas Red (Invitrogen; 1:50) and monoclonal anti- α-SMA conjugated with FITC 
(Sigma-Aldrich; 1:200) for one hour at 37 °C. The DAPI stained the nucleus of the cells and 
phalloidin targeted the F-actin of the cytoskeleton. Cells were visualized using confocal 
microscopy (Olympus America Inc., Center Valley PA). Projection image Z-stacks of 
approximately 30 microns were collected and used for analysis. To calculate circularity, ImageJ 
software was used to trace cell perimeter and calculate subsequent areas of at least 20 cells per 
time point. The following equation was used to determine circularity, so that the value is 
normalized to one: 
    (1) 
 To quantify the phosphorylation of smad2/3, a rabbit polyclonal antibody (#5678; Cell 
Signaling, Danvers, MA; 1:125) and secondary Texas Red-tagged goat anti-rabbit Ab were 
utilized to quantify smad2/3 phosphorylation. The intensity of the fluorescence within the 
nucleus of the cell (determined by DAPI staining) was normalized to the intensity within the 
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outline of the cell body (determined by phalloidin staining) for three cells from three images for 
each condition using the open source software, ImageJ. 
3.1.7 Fabrication and characterization of PDMS construct holder 
 The experimental apparatus consisted of a thick polydimethylsiloxane (PDMS) block in 
which two wells were created to hold 3D hydrogel constructs. A schematic of one of the wells is 
shown in Figure 3.1A. The dimensions of the PDMS substrate and construct wells are given in 
Figure 3.1B.  
 
 
 
 
Because of the elastomeric properties of PDMS, this substrate allows for the application of cyclic 
mechanical strain to the cell-seeded gels inside each of the wells. The wells were also fitted with 
inlet ports to allow fluid to pass through the constructs. The gap between the well inlet port and 
the cell-seeded construct was filled with an acellular collagen gel. The purpose of this layer was 
to allow lateral (z-x) distribution of the entering fluid before it entered the cell-seeded construct. 
Figure 3.1 - PDMS flow/strain wells: A) A layer of porous, acellular collagen allows for 
distribution of flow in the zx plane, prior to passing through the cell-seeded gel in the positive y 
direction. Cyclic tensile strain is applied in the z direction. (B) Schematic of wells (dimensions 
in mm) 
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The fabrication and characterization of the construct holder and collagen gel constructs are 
described in more detail in the paragraphs below.  
 The construct holder was made and prepared for use with collagen constructs by a multi-
step process shown schematically in Figure 3.2.  
 
Figure 3.2 - Fabrication and preparation of PDMS wells: A) Delrin mold is fused with two 
porous polyethylene blocks, and a non-stick coating is applied. B) PDMS mixture is poured into 
the primary mold, and enters the inlet molds due to surface tension. C) After baking at 150 C for 
10 minutes, the PDMS is removed from the mold.  Using dowels to seal the inlets, 10 M sulfuric 
acid is used to etch the PDMS for 90 minutes. D) After autoclaving to sterilize the etched PDMS, 
a 20 µg/mL collagen I solution is used to coat the surface. E) The PDMS is incubated at 4 C for 
4-5 days, and then a 300 μL, 2 mg/mL collagen hydrogel is added. F) Once the gel has solidified, 
a 700 μL cell-seeded collagen hydrogel is added and allowed to solidify. 
 
PDMS base and curing reagent (Sylgard 184 Silicone Elastomer Kit, Dow Corning, Midland MI) 
were combined in a 10:1 (wt/wt) ratio and were mixed thoroughly. The substrate mold was 
created using a primary Delrin template containing porous polyethylene blocks (Small Parts, 
Seattle, WA) to produce textured wells. The mold was sprayed with NoStick (Stoner, Quarryville 
PA) to facilitate removal of the formed substrate (Fig. 3.2A). Inlet molds were inserted to create 
the inlet port to each well and the PDMS mixture was poured into the mold (Fig. 3.2B). The 
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assembled and filled mold was baked at 150 °C for 10 minutes and the cured PDMS substrates 
were removed from the mold. The inlet ports were then sealed with dowels and each well was 
filled with 10 N sulfuric acid for 90 minutes in order to etch the silicone surface and promote 
protein attachment (Fig. 3.2C). The wells were then thoroughly rinsed in deionized water and 
sterilized by an autoclave. Each well was filled with a solution of 20 µg/mL collagen Type I 
dissolved in PBS and incubated at 4°C for four to five days to facilitate collagen deposition (Fig. 
3.2D). In preparation for experiments, the dilute collagen solution was removed from the wells 
and the acellular and cell-seeded collagen gels were fabricated in the wells.  
 In order to examine the effects of acid etching on the PDMS well surface, samples were 
analyzed by scanning electron microscopy. A control sample was taken directly after the curing 
process. Samples were also taken after the acid etching and after the collagen coating steps. All 
samples were sputter coated with platinum-gold, and images were collected at two 
magnifications on a scanning electron microscope (FEI Company, Hillsboro OR). For the 
acellular collagen sublayer, 300 μL of acellular gel was poured into the PDMS wells and allowed 
to gel at 37 °C in a humidified 5% CO2 incubator. After an hour of incubation, 700 µL of cellular 
gel was added on top of the set acellular gels, and again allowed to gel at 37 °C in a humidified 
5% CO2. Constructs in wells were kept in the incubator for 24 hours before permeability testing 
or flow visualization. 
3.1.8 Finite element modeling of PDMS well mechanics 
 COMSOL Multiphysics version 4.0 (COMSOL Inc., Burlington, MA) was used to 
construct a finite element model of the PDMS substrate under 5% normal strain in the z 
direction. The software was used to render the geometry of the 3D substrate and create a 
quadrilateral mesh. The mesh size was determined by increasing node resolution until the 
39 
 
computed strain distribution was unaffected by changing the resolution. The hydrogels were not 
included in the model because their elastic modulus is three orders of magnitude less than the 
PDMS [Schneider, 2009], and hence do not affect the mechanics of the PDMS. Because the gel 
was affixed to the PDMS, the strain calculated on the surfaces of the PDMS wells was assumed 
to be equal to the strain experienced by the gel. The PDMS was modeled assuming infinitesimal 
strains and isotropy, so the compliance tensor, C, in the stress-strain governing equation can be 
fully described by the elastic modulus and Poisson‘s ratio.  
        for i,j = 1,2,3   (2) 
where σ is the stress tensor, and u is the displacement tensor of the solid. The values of these 
parameters, E = 1.8 MPa and υ = 0.45, were taken from a previous study [Schneider, 2009].  
3.1.9 Application of strain and flow 
 The set-up used to apply interstitial flow and mechanical strain to 3D constructs is shown 
in Figure 3.3. As shown in the schematic in the inset, fluid flow was applied through the inlet 
ports of the PDMS wells while strain was applied by stretching the entire PDMS substrate. The 
whole system was maintained at 37 °C using an outer water bath. The PDMS substrate was held 
by nylon grips, one of which was affixed to the floorplate of the bath chamber, while the other 
was affixed to an axial mechanical actuator system and control software (Test Resources, 
Shakopee MN). Interstitial flow was supplied by a syringe pump (KD Scientific, Holliston MA) 
through tubes connected to the well inlet ports, which were fitted with pressure sensors 
(Freescale Semiconductor, Austin TX).  
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Figure 3.3-  Assembled flow/strain apparatus: A) Feed and return lines for 37 C water heated 
by a water bath (not pictured). B) Tubes connected to the double-barreled syringe pump that 
delivers flow. C) Outer chamber filled with 37 C water. D) Inner chamber filled with media 
containing HEPES buffer to maintain pH over long periods of time. E) PDMS wells held by 
nylon clamps. F) Pressure tap locations. 
 
This apparatus has the capability to apply strain and flow, either separately or in 
combination. For the experiments described here, the strain protocol was to apply 5 % cyclic 
strain at 1 Hz, while interstitial flow was applied at 10 μL/min. The strain was kept below 5% to 
maintain the infinitesimal strain assumption used in the finite element modeling. Strains greater 
than 15% caused failure in the PDMS substrate. Moreover, 10% strain applied at 1 Hz for two 
days caused detachment of the gel from the substrate. A magnitude of 5% was chosen to prevent 
detachment, and because prior studies demonstrated that 5% strain significantly affects the cell 
response of cardiac fibroblasts [Butt, 1997]. The flow rate was chosen to match previous 
interstitial flow studies [Chee Ping, 2003; Chee Ping, 2005]. 
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 All gels were cultured at 37C with 100% humidity and 5% CO2 for 24 hours prior to 
further testing. Gels digested after the 24 hour incubation served as initial controls, while the 
remaining gels were transferred to the testing apparatus or to an oxygen-controlled incubator set 
at 2.5% O2 for an additional 48 hours. Gels transferred to the bath but not exposed to any 
loading served as controls (denoted 48 h control). The remaining unloaded gels were transferred 
from the bath into the incubator for another 48 hours (denoted the 96 h control). The loading 
conditions included flow, strain, and a combination of strain and flow with and without inhibitors 
of angiotensin II type I receptor and TGF-β.   
3.1.10 Permeability Testing 
 The testing setup provided a straightforward method of measuring permeability, since the 
syringe pump delivered a constant and known flow rate (Q), the pressure sensors could measure 
the pressure upstream of the constructs, and the thickness of the gels could be measured visually. 
Assuming the downstream pressure was atmospheric and negligible pressure drop between the 
measuring point and the constructs (~10 cm), the sensors gave the total pressure drop across the 
constructs (dP/dx). Because the dimensions of the constructs were confined by the PDMS wells, 
the area (A) was also known. Hence, permeability could be calculated using Darcy‘s equation for 
porous flow: 
                   (3) 
Acellular and cellular gels were tested separately, and both were incubated for 24 hours prior to 
testing to allow for complete gelation and attachment to the PDMS substrate. The pressure 
measurements were made once a steady state was reached, which occurred after about two hours 
of fluid flow.   
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3.1.11 Flow Visualization 
 To assure the fluid flow distributed in the z-x plane in the acellular region before passing 
through the cell-seeded gel, photographic image-based flow visualization was used. Erioglaucine 
(792.85 g/mole, also known as brilliant blue FCF food coloring) was added to PBS in a 1:100 
ratio (v/v), and supplied through the well inlet ports at 10 μL/min. The gels were then imaged at 
intervals up to  ~80 minutes under both static conditions and while being exposed to a 5 % cyclic 
strain at 1 Hz. 
3.1.12 Assessment of cell viability 
 Cell viability was assessed using the Live/Dead® assay kit (Invitrogen, Carlsbad CA). 
The gels were removed from the PDMS substrates, and washed 3X with PBS. The gels were then 
incubated at 37 °C for one hour in a PBS solution containing both ethidium homodimer and 
calcein AM in concentrations recommended by the manufacturer (4 µM and 2 μM respectively).  
After incubation, the gels were again washed 3X in PBS and visualized with an Olympus 500 
confocal microscope at 10X magnification. Cell viability at the initial time point, as well as at 48 
hours and 72 hours under static, no-flow conditions served as controls. Viability also was 
assessed after exposure to 10 μL/min fluid flow, 5 % strain at 1 Hz, and combined flow and 
strain at these levels. 
3.1.13 Proliferation Assays  
 DNA quantity was assessed using a PicoGreen assay. Cell-seeded collagen gels were 
washed thoroughly with PBS, frozen at -80 C, then lyophilized overnight before being incubated 
in a proteinase K solution at 55 C for 12-16 hours. DNA quantity was normalized to the initial 
time points. 
 3.1.14 Immunoblotting   
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 Gels were homogenized in Garner buffer containing protease and phosphatase inhibitors 
(50mM Trizma base, 150 mM NaCl, 1 mM phenylmethanesulfonylfluoride, 1% Triton X-100, 1 
mM sodium orthovanadate, 10 mM sodium phosphate, 50 mM sodium fluoride, and ddH2O) for 
cellular protein separation.   Tubes were then boiled in a water bath for 3 minutes, sonicated for 
10 minutes, and centrifuged 3 times at 2000 g for 15 seconds, before quantifying protein with a 
BCA assay (Thermo-Fisher, Rockford, IL), and storing samples  at -20C until immunoblotting. 
For gels treated with control and AT1R lentivirus particles, trypsinized cells washed in PBS were 
lysed in ice-cold sample buffer (24.77% glycerol, 1.63% SDS, 0.1 M Trizma stacking buffer, 
3.31% Bromophenol Blue stock solution, 24.88 mM DTT, 1.78 mM leupeptin), and then stored 
at -20C.  
 In preparation for protein separation, samples were boiled for 3 min, sonicated for 10 
min, and then mixed with sample buffer in a 1:1 ratio.  Proteins were separated with 12% or 4-
12% gradient SDS-polyacrylimide 12 well gels (Bio-Rad), and then transferred onto a PVDF 
membrane overnight.  The PVDF membrane was then blocked in either 5% dry nonfat milk or 
BSA, washed in Tris buffered saline (TBS), and incubated overnight at 4
o
C with either a rabbit 
polyclonal antibody against phosphorylated smad2/3 (3101; Cell Signaling; 1:500), a rabbit 
polyclonal antibody against smad2/3 (3102; Cell Signaling; 1:500), or a rabbit polyclonal 
antibody against AT1R (sc-1173; Santa Cruz Biotech, Santa Cruz, CA; 1:200). The next day, 
blots were rinsed with TBS and incubated for 45 minutes at room temperature with HRP-linked 
anti-rabbit secondary antibodies (7404; Cell Signaling; 1:2000). Gels were silver stained and a 
representative protein band was used to normalize for protein loading on the blot for the AT1R 
knockdown verification. Immunodetection was visualized with chemiluminescence using Pierce 
ECL Western Blotting substrate (Thermo-Fisher). 
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3.1.15 Lentiviral knockdown   
 Cardiac fibroblasts isolated from neonatal rats were grown to 50% confluency in 100 mm 
diameter Petri dishes over 4-6 hours after plating, and yielded approximately 9000 cells/cm
2
. 
Lentiviral-mediated gene transfer was initiated by adding viral particles to M199 media 
containing 5 g/mL Polybrene (Santa Cruz Biotech) for 16-20 hours. Gene transfer with 
lentivirus utilized an MOI of 1 and included controls containing scrambled shRNA (sc-108080, 
Santa Cruz Biotech), and an experimental group with shRNA to disrupt AT1R production (sc-
155992-V, Santa Cruz Biotech). After viral transduction, cells were split and cultured in T75 
culture flasks. 24 hrs later, media was replaced with puromycin-containing media (2.5 g/mL) to 
deplete non-infected cardiac fibroblasts from the cultures.  After 48 hours in puromycin-
containing media, the cells were seeded into gels within a week after primary dissociation.   
Knockdown verification on immunoblots was completed using aliquots of lysed cells prior to 
initiating cell incorporation into hydrogels. 
 MSC were incubated for 2 hours after plating to ensure cell attachment. Lentiviral-
mediated gene transfer was initiated by adding viral particles to DMEM media containing 5 
g/mL Polybrene (Santa Cruz Biotech) for 14 hours. Viral particles were added at a density of 
4.44 k/cm2, resulting in an MOI of 1.33. After the viral incubation, the medium was replaced 
with fresh DMEM and the cells allowed to proliferate.  
3.1.16 Mesenchymal stem cell delivery 
A micromanipulator was used to assure that the cell injections were uniform in amount 
and location in the collagen hydrogels. MSC injection was performed 12 hours after 
polymerization of the collagen hydrogel. A 1 mL syringe equipped with a 1‖ 25 gauge needle 
was mounted on the manipulator at an angle of 30 degrees from the gel surface. The 3 axis 
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manipulator allowed for axial displacement control, so the needle tip penetrated 5 mm into the 
gel. A schematic of the dimensions of the injection is shown in Figure 3.4. Once the needle 
reached its desired position, 40 µL of 6.25 M/mL MSC solution was injected into each gel, 
resulting in the addition of 250,000 MSC. Gels were then incubated for one hour at 37 C before 
being returned to culture medium to allow for attachment of the stem cells. 
3.1.17 ELISA 
Quantikine ELISA assays purchased from R&D systems were used to quantify the 
presence of VEGF and IGF-1 in the supernatants from the coculture hydrogels. When being 
removed from the PDMS wells, the gels would leave 100-150 µL of supernatant. This solution 
was collected in polypropylene microtubes and stored at -20C for 1-2 months until ELISAs were 
performed. 
 
Figure 3.4 - Schematic of injection placement within the cell-seeded gel: A micromanipulator 
was used to ensure the injections were not variable with each test. The cells were injected at a 30 
degree angle from the gel surface. The dotted lines show where the gels were sectioned to 
analyze the fibroblast response. 
46 
 
 
3.1.18 Statistical Analysis 
Data are reported from sample sizes of 3-6 separate experiments. The error bars presented 
on the graphs represent one standard deviation. For comparisons of two groups, an unpaired 
Student‘s t-test was used to determine statistical significance with p < 0.05 considered 
significantly different. An analysis of variance (ANOVA) followed by Tukey‘s multiple 
comparison test (p<0.05) was used to compare multiple groups using the open source statistical 
package R (http://www.r-project.org/). 
3.2 Mathematical Model 
Note: The development of this model was carried out in collaboration with Dr. Ben Vaughan of 
the University of Cincinnatti. 
 As illustrated by Figure 3.1, the cell-seeded gel is molded above an acellular gel, and 
bounded on its side walls by the PDMS well. As described previously, the gels were exposed to 
three different modes of mechanical stimulation: 5% cyclic strain, 10 μL/min of cross flow, or a 
combination of strain and cross flow. Figure 3.5 illustrates these different modes, and a 
representation of the appropriate boundary conditions. 
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Figure 3.5 – Physical basis for poroelastic model boundary conditions: A) The gel was 
bounded on both sides by PDMS, open to atmosphere at the top boundary, and attached to the 
acellular region on the bottom boundary. B-C) Graphical representation of the boundary 
conditions for application of cross flow: a dotted line represents an open boundary, and a triangle 
denotes a boundary that is fixed in both the x and y directions. 
 
We model the gel as a Biot poroelastic medium (cite). The u p formulation is 
  (4) 
  (5)  
where  is the solid displacement, p  is the pressure, s  and  are the solid Lamé 
constants,  is the hydraulic conductivity, is the permeability, and f  is the fluid 
viscosity. Here, we have assumed that the solid matrix is intrinsically incompressible and the 
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fluid in infinitely incompressible. Using Darcy‘s law, we relate the relative fluid velocity, 
, to the pressure by the relation 
 . (6) 
The gel resides in a two-dimensional rectangular domain of length L and height H , where the 
wall at 0x is an oscillating wall with frequency  and amplitude A . Since we will examine 
two different domain configurations, we shall discuss boundary conditions specific to each 
configuration separately. 
Domain Configuration: 
In this configuration, we have two solid walls (one fixed and one oscillating) and two open 
boundaries to allow a crossflow due to a pressure gradient to occur (Figure 3.6).  
 
Figure 3.6 - Domain configuration and boundary conditions with crossflow: Shear stress at 
all the walls is set to zero, and the pressure gradient is fixed at boundaries with no flow. The 
value of P1 determines the presence of cross flow.  
 
Here, the components of the stress tensor are   
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  (7) 
  (8) 
  (9) 
If we assume the following scales 
  (10) 
we obtain the non-dimensional  equations 
  (11) 
  (12) 
along with the non-dimensional Darcy‘s law 
  (13) 
 
The dimensionless boundary conditions are now 
  (14) 
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We begin by removing the inhomogeneous pressure boundary conditions separating the 
crossflow solution from the oscillatory solutions: 
  (15) 
The crossflow solution does induce any deformation in the medium. We can now obtain the 
solution 
  (16) 
  (17) 
  (18) 
The relative fluid velocity, including the crossflow, is 
  (19) 
with no flow in the horizontal direction. The values input into the model are taken both from 
solid mechanics characterization of the hydrogels, including elastic modulus (15111 Pa) and 
Poisson‘s ratio (0.33). The permeability was calculated to be 1.43E-11m2 for cell-seeded gels, 
and the porosity was estimated to be 0.996, using an equation from [Ramanujan, 2002]. The 
pressure at the top boundary, P1, was assumed to be zero. The upstream pressure, P2, was 
calculated from the known volume flow rate of the syringe pump, the thickness and width of the 
gel, and the permeability of the gel: 77.6 Pa. The y component of fluid shear stress was 
calculated from the Tarbell equation [Wang, 1995]: 
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          (20) 
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Chapter IV 
 
Results 
 
4.1 Effect of serum and substrate compliance on the myofibroblast transition  
 3D Collagen Gel Compaction: Our studies demonstrated media, serum concentration, 
and cell density each significantly influence the ability of fibroblasts to transition to the 
myofibroblast phenotype. In our first experiments, these variables altered the ability of the 
hydrogels to produce the compaction of released 3D gel cultures over the course of 120 hrs in 
culture. Gel compaction, defined as ratio of measured gel volume to original volume at t = 0, is a 
measure of passive fibroblast contractility and compaction increases over time in culture when 
gels are seeded with fibroblasts. Significantly higher compaction is observed with low serum 
(5% FBS) compared to high serum (10% FBS) levels in culture media (Fig. 4.1A). The highest 
compaction rate occurred within 6 h after initiating the culture for both serum formulations and 
the lower serum media produced the highest level of compaction (to 9.5 % of original volume). 
These results were repeated for cells given DMEM media, though compaction was not as high as 
the M199 results (Fig. 4.1B). Moreover, the effect of serum was not as evident in the DMEM 
data set, as indicated by the lack of significance at the 120 hour time point. Increased fibroblast 
cell density also stimulated gel compaction when comparing gels seeded with 0.5-, 2.5- or 5- x 
10
5
 cells (Fig. 4.1C).  
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Figure 4.1 - Influence of serum concentration and cell density on compaction: A) Higher 
FBS concentrations in M199 attenuated the compaction for all time points. B) These results were 
repeated for DMEM media. C) Gels cultured with M199 + 10% FBS and seeded with different 
cell densities compared at three time points. Statistical comparisons were carried out using 
ANOVA and Tukey‘s multiple comparison test with p<0.05 (*) indicating significant 
differences. 
 
 Effect of Gel Constraint:  Released and constrained gels were compared to evaluate the 
influence of matrix stiffness on message and protein expression of collagen I and III, TFG-β, and 
α-SMA along with fibroblast morphology. Figures 4.2 and 4.3 compare gene expression and 
representative immunocytochemistry results from cardiac fibroblasts cultured in released versus 
M199 
DMEM 
Vfinal / Vinitial 
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constrained 3D collagen matrices for up to 48 h in M199 supplemented with 5 and 10% FBS. No 
significant difference in collagen I, collagen III, or TGF-β, or α-SMA gene expression was 
observed between released and constrained gels at 5% serum concentration (Fig. 4.2A). Released 
and constrained gels were then studied with the higher 10% FBS concentration to determine 
whether nutrient availability affected the effect of matrix stiffness on this transition. Though 
other message levels were again unaffected, expression of α-SMA was significantly higher in 
constrained matrices at the 6 and 24 h time points compared to released gels (Fig. 4.3A).  
 
 
Figure 4.2 - Message expression and cellular morphology in gels cultured in M199 with 5% 
FBS: A) message expression of col1a1, col3a1, TGF-β, and α-SMA in released (left panels) or 
constrained (right panels) fibroblast-seeded gels. B) merged images of constrained (left panel) 
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and released (right panel) collagen gels stained for DAPI (blue), actin (red), and α-SMA (green). 
C) quantification of the immunofluorescence images shown in Panel B, using a circularity 
parameter. 
 
 The increase in α-SMA message levels observed in response to this increased matrix stiffness 
provided evidence that passive tension accelerates the transition of these cells to myofibroblasts. 
These finding suggests that lack of serum nutrients and increased matrix stiffness each modulate 
the expression of α-SMA in the myofibroblast transition, but their effects may not be additive. A 
similar association between constrained and released gel environments was noted when 
analyzing cell morphology. Morphological changes generally developed in concert with α-SMA 
expression, with α-SMA-positive cells displaying fewer and shorter processes and a more 
spherical morphology (Figs. 4.2B and 4.3B). In order to quantify this spherical morphology, 
ImageJ was used to calculate circularity of the cells. For cells exposed to 5% serum, there was no 
significant difference in circularity between released and constrained gels over the three time 
points (Fig. 4.2C). In contrast, cells cultured in 10% serum in released gels showed significantly 
less circularity for the first 24 h. The circularity results follow the message levels of α-SMA 
produced by cells in the constrained and released gels and indicate a more compact cellular 
morphology accompanies α-SMA expression and differentiation into the myofibroblast 
phenotype. 
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Figure 4.3 - Message expression and cellular morphology in gels cultured in M199 with 
10% FBS: A) cells cultured in M199 media containing 10% FBS showed significantly less α-
SMA expression for the first 24 hours when seeded into the released hydrogel compared to 
constrained gel. However, by 48 hours, the expression of the protein was statistically 
insignificant. B) merged images of constrained (left panel) and released (right panel) collagen 
gels stained for DAPI (blue), actin (red), and α-SMA (green). C) quantification of the 
immunofluorescence images shown in Panel B, using a circularity parameter. The significant 
differences in circularity at 6 and 24 h mirror the differences in message levels of α-SMA (Panel 
A). Results were compared using a Student‘s t-test p<0.05 (*) considered significantly different. 
 
 Effect of Serum Content: The above studies demonstrated an important role for serum in 
determining the functional phenotype. Thus, the influence of serum on expression of collagens I 
and III, TGF-β, and α-SMA was further analyzed in the released gels as a function of time. Cells 
cultured in 5% serum produced significant increases in gene expression of α-SMA within 6 h and 
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TGF-β at 24 h relative to cultures supplemented with 10% serum (Figs. 4.4C and 4.4D). There 
does not appear to be any significant effect of serum on these message levels beyond 24 h. 
Because matrix stiffness had little influence on collagen and TGF-β gene expression, this result 
suggests nutrient and mechanical stimuli may stimulate α-SMA expression and/or other upstream 
events in myofibroblast development via different pathways.     
 
 
Figure 4.4 – Message levels of cells seeded in released gels cultured in M199 with 5% and 
10% FBS:  A) Col1a1 expression significantly decreased, while B) col3a1 significantly 
increased over time, although there were no differences in response to FBS levels. C) For cells 
cultured in 5% FBS, significantly higher TGF-β expression occurred at the 24 hour point 
compared to other time points. A spike in TFG-β expression also was observed at 24 hrs with 
10% FBS, although this increase was significantly less than that observed with 5% FBS. D) A 
biphasic change in α-SMA expression was observed with both serum levels, with an initial 
decrease, followed by a return toward the 6 hr level after 24 hours. Significant differences were 
determined using ANOVA and p<0.05 (*) considered significantly different using a post-hoc 
Tukey multiple comparison tests. 
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 The results also provide evidence that expression of these key indicators mirrors the 
functional response, although the temporal response appears to be specific for each indicator 
(Fig. 4.4). For example, collagen I expression decreased significantly while collagen III 
expression steadily increased between 6 and 120 h for both serum concentrations (Figs. 4.4A and 
4.4B).  The level of TGF-β expression (Fig. 4.4C) also peaked at 24 h before declining to lower 
levels at the 48 and 120 h timepoints for both serum levels. Interestingly, a bimodal α-SMA 
expression profile develops for both serum concentrations, with the highest expression at 6 h, 
followed by a significant dip at 24 h and a secondary rise at 48 h and 120 h (Fig. 4.4D).  These 
transcript-specific patterns of expression provide additional evidence this differentiation process 
not only involves different pathways, but also utilizes complex spatial and temporal signaling 
events.  
 The general trends of this data were repeated in cell-seeded gels cultured in DMEM, as 
shown in Figure 4.5. The cells exhibited the same general trends in decreased collagen I 
expression, and increased collagen III expression (Fig. 4.5A,4.5B). For cells exposed to 5% FBS, 
the 24 hour time point had significantly higher expression of TGF-β than the 6 hour and 120 
hour time points (Fig. 4.5C). The α-SMA expression significantly decreased at the 24 hour time 
point, prior to significantly increasing by the 120 hour time point (Fig. 4.5D). Again, this 
expression pattern follows the stiffness of the released gels. Unlike the M199 data set, there were 
significant differences between the two serum levels in the α-SMA message levels for all but the 
24 hour time point, when levels were attenuated almost to zero. 
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Figure 4.5 – Message levels of cells seeded in released gels cultured in DMEM with 5% and 
10% FBS:  A-D) Message levels of col1a1, col3a1, TGF-β, and α-SMA followed the same 
patterns of cells cultured in M199 at the same serum levels. 
 
 Mechanical Properties of 3D Collagen Matrices: Serum influences on neonatal fibroblast 
cultures also influenced the bulk mechanical properties of released gels. Elastic modulus (Fig. 
4.6A) and phase loss angle (Fig. 4.6B) were measured at the initial (6 h) and final (120 h) time 
points in hydrogels seeded with neonatal fibroblasts and cultured in either 5 or 10% FBS. The 
elastic modulus increased significantly over time with both serum concentrations (Fig. 4.6), 
indicating that matrix stiffness increased as the neonatal cells differentiated over time.  
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Figure 4.6 - Elastic moduli and loss angle of released gels cultured in M199 + 10% FBS: A) 
Released gels were strained at high strain rates (30%/s) to determine the elastic moduli or B) 
cyclically compressed at 1 Hz to determine the loss angle of the samples. Results were compared 
using a Student‘s t-test p<0.05 (*) considered significantly different.  
 
The lower FBS concentration produced significantly less compliant gels at 6 h (Fig. 4.6A), but 
this serum-dependent difference in elastic modulus was abolished after 120 h in culture. 
Similarly, Figure 4.6B shows that the viscoelastic phase angle for gels cultured in low FBS was 
significantly lower than that for 10% FBS at the initial time point, but was not different at the 
later time point. The decrease in phase angle indicates the gel became stiffer over time, while 
also losing its viscous fluid properties and behaving more like an elastic solid. The differences in 
gel mechanical properties were largest at the early time point, which corresponds to the point 
where the differences in the degree of compaction also were greatest.   
4.2 Application of simultaneous cyclic strain and interstitial fluid flow 
Adhesion of collagen constructs to PDMS wells 
 In order to apply simultaneous cyclic strain and defined fluid flow through the construct, it is 
necessary that the collagen matrix remains firmly attached to the walls of the PDMS well to 
prevent fluid leakage around the edges of the gel. Cardiac fibroblasts seeded in a 3D collagen 
matrix will remodel and compact the collagen fibers [Poobalarahi, 2006] and in the presence of 
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uniaxial cyclic strain the cells will align the matrix in the direction of the strain [Voge, 2008]. 
These processes produce forces that can pull the collagen matrix away from the walls of the well, 
and therefore these cellular forces need to be overcome to maintain attachment of the gel to the 
PDMS. Acid etching of the PDMS and subsequent coating with dilute collagen was used to 
promote construct adherence to the wells. In the absence of any treatment, hydrogels detached 
from the PDMS after 4-6 hours. After etching the PDMS with 10 N sulfuric acid, gels stayed 
attached for 2-3 days. When additionally coated with 20 µg/mL collagen type I after etching, the 
3D gels remained attached to the PDMS for 14-18 days. To determine whether the etching 
produces surface changes to the PDMS that might be responsible for increased collagen 
adherence, scanning electron microscopy was used to analyze the microstructure of the surface. 
Figure 4.7 shows electron micrographs of untreated (Figs. 4.7A-B), acid etched (Figs. 4.7C-D), 
as well as etched and coated PDMS surfaces (Figs. 4.7E-F). Untreated surfaces were essentially 
smooth with <1 µm surface features. After 90 minutes of etching with sulfuric acid, the PDMS 
displayed clearly larger surface features, on the order of 10 µm. After collagen coating, the 
surface once again exhibited a smooth appearance, presumably due to filling of the features with 
collagen matrix. While acid etching produced a much rougher surface topography, it is not 
known whether it also changed the surface chemistry or charge. The rougher surface provided 
improved gel adhesion, but subsequent collagen coating clearly had the greatest positive effect 
on collagen gel adherence. 
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Figure 4.7 - SEM images of the PDMS surface: A-B) Control (after curing).  C-D)  After 90 
minutes of etching with 10 N sulfuric acid.  D-E) After 24 hours of incubation with collagen-
PBS solution following acid etch.  Scale bars for ACE = 20 µm, BDF = 10 µm. 
 
Finite Element Model 
 A global uniaxial strain of 5% was applied to the apparatus based on the initial PDMS 
substrate dimensions. We performed finite element modeling to better characterize the strain 
field and to determine the actual magnitude of strain on the constructs within each of the wells. 
The results of this modeling are shown in Figure 4.8, and show that there are regional variations 
in the applied strain. Figure 4.8B shows the z component of the strain tensor ( ) along a y-z 
slice through the midline of the deformed PDMS substrate. The model shows that the PDMS 
material separating the wells is essentially unstrained in the z-direction, while the floor surfaces 
of the wells exhibited axial strains of slightly greater than 5%. The strain distribution was 
relatively continuous on the surface of the well with the exception of the location of the fluid 
inlet. 
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 Due to the relatively high Poisson‘s ratio of the PDMS (υ=0.45), an axial strain of 5% in the 
z direction also produced deformation in the x and y directions. The bottom surfaces of the 
deformed wells are shown in Figure 6C-E, which show the x-, y-, and z-components of the strain 
tensor, i.e. ( ) respectively. The averages and standard deviations of the 
strain values for these surfaces were calculated for each well. The average strain in the x-
direction on the surface was -0.029 +/- 0.008 for both the wells, -0.018 +/- 0.009 for both wells 
in the y direction, and 0.065 +/- 0.014 for both wells in the z direction.  
 
Figure 4.8 - Finite element model of well deformation:  A) 3D finite element mesh that 
discretizes the geometry of the PDMS substrate, B) A y-z slice through the centerline of the 
substrate that shows a contour plot of the zz component of the strain tensor. C-E) A z-x slice 
through the substrate at the bottom surface of the wells showing contour plots of the xx (C), yy 
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(D), and zz (E) components of the strain tensor.  For all contour plots, the solid lines indicate the 
original, undeformed geometry of the substrate, and the x-y-z grid is shown in part B.   
 
Therefore while there was slight compression (2-3%) in the x and y directions, the tensile strain 
applied to the wells was approximately 6.5%. These results validate that the primary component 
of strain was in the z direction, though the magnitude was slightly greater than the global applied 
strain. The local variation in the strain field that was observed suggests that this model is not 
appropriate for microscale analysis of the effects of strain. However, it is appropriate for tissue-
level analysis since the wells experienced similar strains that were close to the applied strain 
magnitude. 
Permeability of unseeded and cell-seeded collagen gel 
 The layer of acellular collagen was used to achieve a uniform flow distribution prior to 
entering the fibroblast-seeded construct. For this approach to work, the acellular collagen layer 
must have significantly higher permeability than the cell-seeded construct, creating a higher 
pressure drop in the y-direction and resulting in preferential flow in the z-x plane. Once the 
pressure has built sufficiently in the acellular region, the fluid will then flow in the y direction 
across the cell-seeded gel, in spite of its lower permeability. Because of the simple geometry and 
known boundary conditions of the PDMS apparatus, it could be used to determine the 
permeability of collagen constructs. 
 Figure 4.9 shows the results of the permeability testing for both acellular and cell-seeded 
constructs under both static and strained conditions. Acellular gels exhibited approximately 4-
fold higher permeability than fibroblast-seeded gels. In previous published studies, the 
permeability values of acellular collagen gels at concentrations ranging from 10-30 mg/mL were 
determined [Ramanujan, 2002]. A curve fit of this data can be extrapolated to 2 mg/mL, resulting 
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in a permeability value of approximately 5.4×10
-11
 m
3
s/kg, which falls within the error of the 
present measurement of acellular gels. Cell-seeded gels exhibited lower permeabilities, around 
1.4×10
-11
 m
3
s/kg. Both types of gels were constrained and attached to the PDMS wells, so that 
gel compaction was prevented in the z-x plane, but not in the y direction. Therefore, compaction 
of the gels in this direction during the 24 hour incubation period could be the cause of the 
reduced permeability, since the thickness of the gels stayed constant after the 24 hour point. 
 
Figure 4.9 - Gel permeability measurements: Permeability was measured for both acellular and 
cell-seeded gels for both static and 5% tensile strained conditions. Error bars represent one 
standard deviation from the mean measurement. 
 
There was no significant difference in the permeability of static gels and strained gels, whether 
they were acellular or fibroblast-seeded. This measurement is important because it confirms that 
5% global stretch did not cause leakage of fluid around the constructs, which would have 
resulted in substantially increased fluid transport. These findings also have significance for 
computational modeling of the gel mechanics, since they indicate that permeability can be 
considered independent of strain for this type of construct.  A previous study analyzed 
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permeability of collagen constructs exposed to compressive strain in the same direction as the 
fluid flow, and showed permeability was affected by strain [Serpooshan, 2011]. The present 
result shows that 5% strain in the plane perpendicular to the direction of flow does not affect 
permeability. 
Flow distribution in acellular support gel 
 To directly test whether flow was uniformly distributed in the acellular region before passing 
through the cell-seeded gel, PBS containing blue dye was injected through the inlet of the 
construct wells under both static and cyclically strained conditions. Images were taken 
perpendicular to the z-x plane as the flow entered the PDMS wells and spread within the 
acellular region.  
 
Figure 4.10 - Flow visualization for a static gel: These images depict the xy plane of the 
layered acellular and cellular gels as 10 µL/min of colored PBS is injected into the PDMS wells. 
The blue dot near the center of the gel indicates the location of the fluid inlet. 
 
Figure 4.10 shows the time course of dye perfusion at a flow rate of 10 μL/min under static 
conditions. The dye perfuses evenly out of the inlet port and distributes within the acellular gel 
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over about 80 minutes.  It was evident that flow did not pass through the cell-seeded gel in the y 
direction until fully distributing in the z-x plane. Figure 4.11 shows similar image data for cyclic 
straining to 5 % at 1 Hz. In this case, the flow distributes uniformly in the x direction, however in 
the z direction the fluid initially flows preferentially in the direction of the applied strain. In 
order to quantify this effect, the position of the leading edge of the flow in the positive z 
direction was compared to the position of the edge in the negative z direction, using the inlet as 
the coordinate axis origin. Figure 4.12 shows the results of this analysis for both the static and 
strained gels. For the static gel, the ratio stays constant at approximately one, indicating uniform 
flow. For the strained gel, the flow is initially skewed in the positive z direction, though as time 
progresses and the acellular region fills, the ratio recovers to approximately one. This result 
indicates that although strain does affect the fluid flow profile, the flow first distributes in the z-x 
plane before passing through the cell-seeded construct for both static and strained conditions. 
 
Figure 4.11 - Flow distribution for a cyclically strained gel: The blue arrow indicates the 
direction of strain, and again the location of the fluid inlet is visible. 
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Figure 4.12 - Quantification of flow visualization: This plot indicates how the flow distribution 
in the cycling gel is skewed in the direction of strain (positive z direction) compared to the 
distribution in a static gel. 
 
Cell viability in constructs under strain and flow 
 In order for the apparatus to be useful for studying cell responses to strain and flow stimuli, 
cell viability must be maintained in the 3D collagen construct. Figure 4.13 shows cell viability 
data for different time points, with and without strain and flow. At the 24 hour time point (Fig 
4.13A), immediately before constructs are mounted in the strain/flow apparatus, cell viability 
was high (above ~85 %). When constructs were maintained in the PDMS wells in the absence of 
flow and strain, viability remained very high at both the 72 hour (Fig. 4.13B) and the 120 hour 
(Fig. 4.13C) time points. After stimulation by either flow (Fig. 4.13D), or strain (Fig. 4.13E), or 
a combination of flow and strain (Fig. 4.13F) for 48 hours (i.e. 72 hours after initial creation of 
the construct), the viability in all constructs also remained very high (generally over 80-90 %). 
These data suggest that cells can be maintained in 3D collagen constructs in PDMS wells and 
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that application of flow and/or strain does not compromise cell viability. This result is important 
for the use of this flow-strain system for the examination of cell function in 3D hydrogels over 
time. 
 
Figure 4.13 - Cell viability for different testing configurations: Live cells enzymatically 
convert calcein AM to fluorescent calcein, while ethidium homodimer is able to penetrate the 
nuclei of dead cells and bind to nucleic acid, increasing its fluorescence emission by 40x. The 
images show a similar ratio of live to dead cells for all testing configurations and time points. All 
times are expressed in terms of hours after creation of the gels. All gels were incubated under 
static conditions for 24 hours, and then exposed to either fluid flow, strain, a combination of 
both, or static conditions (control). 
 
 Because the viability experiments lasted for two days, the pressure drop across the stacked 
gels provided insight into whether the permeability of the gels changed with time. The 
permeability of the acellular gel, without cells to remodel the matrix, was assumed to stay 
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constant. A change in permeability of the cellular gel would indicate remodeling of the matrix by 
the cells. However, over the two day testing period of the viability experiments, the pressure 
drop stayed constant once steady state was reached. 
4.3 Cardiac fibroblast response to cyclic strain and interstitial fluid flow 
The Effect of Mechanical Stimuli on Expression of Myofibroblast Markers 
  The present study demonstrates that mechanical stimuli modulate the fibroblast to 
myofibroblast transition, though the mechanisms involved result in distinct transduction of fluid-
induced and stretch-induced stresses. As showed in Figures 4.4-4.5, fibroblasts in collagen gels 
created in standard culture plates and cultured for 48 and 96 h transitioned to a myofibroblast 
phenotype, marked by significant elevations in the mRNA message levels for collagen type III 
and α-SMA, and a reduction in TGF- 1 expression. This baseline pattern was repeated in gels 
polymerized in the PDMS wells in the present study, as indicated in Figure 4.14. Note that the 
time points designated ―48 h‖ and ―96 h‖ are identical to the ―72 h‖ and ―120 h‖ time points in 
Figures 4.1-6. 
 
Figure 4.14 – Baseline trends in message levels: Message expression of the 48 h and 96 h 
control samples levels showing collagen type I (A), collagen type III (B), TGF-  (C), and -
SMA (D) after. Levels are normalized to initial (t=0) levels. A * designates significance from the 
initial time point, as determined by 2 sample t-tests. 
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Collagens type I and III serve as markers for matrix deposition in the myocardium, and α-SMA 
as a marker for the myofibroblast phenotype.  Therefore, polymerizing cardiac fibroblast-seeded 
collagen gels in PDMS wells did not alter the baseline shift to a myofibroblast phenotype.  
 mRNA expression of myofibroblast markers (collagen I and III, α-SMA, and TGF-β1) was 
measured and immunolocalization of α-SMA were performed in response to a 48 h exposure to 
combinations of interstitial flow and cyclic strain, as well as to a 2.5% oxygen environment.  As 
shown in Figure 4.15A, neither mechanical stimulation (by cyclic stretch or cross-flow) nor 
hypoxia significantly affected collagen type I message levels. However, cross flow significantly 
increased collagen type III levels over control levels, both in the presence and absence of cyclic 
strain, whereas cyclic strain alone did not significantly affect message levels (Fig. 4.15B). 
Similarly, cross flow both with and without cyclic strain prevented the drop in TGF-β1 
expression observed in the control samples and in cyclic strain conditions (Fig. 4.15C). 
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Figure 4.15 – Message level response to exogenous stimuli: Influence of hypoxia and 
mechanical stimuli produced by cross flow and cyclic strain on message levels of collagen type I 
(A), collagen type III (B), TGF-  (C), and -SMA (D) after 48 h of stimulation, indicating 
significant differences compared to initial control levels (*: p<0.05) and showing significant 
differences compared to 48 h controls (†; p<0.05). Relative quantity (RQ) is defined as 2-ΔΔCT, 
where CT is the cycles to threshold, double normalized to both GAPDH and the initial control 
levels. 
 
Cross flow alone produced a marked increase in α-SMA message levels compared with both the 
initial control level and that of samples exposed to cyclic strain. The competing effects of cross 
flow and cyclic strain were most apparent in the samples exposed to a combination of both fluid 
flow and cyclic strain, which resulted in no significant change from the 48 h controls (Fig. 
4.15D). Hypoxia caused a significant increase in collagen type III and α-SMA message, but not 
in TGF-β1 levels. Assessment of DNA content in these constructs showed that cell numbers 
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were constant across samples, and therefore the observed effects were not a result of changes in 
proliferation or cell death (Figure 4.16). 
 Immunohistochemistry was performed to provide insight into the mechanical influences on 
cell phenotype (Fig. 4.17). Previous studies indicated that the myofibroblast transition is 
associated with a distinct morphology characterized by prominent stress fibers and a less stellate 
shape. The observed increase in α-SMA gene expression was corroborated by the presence of 
distinct stress fibers that stained for -SMA. This effect was evident in control samples, which 
exhibited increased positive staining for -SMA over 96 h (Fig. 4.17a-c). Cells exposed to cross 
flow exhibited prominent stress fibers, a more stellate morphology, and markedly increased -
SMA staining compared to the other conditions (Fig. 4.17d).  
 
Figure 4.16 - Cell proliferation assay: DNA concentrations quantified using the picoGreen 
assay were normalized to initial levels for many of the testing conditions.  No significant 
differences were found. 
 
Cells exposed to cyclic strain, both with and without the presence of cross flow, showed 
decreased expression of -SMA compared to the cross flow samples (Fig. 4.17e, f). Moreover, 
the cells exposed to strain appeared to align with the direction of strain, though they exhibited 
less prominent stress fibers compared to the 96 h controls and cells exposed to flow alone. These 
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results support the qRT-PCR data for α-SMA message levels, further implicating that cross flow 
stimulates and cyclic strain attenuates the myofibroblast transition. 
 
Figure 4.17 – Cell morphology and α-SMA protein expression in response to mechanical 
stimuli: Immunofluorescence images of embedded fibroblasts for initial, 48 h, and 96 h controls 
(A-C) and for flow (D), strain (E), and strain + flow (F). Blue indicates DAPI staining of the 
nucleus, red shows Texas red phalloidin staining of fibrillar actin, and green represents FITC-
stained anti- -SMA. Note scale bars and higher magnification in panels C and E, compared to A, 
B, D, F. 
 
 The role of the AT1R and TGF-  signaling pathways in cardiac fibroblast 
mechanotransduction 
  Since the response of cardiac fibroblasts exposed to cross flow and cyclic strain revealed 
distinct and opposing effects of these two types of mechanical signal, we performed experiments 
to further examine signal transduction in these cells. In particular, we blocked TGF-  and AT1R-
mediated signaling to determine the roles of these pathways in the cellular response, as shown in 
Figure 4.18. Blocking of TGF-  to inhibit autocrine and paracrine signaling by the cells through 
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this growth factor did not affect collagen type I message levels, both in the presence or absence 
of cross flow (Fig. 4.18A). However, inhibiting TGF-β attenuated the cross flow-induced 
increase in both collagen type III and TGF-β1 expression (Fig. 4.18B-C). The presence of the 
antibody did not affect levels of either marker in the absence of flow. However, blocking TGF-β 
not only prevented the cross flow-induced increase in α-SMA expression, but also reduced the 
message levels to initial control levels both with and without cross flow (Fig. 4.18D), suggesting 
that cross flow might be activating a separate pathway.  
 
Figure 4.18- Blocking TGF-β signaling and AT1R function: Effects of inhibition of AT1R and 
TGF-β on message levels of collagen type I (A), collagen type III (B), TGF- 1 (C), and -SMA 
(D), using a pan-specific TGF-  blocking antibody (dark grey bars) and the AT1R antagonist, 
losartan (light grey bars). Immunofluorescence images of cardiac fibroblasts treated with anti-
TGF-  (E, F) and losartan (G, H) at both the 48 h control (E, G) and cross flow conditions (F, 
H). Blue corresponds to DAPI, red to phalloidin, and green to anti- -SMA.  All images are 600 x 
600 μm. 
 
 TGF-  signaling is known to be enhanced by activation of angiotensin II receptors, and 
AT1R in particular has been linked to flow-induced mechanotransduction [Zou, 2004]. We 
therefore examined the role of AT1R in the cross flow response by blocking this receptor using 
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losartan. The antagonist had a similar effect to blocking of TGF-β on the message levels of 
collagens type I and III and TGF-β1 (Fig. 4.18A-C), providing further evidence for a relationship 
between AT1R-activated signaling pathways and the production of TGF-β1 by the cell for 
autocrine/paracrine signaling. In contrast to the TGF-β blocking antibody, the addition of 
losartan did not affect the baseline increase in -SMA message levels (Fig. 4.18D). However, 
the presence of losartan in the perfusing media did block the flow-induced effect on message 
levels (Fig. 4.18D). These results suggest that cross flow may act through AT1R, which when 
activated elicits TGF-β1 expression and thereby initiates the myofibroblast transition. 
Immunofluorescence was also used to validate the observed trends in α-SMA message levels, 
and to gain insight into the effect of these blocking agents on cell morphology. Cells treated with 
the TGF-  blocking antibody exhibited similar morphology and -SMA expression to the initial 
controls (Fig. 4.18E,F). Losartan-treated cells appeared similar to the 48 h controls (Fig. 
4.18G,H). This is evident for both the control conditions (Fig. 4.18E,G) and for the cells exposed 
to cross flow (Fig. 4.18F,H).  
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Figure 4.19 – AT1R shRNA-mediated knockdown: The effects of shRNA knockdown of 
AT1R on flow-mediated phenotype shifts in cardiac fibroblasts. A) Immunoblot verifying 
knockdown of AT1R. B-E) Message levels of key phenotype markers in response to treatment 
with AT1R shRNA and scrambled shRNA, as well as cross flow and 48 h controls. Relative 
quantities were normalized to initial controls treated with scrambled shRNA. AT1R shRNA had 
no significant effect on initial controls infected with scrambled shRNA. * denotes significance 
from initial levels, and + denotes significance from control levels. 
 
 Losartan may affect the TGF-β receptor and a previous study demonstrated its ability to 
block angiotensin II type 2 receptors [Habashi, 2011]. Therefore, since losartan is capable of 
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blocking both AT and TGF-  pathways, demonstration of the role of AT1R-mediated signaling 
in the cellular response required more specific targeting of the receptor. Lentiviral transduction 
was used to insert a shRNA against AT1R into cardiac fibroblasts, and results are shown in 
Figure 4.19. AT1R shRNA knocked down AT1R levels to around 55% of the levels present in 
cells infected with a scrambled shRNA (Fig. 4.19A). Cells treated with shRNA were then 
exposed to the cross flow regimen. Figures 4.19B-E show message levels for samples exposed to 
shRNA (AT1R and scrambled) at the 48 h control and the cross flow condition. In general, cells 
infected with scrambled shRNA responded similarly to non-infected cells, with the exception of 
a statistically significant increase in collagen type I and III expression for the 48 h time point 
(Fig. 4.19B-C). Moreover, cross flow did not significantly increase collagen type I or III 
expression relative to initial controls (Fig. 4.19C). Scrambled shRNA produced the same patterns 
of TGF-β1 and α-SMA expression as non-infected cells (Fig. 4.19D-E). In general, the 
incorporation of the AT1R shRNA produced similar effects to losartan treatment. However, the 
combination of AT1R shRNA and cross flow caused a significant increase in collagen type I 
compared to initial control levels (Fig. 4.19B).  
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Figure 4.20 - Effect of cyclic strain on smad2 phosphorylation: Western blot of cardiac 
fibroblasts exposed to cyclic strain using smad2/3 (A) and phospho-smad2 (B) antibodies. 
Representative lanes from silver staining (C) indicated uneven protein loading caused by 
separation of cellular protein from the collagen hydrogel. The ratio of phosphor-smad2 to total 
smad2 is quantified in (D). Immunohistochemistry of smad2/3 and its localization to the nucleus 
during phosphorylation. E) shows images of cardiac fibroblasts stained for smad2/3 and F) 
shows quantification of nuclear localization. G) illustrates how smad2/3 is shuttled into the 
nucleus to affect transcription. 
 
  Moreover, AT1R shRNA prevented a significant increase in collagen type III expression 
in the 48 h control samples (Fig. 4.19C). Nonetheless, AT1R shRNA prevented the rise in TGF-
β1 message levels to the initial control levels with the addition of cross-flow (Fig. 4.19D). 
Similarly, AT1R shRNA attenuated the rise in α-SMA expression in response to cross flow, 
while still allowing for the baseline increase in this message level at the 48 h time point. Taken 
together, these results suggest that AT1R directly participates in the transduction of the 
mechanical stress exerted by cross flow. 
80 
 
The effect of cyclic strain on smad2 phosphorylation 
  Because our results suggested that cross flow acts through AT1R to facilitate the 
myofibroblast transition, experiments were conducted to determine if cyclic strain also works 
through a TGF- -related pathway in order to clarify the degree and type of crosstalk between 
these stimuli. In particular, we examined the phosphorylation of smad2, a downstream effector of 
TGF- , in cells exposed to cyclic strain, as shown in Figure 4.20. Immunoblotting (Fig. 4.20A-
B) showed a band at 60 kDa, which represents smad2 levels (the 52 kDa band in the phospho-
smad blot represents cross-reactivity of the antibody with smad3). The amount of protein varied 
between blots (Fig. 4.20C) due to the difficulty in isolating cellular proteins from the protein-
based hydrogels, however silver staining showed that the relative levels of smad2 were not 
significantly different across all samples. Comparison of the ratio of phosphorylated to total 
smad2 (Fig. 4.20D) showed that relative phosphorylation of smad2 increased in control samples 
as time progressed, which mirrored the observed increases in collagen type III and -SMA 
message levels. Interestingly, the application of cyclic strain attenuated the phosphorylation to 
initial control levels, which also matched the effect of strain on -SMA message levels. To 
verify the results of immunoblotting, the levels of smad2 phosphorylation were also examined 
using immunohistochemistry, as shown in Figure 4.20E. Previous studies have shown that once 
phosphorylated, smad2/3 is shepherded into the nucleus by smad4 to mediate transcription (Fig. 
4.20G). Examination of the ratio of fluorescence intensity between the nucleus and cytoplasm 
(Fig. 4.20F) showed that the 48 and 96 h controls had significantly higher levels of 
phosphorylated smad2 compared to initial controls and cyclically strained samples, which aligns 
with the immunoblotting results. Overall, these data suggest that the observed changes 
phosphorylated smad2 were due to transduction of the mechanical strain stimulus.  
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4.4. Poroelastic model to describe cell-seeded gel mechanics 
Pressure and relative fluid velocities for the strain only condition 
 Applying a 1 Hz, 5% cyclic strain in combination with 10 μL/min of cross flow produces 
a substantial difference in fibroblast message levels, morphology, and α-SMA protein expression 
compared to gels exposed only to strain. A poroelastic model was chosen to determine the effect 
of cross flow on fluid pressure, relative fluid velocity, and fluid shear stress distributions in the 
hydrogels. First, these parameters were calculated for the strain only condition. Figure 4.21 
shows the fluid pressure in a 5% cyclically strained hydrogel at three discrete times in the cycle 
(t = 0, 0% strain (black), t = 0.25s, 2.5% strain (orange), t = 0.5s, 5% strain(green)). As the figure 
shows, there is a considerable pressure gradient at the ends of the gel (y = 0 mm, y = 1 mm), due 
to the open boundaries with the surrounding fluid. The magnitude of this gradient is highest at 
2.5% strain, compared to 0 and 5% strain. This result is intuitive since the strain rate is also at a 
maximum at 2.5% strain rate, due to the sinusoidal waveform at the cycled boundary.  
 As shown in equation 20, the shear stress on cells within the hydrogel can be estimated 
by a direct multiple of the relative fluid velocity. Figure 4.22 shows the shear stress profile along 
the y axis at the x centerline for three different points in the strain cycle. As could be predicted 
from the pressure profile, the highest levels of shear stress occur at the ends of the gel on the y 
axis. In fact, there is zero shear stress in the midpoint of the gel along the y axis, the area most 
removed from the open boundaries.  
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Figure 4.21 - Fluid pressure during cyclic strain: Fluid pressure along the y axis of the 
hydrogel, at the x axis centerline for a 5% strain, 1Hz cycle. Black: 0% strain, orange: 2.5% 
strain, green: 5% strain 
 
This result is caused by exchange between the surrounding fluid outside the gel with interstitial 
fluid within the hydrogel. The model predicts shear stresses from about -2 dyn/cm
2
 to 2 dyn/cm
2
, 
which is within the range of physiological values of interstitial fluid flow in the wall of arteries 
[Wang, 1995]. 
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Figure 4.22 – Estimated shear stress during cyclic strain: Fluid shear stress along the y axis of 
the hydrogel, at the x axis centerline for a 5% strain, 1Hz cycle. Black: 0% strain, orange: 2.5% 
strain, green: 5% strain 
 
 These results indicate that cyclic strain induces substantial interstitial fluid flow within 
the hydrogels. But because the gels are being strained, the cells are also exposed to solid stress 
from the deformation. Figure 4.23 shows the solid displacement of the gel along the y axis at the 
x centerline of the gel. Due to the Poisson‘s ratio of the hydrogel, the cells are also strained in the 
y direction during the strain cycle. This deformation is in addition to the strain in the x direction 
caused by the cycling boundary condition. Hence, the total stress on cells within the hydrogel has 
both a substantial fluid stress component as well as a solid stress component. As the gel is 
positively strained in the x direction at 2.5% strain, there is a totally negative displacement in the 
y direction. The maximum displacement occurs at the top surface of the gel. The addition of 
cross flow to the hydrogel does not affect the y displacement of the gel, hence Figure 4.23 is 
identical to the displacement distribution for the addition of cross flow. 
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Figure 4.23 – y displacement during cyclic strain in the x direction: Solid displacement in the 
y direction of the hydrogel undergoing a 5%, 1 Hz tensile cyclic strain. Black: 0% strain, orange: 
2.5% strain, green: 5% strain. 
 
Even though cross flow does not affect the solid mechanics of the hydrogel, the model 
can analyze the effect of adding cross flow to the fluid pressure and shear stress distributions. To 
facilitate the addition of cross flow, the only change to the model is the addition of a pressure 
gradient along the y axis of the gel. The results of the altered pressure distribution are given in 
Figure 4.24. The distribution appears to be quite similar to the distribution for strain only (Fig. 
4.21), with the pressure shifted up at the bottom boundary, y = 0 mm. For example, the pressure 
gradients are again highest at the edge of the gels (y = 0 mm, y = 1 mm). In contrast to the strain 
only condition, there does exist a small pressure gradient near the center of the gel (y = 0.5 mm), 
caused by the addition of the pressure gradient. 
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Figure 4.24 - Fluid pressure during cyclic strain and applied cross flow: Fluid pressure 
within the hydrogel undergoing a 5%, 1 Hz cyclic strain in addition to a 77.6 Pa cross flow 
pressure gradient. Black: 0% strain, orange: 2.5% strain, green: 5% strain. 
 
Figure 4.25 shows the effect of the cross flow on the fluid shear stress on the cells 
embedded in the hydrogel. Again, there is not much difference between these distributions and 
those calculated for strain only (Fig. 4.22). However, cells at the midpoint of the gel (y = 0.5mm) 
are exposed to a constant 0.1 dyn/cm
2
 fluid shear stress caused by the cross flow. Hence, the 
cross flow produced a shear stress that is about 20 times less than the flow-induced stress caused 
by the 5% cyclic strain. This result underscores the porosity of the hydrogels, and the high level 
of coupling between the solid and fluid mechanics of the poroelastic medium.  
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Figure 4.25 – Estimated shear atress during cyclic strain and applied cross flow: Fluid shear 
stress within the hydrogel undergoing a 5%, 1 Hz cyclic strain and 77.6 Pa cross flow pressure 
gradient. Black: 0% strain, orange: 2.5% strain, green: 5% strain. 
 
The results of the model indicate that there is considerable interstitial fluid flow produced 
by strain, but not substantial strain produced by fluid flow. Considering that cross flow alone had 
such a significant effect on α-SMA expression compared to strain alone (Fig. 4.15), this result 
suggests that cyclic strain may be the determining stimulus on fibroblast phenotype. The 
mechanism underlying this response may be explained by the effect of cyclic strain on smad2 
phosphorylation. It is also possible that the transient nature of the cyclic strain may be causing a 
distinct response in the fibroblasts, compared to the constant cross flow. To test this possibility, a 
1 Hz pulsatile cross flow of 10 μL/min was applied to the gels. Figure 4.26 shows that the 
pulsatile cross flow does cause increased α-SMA protein expression in the cells. However, the 
morphology does appear to be different from the constant cross flow results (Fig. 4.17). 
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Nonetheless, the increased α-SMA expression indicates that it is the solid stress produced from 
cyclic strain that is the determining factor in fibroblast response, not any transient effect. 
 
Figure 4.26 - Effect of pulsatile flow on fibroblast morphology and α-SMA: 
Immunofluorescence of cells at the initial time point (A), at 48hr controls (B), and after exposure 
to pulsatile (1 Hz) 10 μL/min cross flow. Blue: DAPI, Red: Texas Red-phalloidin, Green: anti-α-
SMA-FITC. All images are 300 x 300 μm. 
 
4.5. MSC injection and paracrine effect in fibroblast-seeded gels 
The effect of MSC injection on fibroblast activation 
 The primary indicator of paracrine action of the injected MSC is the level of activation of 
surrounding cardiac fibroblasts seeded into the collagen hydrogel. The previous results indicated 
that fibroblasts seeded into the hydrogel have a baseline level of activation, as indicated by 
increased expression of collagens I and III, TGF-β, and αSMA, and augmented activation by 
fluid flow and hypoxia. Hence, fibroblasts removed from the injection site by at least 0.25 mm 
were immunostained for αSMA-FITC and visualized with a confocal microscope. The results are 
shown in Figure 4.27. For all time points and testing conditions, the morphology of the 
fibroblasts does not appear to change substantially with the exception of cells exposed to 
hypoxia, which appear to not spread as many cell processes into the extracellular matrix. There 
appears to be slightly higher αSMA expression at the initial time point and flow condition 
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compared to the other samples. Nonetheless, large stress fibers and high levels of positive αSMA 
staining appear to be absent from the cells, indicating a deactivation of the myofibroblast 
transition. 
 
 
Figure 4.27 – Effect of MSC injection on fibroblast morphology and α-SMA expression:  
Immunofluoresence of cardiac fibroblasts isolated from the injection area for different testing 
conditions. Each image is 300 x 300 µm. DAPI is used to visualize the nuclei, Texas Red-
phalloidin for the actin cytoskeleton, and FITC conjugated anti-α-SMA to observe the 
myofibroblast transition. 
 
 In order to quantify the fibroblast response, portions of the hydrogel removed from the 
injection site were homogenized to collect RNA for qRT-PCR. The results of the message level 
analysis are given in Figure 4.28. For all the messages measured, none of the testing conditions 
produced a significant increase from the initial control levels. In fact, with the exception of the 
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αSMA message in response to flow, all the messages were actually significantly downregulated 
compared to the initial time point. Interestingly, the addition of flow caused a significant 
decrease in collagens I and III message compared to control. Moreover, hypoxia nearly 
extinguished TGFβ levels in these cocultured fibroblasts. These message levels contrast starkly 
with the levels produced by fibroblast-only gels exposed to the identical testing conditions. 
Overall, the results indicate that not only does the addition of MSC attenuate fibroblast 
activation, but it appears to reverse the fibroblast to myofibroblast transition.  
MSC response to mechanical and biochemical stimulation 
 Once implanted in the collagen gel, the MSC line the sides of the injection cone and 
attach to either the surrounding collagen gel or form cell-cell contacts. Over time, the MSC 
migrate out of this initial cone and into the surrounding collagen hydrogel. To understand how  
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Figure 4.28 - Message levels of fibroblasts isolated from the injection site:  This data 
complements the immunofluorescence images in the previous figure. Four markers for the 
myofibroblast transition were measured and compared to initial control levels (a * denotes 
significance from the control test condition, all levels are significant from initial levels except 
αSMA in response to flow). 
 
specific stimuli affect this migration and the expression of cd90, a stem marker, 
immunofluoresence images are taken at the cone-gel interface. The results are summarized in 
Figure 4.29. At the initial time point, there is minimal migration because the stem cells have only 
been present in the gel for 12 hours. In the absence of stimulation, the control cells indicate that 
the MSC migrate regardless, but with no loss to the cd90 expression. In the presence of hypoxia, 
the migration of the stem cells is increased significantly from control samples, and again the 
stem marker is maintained in the cells. While both fluid flow and cyclic strain increased 
migration significantly compared to controls, mechanical stimulation appeared to attenuate the 
expression of cd90 within the stem cells. The phalloidin stain indicates that there is no 
substantial change in the morphology and distribution of the surrounding cardiac fibroblasts.  
 The migration distance of the stem cells is represented by a dotted line in Figure 4.29, 
and these distances are quantified in Figure 4.30. As expected from the immunofluorescence 
images, the migration distance of MSC is maximized by stimulation with hypoxia. Interestingly, 
mechanical stimulation by both interstitial fluid flow and cyclic strain produces statistically the 
same levels of migration. All stimuli produced significantly higher migration distances than 
control and initial levels. The highest migration distance approached 500 µm, which translates to 
an average cell velocity of 0.139 µm/s. Interestingly, this is approximately the same average 
velocity as the initial time point, which migrated about 100 µm in a time of 12 hours. This 
calculation suggests that only hypoxia is able to sustain the initial migration averaged velocity.  
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Figure 4.29 - A summary of the MSC response to different conditions: Each row represents a 
testing condition, and each column a specific fluorescence channel. DAPI and Texas Red 
phalloidin were used again, in addition to a cd90 antibody. MSC could be distinguished because 
of the GFP transfection. Dotted lines represent the calculated penetration distance. 
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Figure 4.30 - MSC penetration in response to exogenous stimuli: Quantification of the 
penetration distance of the MSC from their initial injection cone into the cell-seeded collagen gel 
48 hours after the initial time point. This penetration can be observed visually in Figure 4.29. 
 
Paracrine release of VEGF and IGF-1 in stimulated cocultures 
 Having demonstrated that the injected MSC affect fibroblast activation, ELISAs were 
conducted to identify which paracrine factors were responsible for this beneficial effect. 
Supernatants from coculture gels as well as from gels populated only by fibroblasts were 
analyzed using ELISAs. To determine the levels produced by the MSC, levels from the coculture 
gels were subtracted from the fibroblast-only gels.  
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Figure 4.31 -VEGF release by the MSC within the collagen gel: Release of this factor was 
measured in gels containing only fibroblast gels (bottom plot), in order to determine the 
contribution of injected MSC (top graph). 
 
This normalization does not necessarily yield the amount of growth factor produced by the MSC, 
because the presence of MSC most likely affects fibroblast paracrine release. Nonetheless, it 
provides a measure of the effect of MSC on total paracrine release by these two cell types. Two 
growth factors commonly associated with the paracrine effect of implanted MSC were analyzed, 
VEGF and IGF-1. The results of the VEGF ELISA are shown in Figure 4.31. VEGF release 
increases with time in the MSC, as evidenced by control levels exceeding the initial levels. 
Hypoxia stimulated substantial VEGF release from fibroblasts and from implanted MSC. 
Interestingly, mechanical stimulation in the form of both interstitial fluid flow and cyclic strain 
decreased the VEGF levels released by both MSC and fibroblasts below controls and the initial 
levels. The results suggest that VEGF is an important mediator in response to hypoxia, but not 
mechanical stimulation. 
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Figure 4.32 - IGF-1 release by the MSC within the collagen gel: Release of this factor was 
measured in gels containing only fibroblast gels (bottom plot), in order to determine the 
contribution of injected MSC (top graph). 
 
 Figure 4.32 shows the results of the IGF-1 ELISA. The production of IGF-1 by 
fibroblasts alone mirrored the release of VEGF stimulated by the testing conditions. However, in 
contrast to the VEGF ELISA, MSC did not appear to release much of this growth factor. In fact, 
no testing condition produced more than 100 pg/mL in the implanted MSC. Fibroblasts in 
response to hypoxia produced very high (> 600 pg/mL) levels of the growth factor. Mechanical 
stimulation from both interstitial fluid flow and cyclic strain produced negligible IGF-1 
concentrations from the fibroblasts. As mentioned, the addition of MSC to the gels did not 
substantially increase the levels of this growth factor. Average IGF-1 levels in response to both 
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hypoxia and fluid flow were less than levels produced by the fibroblasts. Only the control testing 
condition resulted in any significant increase over the initial levels. The results of this ELISA 
indicate that IGF-1 production is not stimulated by either hypoxia or mechanical stimulation. 
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Chapter V 
Discussion 
 The results presented in this dissertation generally support the two hypotheses stated in 
the introduction: first, mechanical stimulation dictates the myofibroblast transition through TGF-
β-related signaling pathways, and second, MSC modulates cardiac fibroblast phenotype through 
release of cardioprotective and angiogenic paracrine factors. The myofibroblast transition was 
first studied in released and constrained collagen gels in order to understand the response of 
these primary cells to changes in substrate stiffness and culture conditions. After characterizing 
the cell response, an apparatus able to apply both interstitial fluid flow and cyclic strain was used 
to determine how fibroblasts responded to specific mechanical stimuli. Experiments were 
conducted to determine the mechanisms underlying the mechanotransduction of the fibroblasts. 
The hydrogel mechanics during application of these stimuli were modeled using an analytical, 
poroelastic model. Finally, the same levels of mechanical stimuli were applied to fibroblast-
seeded gels injected with MSCs to determine how specific elements of the fibrotic myocardium 
affect paracrine release. The results not only indicate that the mechanical stress within the 
myocardium is a key regulator of both fibroblast function and MSC paracrine release, but 
provide insight into the mechanisms by which the cells sense and respond to mechanical stimuli.  
 This chapter provides a detailed discussion of the results in the context and order of the 
specific aims. The discussion also describes how these results may explain the development of 
scar tissue as well as assist in the development of treatments that impede the growth of fibrotic 
scars in the myocardium. For example, by showing that increased matrix stiffness facilitates the 
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myofibroblast transition that leads to augmented matrix production, a positive feedback 
mechanism is identified that has implications for scar growth. Another example is the different 
responses of the fibroblasts to solid stress and fluid stress. The in vivo scar environment is 
characterized by the death of beating cardiomyocytes (reduced strain), and by the formation of 
disorganized microvasculature (interstitial fluid flow). Taken together, the results of the study 
suggest a means by which altered mechanics in fibrosis can stimulate fibroblasts to transition to 
myofibroblasts.  
 Finally, the results are discussed in the context of other published studies focusing on the 
myofibroblast transition and MSC paracrine release. There have been exceptional studies 
investigating these topics, and this chapter will detail how the results both relate and add to 
previously published work. For example, the introduction described extensive work conducted 
on the effect of mechanical stress on the myofibroblast transition in 2D systems, and on the use 
of conditioned medium to elucidate the effect of MSC on cardiomyocyte and fibroblast response. 
Moreover, in vivo studies have also addressed the myofibroblast transition and benefit of MSC 
injection. The following sections will address areas in which the results both confirm and 
contrast with earlier work.  
5.1 Characterization of the myofibroblast transition in vitro 
 The results presented in section 4.1 revealed the individual and combined effects of serum 
content and matrix stiffness on the myofibroblast transition, a key event in the fibrotic process 
that follows myocardial infarction. The transition was assessed at multiple levels by measuring 
gene expression of proteins associated with this transition, as well as qualitative protein 
expression, cellular morphology, and cell-mediated gel compaction. Lower serum content was 
found to significantly increase the ability of the fibroblasts to compact the gels (Fig. 4.1A). Both 
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serum levels and matrix stiffness modified gene expression of α-SMA and cellular morphology 
(Figs. 4.2-3) as these cells transitioned to myofibroblasts. Reduced nutrient availability at lower 
serum concentration also modified gene expression of TGF-β, 
transition (Fig. 4.4-5). Moreover, gels cultured in both serum levels exhibited distinct patterns in 
the gene expression of collagens I and III in addition to α-SMA and TGF-β.
indicated that the transition to the myofibroblast phenotype in turn affected bulk mechanical 
properties of the hydrogels (Fig. 4.6).  
 The ability of fibroblasts to cause 3D protein gel compaction has been used as a measure of 
the intracellular actin-myosin interaction and the resulting increase in passive contractile 
function which develops as fibroblasts shift their phenotype to a myofibroblast state 
[Poobalarahi, 2006]. Lower serum levels accelerated the rate of gel compaction, which correlated 
generally with the increased expression of α-SMA, a marker of the myofibroblast phenotype. 
Experiments in which the cell concentration was varied showed that higher fibroblast 
concentrations resulted in increased gel compaction. Since cell proliferation can be expected to 
be decreased in low serum conditions, this finding supports the conclusion that cardiac 
fibroblasts in 3D collagen gels can be stimulated to become myofibroblasts by limitations in 
nutrient availability after a myocardial infarction.  
  Gels exposed to 10% serum showed a greater response to gel constraint than those 
cultured in 5% serum. It has been shown that serum modulates the response of cardiac fibroblasts 
to varying mechanical environment on a 2D substrate, e.g. collagen production was found to 
increase with mechanical load only when cells were cultured in high serum media [Butt, 1996]. 
Hence, the results of this study show a similar result in the 3D environment of a collagen gel. 
However, there was no significant difference in message levels for the collagens or TGF-β 
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between released and constrained gels. Interestingly, the morphology of the cells as measured by 
circularity was shown to correspond directly to α-SMA expression. Low serum and gel 
constraint were each associated with elevated α-SMA and circularity, while only low serum 
stimulated an effect on both α-SMA and TGF-β for cells cultured in M199.  This divergence 
indicates nutrient levels and mechanical stimuli each contributes to the myofibroblast transition 
yet these two factors may work via variations in spatial/temporal activation of common pathways 
and/or activation via unrelated mechanisms. More work is required to determine such 
mechanisms.  
  The response of cardiac fibroblasts to serum level also was illuminated by characterizing 
gene and protein expression over time in culture in 3D collagen gels. Collagen type I gene 
expression decreased with time regardless of serum concentration or culture media. This effect 
can be attributed to the fact that collagen type I is the main component of the hydrogel matrix, 
which may cause downregulation of expression by embedded cells. Collagen type III expression 
increased over time in both serum concentrations, providing further phenotypic evidence of the 
cellular myofibroblast transition and subsequent increase in matrix secretion. In all treatments, 
expression of α-SMA was initially high immediately after gel formation (6 h time point), but 
decreased by 24 h and then increased over time in culture. This bimodal trend mimics the change 
in matrix compliance. The high initial α-SMA expression levels were probably a result of 
culturing the cells on stiff tissue culture plastic prior to making gels. Expression decreased as the 
gels remodeled, but subsequently increased as the compliance of the compacting gels decreased. 
The mechanical testing data corroborates this increase in stiffness between the 6 h and 120 h 
time points. In addition, α-SMA expression appeared to lag behind TGF-β expression, which was 
highest at the 24 h time point, suggesting a possible autocrine or paracrine effect in promoting 
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the differentiation of fibroblasts to myofibroblasts. Future mechanistic studies with this 3D 
matrix can be utilized to better understand whether TGF-β is required for the matrix compliance-
induced shift in fibroblast function. 
 Mechanical testing showed that the stiffness of the 3D collagen matrix increased over time in 
released gels, regardless of serum content. This result verified that cells in released gels were 
exposed to an increasingly stiffer environment. There was an effect of serum: gels cultured in 
low serum exhibited higher stiffness, as measured from the elastic moduli and lower loss angles 
than their high serum counterparts at the initial time point. The fact that serum has a significant 
effect is evidence of a positive feedback loop between cell phenotype and matrix stiffness: 
reduced serum induces the myofibroblast phenotype, which increases the stiffness of the 
extracellular matrix, and in turn accelerates myofibroblast development. This process is 
illustrated in Figure 5.1. 
 
Figure 5.1 – Fibroblast-myofibroblast positive feedback: Summary of the positive feedback 
that occurs between the extracellular matrix environment and the fibroblast phenotype. 
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 The mechanical feedback loop is likely to be an important component of the in vivo fibrotic 
process. It may be accelerated in ischemic regions with less access to serum factors and 
necrotic/scarred regions experiencing high stress. Thus, this process is likely to play a key role 
during pathophysiological cardiac remodeling and will require critical consideration for stem cell 
therapies targeted to heart failure.  
 The gene expression, morphology, and compression results of the present study suggest that 
there is a limit to which reduced serum content and increased matrix stiffness can initiate the 
myofibroblast transition. For example, the gene expression and morphology of cells cultured in 
reduced serum in released and constrained gels showed that the effects of serum and stiffness 
were not additive in increasing α-SMA expression or creating a more spherical morphology (Fig. 
4.2-3). For higher serum content, the significant difference in α-SMA expression and spherical 
morphology between released and constrained gels lasted only for the first 24 hours (Fig. 4.2-3). 
Also, compression testing of released gels indicated that the effect of reduced serum content was 
abolished by the final time point, since there was no difference in elastic modulus or loss angle 
between gels cultured in 5 and 10% FBS (Fig. 4.6). These results suggest that the increased α-
SMA expression caused by reduced serum reached a limit, and increasing matrix stiffness in the 
compacting gels could only produce increased α-SMA message levels in the higher serum data 
set. The results also lead to further work to determine if extraneous mechanical stimulation such 
as cyclic strain or interstitial flow could increase α-SMA expression beyond the levels produced 
by serum and matrix stiffness. 
 A better understanding of the cardiac fibroblast response to environmental factors is 
important to elucidate the causes and possible treatments of cardiac fibrosis and scarring as well 
as other diseases caused by unwanted tissue remodeling. Such knowledge also is important in 
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developing improved in vitro models of fibrosis, which can be used to study the disease and 
develop diagnostic and therapeutic strategies to treat the cardiac dysfunction and heart failure 
produced in the aftermath of myocardial ischemia.  Interestingly, the cell-seeded hydrogels in 
this study exhibited elastic moduli in the range of in vivo fibrotic tissue [Discher, 2009], though 
it can be problematic to compare modulus values obtained by different test methods. Fibrosis can 
be studied in vivo and the process can be manipulated by the administration of pro-fibrotic 
factors (e.g. TGF-β, angiotensin II) or by knocking out anti-fibrotic cytokines (e.g. brain 
natriuretic peptide) [Tamura, 2000], but it is difficult to control all the mechanical and biological 
factors contributing to fibrosis in animal models.  The development of in vitro testbeds, such as 
the hydrogel model described in the present study allows for a more controlled mechanical and 
chemical/hormonal environment to better understand the mechanisms responsible for cardiac 
fibrosis. 
5.2 Application of simultaneous flow and strain 
 The results of section 4.2 validate the use of the PDMS apparatus to apply simultaneous 
fluid flow and cyclic strain to cell-seeded hydrogels. The design is based on previously described 
interstitial flow bioreactors [Chee Ping, 2003], with the key addition of applying simultaneous 
uniaxial, cyclic strain. The flexible PDMS chamber allowed for strain application and the surface 
could be modified to retain gel adherence over the duration of the experiment (72 – 120 h). Finite 
element modeling was used to determine that the main component of the applied strain was in 
the axial direction, though the strain applied to each of the 3D constructs was slightly higher than 
the global strain on the PDMS well. Because of the Poisson‘s ratio of the PDMS, the gels 
experience minimal strain in the components perpendicular to the axial direction of cyclic strain.  
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 The results of the permeability and flow visualization experiments directly validated the 
approach of using an acellular gel upstream of the cell-seeded gel to distribute the fluid flow 
evenly across the seeded construct. The acellular gel yielded higher permeability values than the 
cell-seeded gel, which caused the flow to distribute prior to passing through the cell-seeded gel. 
It is unclear why the acellular gel has a higher permeability, since the gels are constrained at the 
edges by the walls of the PDMS. One possibility is that the cell-seeded gel is compacting in the y 
direction, which is causing the permeability to decrease. It is also possible that the fibroblasts in 
the cell-seeded gel are secreting their own matrix, though matrix secretion was not explicitly 
quantified beyond message levels of collagens I and III. Imaging and viability studies confirmed 
that cells survived in the 3D protein hydrogel, under both static, as well as strained and fluid 
flow conditions. All testing conditions produced viability levels higher than 90%. For the time 
span observed, the control fibroblasts showed no substantial change in viability. This result 
implies that nutrients within the medium were able to freely diffuse into the gels to reach the 
embedded cells.  
 The ability to apply simultaneous interstitial flow and cyclic strain has relevance to the study 
of in vivo microenvironments. The type of simple bioreactor system described here can be used 
to model tissues such as the myocardium, which experiences interstitial fluid flow from 
perfusion through the extracellular matrix as well as cyclic strain from the systole-diastole cycle 
of the heart. It is not trivial to apply both cross flow and cyclic strain to cell-seeded hydrogels 
because of gel attachment. Moreover, the myofibroblast transition is characterized by increased 
contractility, which makes gel attachment even more difficult because of augmented gel 
compaction. Nonetheless, the apparatus was able to successfully apply both mechanical stimuli 
to the gels. Unfortunately, the apparatus could not control oxygen concentration, since it did not 
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fit within an incubator. Future work may involve decreasing the size of the system so that 
mechanical stimuli can be combined with hypoxia to further imitate the microenvironment of the 
in vivo fibrotic scar. 
5.3 Mechanisms of fibroblast response to exogenous stimuli 
  There is increasing evidence that mechanical stimulation is a key regulator of the 
fibroblast to myofibroblast transition in the myocardium. Our experimental and computational 
data suggest that cardiac fibroblasts distinguish between fluid-induced and strain-induced 
mechanical stresses, though there is crosstalk between the mechanotransduction mechanisms. 
The cellular response to both types of mechanical stress involves the TGF-β and AT1R signaling 
pathways, and the possible interaction between these pathways is shown schematically in Figure 
5.2.  
 
Figure 5.2 - Schematic of experimental results: Summary of the crosstalk between AT1R 
activation and TGF-β signaling in cardiac fibroblasts undergoing fluid- and strain-induced 
mechanical stimulation. 
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 Direct activation of AT1R by fluid-induced shear stimulates the production of TGF- 1, 
which in turn acts in an autocrine and paracrine manner to create a positive feedback loop 
promoting the myofibroblast phenotype. Blocking of AT1R using losartan or shRNA negates 
this effect. At the same time, cyclic strain attenuates the phosphorylation of smad2, a 
downstream effector of TGF-β signaling, and therefore prevents the myofibroblast transition. 
These mechanisms indicate that increased interstitial perfusion would initiate the fibrotic 
response, while also suggesting a protective effect of cyclic strain in preventing cardiac fibrosis. 
This finding may have a direct impact on both the understanding and treatment of fibrosis in the 
myocardium, since our study suggests AT1R is a potential target to block the mechanical stress-
induced transition to the myofibroblast phenotype. These results also provide insight into recent 
clinical findings that AT1R inhibitors used to treat hypertension can also improve the function of 
fibrotic hearts, and reduce the occurrence of heart failure [Konstam, 2009]. 
 Changes in α-SMA message levels provided the clearest demonstration of the divergent 
signal transduction of cross flow and cyclic strain. Cross flow alone caused a nearly nine-fold 
increase in message, while cyclic strain caused a decrease to the initial control level. However, 
the combination of cyclic strain and cross flow resulted in α-SMA message levels not 
significantly different from the 48 h control, suggesting that the two modes of mechanical 
stimulation act through connected signaling pathways. Inhibition experiments indicated that 
inactivation of AT1R attenuated the cross flow-induced effect, but only blocking TGF-β negated 
both the flow-induced α-SMA message increase and the baseline rise between the initial and 48 h 
controls. A summary of the different stimuli on message levels is provided in Figure 5.3. 
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Figure 5.3 - Summary of fibroblast response to mechanical and hypoxic stress: Message 
levels of four markers for the myofibroblast transition, col1a1, col3a1, TGF-β, and α-SMA were 
compared to 48 hr control levels. 
 
This result not only identifies AT1R as a transduction receptor for cross flow, but also suggests 
that TGF-β1 is a master regulator of the mechanical stress-induced myofibroblast transition. 
Further evidence for the role of TGF-β1 as a regulator of mechanotransduction was provided by 
experiments in which fibroblasts were exposed to hypoxic conditions. The low oxygen 
environment stimulated the myofibroblast transition, as evidenced by increased collagen type III 
message levels, but did so without the increase in TGF-β1 expression observed in cells exposed 
to cross flow. Finally, immunoblotting for phosphorylated smad2 indicated that cyclic strain 
affected TGF-β signaling, providing the link between the transduction of flow and strain. 
 Analytical studies of the mechanics of hydrogels tested in our flow-strain bioreactor have 
shown that the deformation of the hydrogel and interstitial fluid flow are also strongly coupled in 
this system, as they are in vivo [Ashikaga, 2008]. Due to the high porosity of the 3D protein 
hydrogel, cyclic strain can cause substantial interstitial fluid flow within the matrix, even in the 
absence of cross flow. In contrast, cross flow itself induces negligible strain-induced stress 
within the hydrogel. In the present study only the cross flow condition caused a marked  increase 
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in α-SMA, although the model predicted a considerable amount of interstitial flow for the all 
three mechanical stimulation conditions examined (flow, strain, and combined flow/strain). 
Therefore, application of mechanical strain clearly attenuated the rise in α-SMA, even though it 
also induced interstitial flow. There is also a possibility that the response of the fibroblasts has 
some temporal dependence, since strain is applied cyclically and interstitial fluid flow at a 
constant flow rate. However, Figure 4.26 indicates that pulsatile flow also stimulates the 
myofibroblast transition. Taken together, these results suggest that interstitial fluid flow is a 
potent initiator of signaling through AT1R, but that cyclic deformation of the extracellular matrix 
is able to override or diminish these effects. Further explanation of the results of the analytical 
model is provided in the following section. 
 The findings of the present study serve to illuminate the fibrotic response in cardiac 
tissue. Since a fibrotic scar is characterized by excessive extracellular matrix deposition, it is 
stiffer than surrounding myocardium. And because a cardiac scar is also characterized by an 
absence of healthy, contracting cardiomyocytes, there is considerably less strain in the scar than 
in surrounding regions. However, the scar region is still perfused by capillary networks 
[Boudoulas, 2009]. Our study provides evidence that this combination of mechanical factors may 
play a role in causing the transition of healthy fibroblasts to the myofibroblast phenotype, 
thereby propagating the fibrotic response. Our findings also provide a potential mechanism for 
the effects of losartan in treating fibrotic hearts, since blocking of flow-mediated phenotype 
shifts in cardiac fibroblasts may be of particular benefit. The in vitro model we used is 
necessarily a simplified version of the complex cellular milieu of the myocardium. However it is 
a promising system for isolating the effects of mechanical stresses in 3D systems, and therefore 
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is of potential importance to clinical trials focusing on the anti-fibrotic potential of losartan and 
its conjugates [NCT ID: NCT01150461]. 
5.4 The collagen gel as a poroelastic medium 
 Predicting the pressures, relative velocities, and solid deformation within mechanically 
stimulated hydrogels is important when analyzing the response of embedded cells. This holds 
true not only for the particular experimental configuration used in the present study, but also 
more broadly for any system that applies solid or fluid stress to three-dimensional cell-seeded 
scaffolds. Cells are exposed to solid stress from the deformation of the matrix as well as shear 
stress from the flow of fluid within the gel. Models such as the one we have developed can 
therefore provide insight into the specific mechanical factors that affect cell function. In the 
present study we applied cyclic strain, cross flow, or a combination of both. The results indicated 
that although cyclic strain can induce fluid flow, imposing a cross-flow causes negligible strain 
in a poroelastic medium. In fact, the fluid velocity induced by 1 Hz cyclic strain was about 10 
times higher than for a static gel exposed to cross flow for the same pressure difference across 
the gel. Because the model assumes no flow-induced deformation in the medium, the results 
suggest that although strain induces fluid flow, fluid flow does not induce strain. 
 The results of the experimental portion of the study indicate that fibroblasts respond 
differently to all three loading scenarios. Combining cross-flow and cyclic strain did not affect 
the solid deformation within the gels, but did affect the relative velocity in the y direction. 
Without cross flow, the relative fluid flow at the centerline of the gel in the x direction was zero, 
indicating no net fluid flow across the gel. Using a common analogy between fluid flow and 
electric current, cyclic strain can be considered to induce an AC current while cross flow causes 
a DC offset to that current. Therefore, even though the effects of strain and cross-flow are very 
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much intertwined, the three loading scenarios of cyclic strain, cross-flow, and a combination of 
both create three different stress states within the gels. This supports the experimental results, 
which indicated a unique response between cells exposed to the different loading conditions.  
 It is unlikely that diffusion of nutrients is a factor, since the high porosity of the hydrogel 
(>99%) does not create a substantial barrier to diffusion. Nonetheless, the Peclet number of the 
hydrogel is still high, meaning that convection does influence the transport of solutes in the 
cycled gel. Because fluid velocity is highest at the ends of the gel, it is possible that cells in the 
middle of hydrogels being cyclically strained are not receiving the same concentrations of 
nutrients as cells near the ends. This effect provides another example of the heterogeneity within 
the stimulated hydrogel. As the results indicated, the stress exerted on the embedded cells 
exhibits both a spatial and temporal dependence. However, this heterogeneity is not captured by 
the quantitative reverse transcription PCR, which involves homogenization of the entire gel. 
However, it would be quite difficult to create a homogenous stress state in a 3D material, and the 
results of the poroelastic model suggest that all three stimuli produce generally distinct stresses 
within the hydrogel. 
5.5 The effect of MSC on the fibroblast transition 
The present study describes a 3D coculture model of MSC injected into a myocardial 
fibrotic scar. The model allows for testing the response of the MSC to specific biochemical and 
mechanical stimuli, in addition to observing the effect of MSC implantation on cardiac fibroblast 
phenotype. The results indicate that the presence of MSC significantly impedes the 
myofibroblast transition, no matter what stimuli the gels are exposed to. Message levels of 
collagens I and III, TGFβ, and αSMA were all held at or below initial levels, a result supported 
by immunofluorescence of the fibroblasts isolated from the MSC injection cone. The behavior of 
110 
 
the injected stem cells was modulated by the different stimuli: hypoxia resulted in higher 
migration distances, but mechanical stimulation resulted in decreased cd90 expression. Finally, 
the levels of VEGF and IGF-1 within the gels were measured using ELISA. Neither factor was 
affected by mechanical stress, but hypoxia had a substantial affect on VEGF production by the 
implanted stem cells. Gels seeded only with fibroblasts also produced significant VEGF and 
IGF-1 levels, indicating that fibroblasts themselves contribute to the paracrine environment in 
the ischemic myocardium.  
The results of the study do not reveal much about the fate of the stem cells after injection 
into the collagen gel. It is notable that the expression of the stemness marker, cd90, is attenuated 
by both cyclic strain and interstitial fluid flow. The result is nonintuitive because the two 
mechanical stimuli had such different effects on the myofibroblast transition. The loss of the 
stem marker, in addition to reduced migration compared to MSC stimulated by hypoxia, suggests 
that mechanical stress and hypoxia lead to differentiation and proliferation, respectively. The 
study does not reveal what lineage the cells are differentiating to, nor is it clear what lineage 
would be optimal for benefiting the myocardium. The MSC can become pro- or anti-
inflammatory, which would substantially affect the set of paracrine factors released by the cells 
and their effect on the surrounding cardiomyocytes and vascular cells. Further work elucidating 
the fate of MSC in engineered cardiac tissue, as well as the mechanisms of action on heart failure 
will be important to advancing the field of cell-based therapies for cardiac pathology 
Nonetheless, the coculture model presented in this study provides a new way to study the 
interaction of implanted stem cells with the fibrotic environment. Injected stem cells are 
surrounded in three dimensions by cardiac fibroblasts, which allows for crosstalk between the 
two cell types. However, although the hydrogel model adds complexity to existing 2D coculture 
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models, it does not come close to mimicking the complete microenvironment of an in vivo scar. 
The microenvironment of a scar not only includes fibroblasts, but also smooth muscle and 
endothelial cells from the vasculature, and possibly even immune cells depending on when the 
cells are injected into the injury site. These cells can certainly modulate stem cell function and 
response, and this effect is not captured by the present model. Nonetheless, it is possible to 
envision incorporating these cells into a collagen hydrogel, similar to the fibroblast-populated 
gels presented in this study.  
As mentioned in the introduction, one current problem with MSC treatment of heart 
disease is the inherent variability in stem cell function. Therefore, it is possible that this hydrogel 
model can be used as a screening system to identify the populations of cells that are more likely 
to produce a beneficial effect. The question remains what element of MSC cell response is 
actually beneficial in vivo. It is unclear whether increased migration is a good thing to have in 
the heart, especially when alterations in the complex microstructure can lead to arrhythmias. The 
immunofluorescence images indicated that mechanical stimulation reduced expression of cd90, a 
marker of stemness, but it is unclear how differentiation would affect MSC-mediated repair. The 
present study does not provide insight into these questions because all the mechanical and 
biochemical stimuli caused downregulation of markers for the myofibroblast transition in 
adjacent fibroblasts, regardless of migration distance, cd90 expression, and paracrine release of 
VEGF and IGF-1. The results of this study verify that stem cell paracrine action is a time-
dependent process, since release of VEGF and IGF-1 changed substantially with time. 
Quantification of migration distance also revealed that cell velocity was significantly different 
between testing conditions. This complicates the design of a ―growth factor cocktail‖ to replace 
the need for cell transplantation. It is unknown whether there was any spatial variation in the 
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paracrine release, since gels were processed in bulk. For example, it would be interesting to 
partition the gel with higher resolution in order to compare the activation of the fibroblasts closer 
to the injection cone with cells further away. Interestingly, neither VEGF nor IGF-1 was released 
more in response to mechanical stress. Even though the list of possible paracrine factors from 
MSC is very long, future work may include measuring the release of other factors beyond VEGF 
and IGF-1.  
 
6. Conclusions, Impact, and Recommendations 
 This dissertation centered on five specific aims, and the results produced five primary 
conclusions from those aims:  
 
 Cardiac fibroblasts seeded in a collagen hydrogel undergo a baseline myofibroblast 
transition under static culture conditions, which is augmented by reduced serum and 
matrix compliance. 
 
 Cross flow and cyclic strain can be applied simultaneously to cell-seeded collagen 
hydrogels in an open PDMS chamber, using an acellular gel layer to evenly distribute 
cross flow. 
 Interstitial fluid flow stimulates the myofibroblast transition through an AT1R/TGFβ 
mediated response, but cyclic strain attenuates this transition through a related 
pathway. 
 
 Cyclically deforming a porous collagen hydrogel produces substantial fluid flow 
within the gel. 
 
 Coculturing MSC with cardiac fibroblasts in a collagen hydrogel, regardless of 
mechanical and biochemical stimulation, results in reduced transition to the 
myofibroblast phenotype. 
 
These conclusions have several implications for how mechanics influences the 
pathogenesis of fibrosis in the myocardium. The preliminary collagen gel model provided in 
vitro evidence of a positive feedback loop in the myofibroblast transition; low serum caused 
fibroblasts to transition to myofibroblasts, which caused an increase in contractility and 
subsequent matrix compaction. The resulting increase in stiffness then further stimulated the 
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myofibroblast transition. This process may explain what happens in vivo, because fibroblasts are 
starved for nutrients during the ischemic phase after a myocardial infarction, and begin to 
transition to a myofibroblast phenotype that secretes thick extracellular matrix. However, 
identifying the presence of this feedback loop does not necessarily lead to treatments to prevent 
it. Currently, there is no means available to simply reduce the stiffness of fibrotic scars, nor 
would that necessarily be a beneficial option. In many cases, especially in systolic heart failure, 
the body forms the stiff scar tissue to maintain the integrity of the myocardium, preventing 
rupture of the ventricle. Reducing the stiffness of fibrotic tissue may alleviate the positive 
feedback cycle leading to the myofibroblast phenotype, but it could have disastrous effects on 
the patient. 
 Mechanical stimulation, both interstitial fluid flow and cyclic strain, were applied to 
represent the stress exerted on cells in vivo. Cyclic strain was used to mimic the beating of the 
heart during systole and diastole, while interstitial fluid flow was employed to account for the 
perfusion of capillaries within the tissue.  However, the magnitude and frequency of these stimuli 
did not match the in vivo rat heart. For instance, the neonatal rat heart rate is about 300 bpm, and 
there have been no estimates of the interstitial flow rates in the rat heart. Nonetheless, the study 
provides an indication of how the fibroblasts respond to two different modes of mechanical stress 
(shear from fluid flow versus structural strain from the deformation of the matrix). The results 
indicate that the fibroblasts respond differently to these two modes, which has implications for 
how the fibroblasts behave in a scar environment. As mentioned, the scar is characterized by 
increased stiffness, reduced cyclic strain, but the persistence of perfusion from microvasculature. 
The ability of fibroblasts to distinguish between two different modes of mechanical stimulation 
may help explain why the microenvironment of the scar instigates the myofibroblast transition. 
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The present work also identifies key pathways that are involved in the myofibroblast 
transition, and can be used to influence the development of treatments that prevent scar growth. 
For example, AT1R inhibitors have been used for many years to block the renin-angiotensin 
system to treat hypertension. By identifying the role of this receptor in the myofibroblast 
transition, the results lend credence to the use of losartan as an anti-fibrotic agent. Moreover, by 
identifying how cyclic strain and interstitial fluid flow differentially affect fibroblast phenotype, 
the present study produces questions about how LVADs affect myocardial fibrosis. For example, 
by unloading the left ventricle, the solid and fluid mechanics are substantially altered, perhaps in 
a manner that facilitates or attenuates scar growth. The results can also be applied to in vivo scar 
conditions, which are characterized by decreased cyclic strain due to death of the cardiomyocytes 
as well as the presence of interstitial fluid flow from the scar microvasculature. 
 There are still several questions that have not been answered by this work. The following 
bullet points detail areas of future work: 
 What MSC paracrine factor is being affected by mechanical stress?  And what is the 
fate of other stem markers after mechanical stimulation?  What lineage are the MSC 
committing to? 
 
  Determine how cyclic strain is being transduced by the cell.  What receptor(s) are 
activated by cyclic strain in a three-dimensional environment? 
 
 Use the collagen hydrogel/myofibroblast model to study cell delivery methods. 
 
 Can the hydrogel/myofibroblast model be used as a testing platform for evaluating the 
potential of patients‘ stem cells to attenuate fibrotic scar growth? 
 
 Adapt the current testing platform to include simultaneous hypoxia and mechanical 
stimulation that is more comparable to in vivo levels. 
 
 
This dissertation demonstrates in vitro that the presence of MSC in the collagen hydrogel 
significantly reduces the myofibroblast transition. However, the results do not identify a 
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mechanism for this beneficial effect. Future work may involve performing more ELISAs to 
determine the paracrine factor induced by mechanical stress. Other assays can be used to 
determine if the MSC are differentiating, beyond observing cd90 expression. Moreover, studies 
can be performed to determine what lineage the cells are differentiating into. Another ambiguity 
is the identity of the receptor through which cyclic strain is transduced in the 3D collagen 
hydrogel. Because the receptor would be sensing structural deformation, it is plausible that 
integrins may be responsible for the mechanism. Nonetheless, the cyclic stretch could be 
affecting ion channels and other cell surface receptors not involved in cell adhesion. Future 
assays could use shRNA to block certain receptors, similar to the method used in this study to 
block AT1R, to identify the responsible receptor. 
 Finally, the collagen hydrogel model has potential to be used as a testing platform to 
further study cell delivery methods as well as to assess the ability of a patient‘s MSC to produce 
a beneficial effect in the heart. One of the major issues with cell therapy is the successful 
engraftment of the cells to the tissue. The collagen hydrogel model presented in this study can be 
used to test these delivery methods, which may include encapsulating the cells in a protein 
matrix prior to injection. The model presents a platform to study the effects of mechanical and 
biochemical stimuli on cell attachment and viability during delivery. Moreover, because the 
collagen gel mimics certain aspects of the in vivo myocardium, it can be used to assess how a 
patient‘s MSC might behave once injected. For this reason, combining hypoxia with more 
relevant mechanical stimulation may more faithfully represent the in vivo microenvironment. For 
example, prior to delivery, MSC can be isolated from a patient and injected into the hydrogel as 
described previously. The behavior of the cells could be observed in the in vitro environment, to 
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predict their response in vivo. Future work will involve identifying metrics to differentiate MSC 
that will be beneficial from those that will not produce an improvement.  
 It is clear that the fields of biomechanics and regenerative medicine have yet to fully 
bridge the gap between traditional engineering approaches and rigorous cell and molecular 
biology. For example, many of the tissue engineering approaches currently rely on ―letting the 
body do the work‖. Understanding how cells behave in the in vivo microenvironment will not 
only aid tissue engineering approaches, but will also assist in the comprehension of pathology. 
For these reasons, comprehending the mechanism of cell response to stimuli like mechanical 
stress is crucial. This advance will involve both improvements in understanding cell 
biomechanics, as well as development in applying new molecular and biological approaches to 
discerning cell response. As the work in this dissertation implies, further work is required to 
better characterize the in vivo mechanical environment before these advancements can be made. 
Nonetheless, the present work is an example of how understanding cell mechanics in vitro has 
significance to characterizing cell behavior in vivo. 
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Chapter VI 
 
Appended Works 
 
6.1  Selected Protocols 
6.1.1  Mechanical Testing of Released Collagen Gels 
 
Materials needed 
 Delrin compression platens 
 Stainless steel spatula 
 Thumb drive 
 Ruler 
 Digital camera 
 
Setup  
1.  Turn on the controller (large black box) and the computer 5-10 minutes prior to turning 
on the power supply (gray box). 
2. Open the application ―Start 1st 800‖, and wait until window opens. 
3. Open the application ―V2‖. 
4. Click File > Open, and choose any file. 
5. Click ―Switch On‖ to engage the power supply. 
6. Click the ―DAQ‖ button and set the destination file, sampling rate, and starting 
specification (manual, automatic, time delayed, etc.) 
7. Click Settings > Offset Readout 
8. Move LVDT or encoder at 5 mm intervals to position the platen before testing (< is 
compression, and > is tension). 
9. Click Test and choose either dynamic or static. 
10. For manual DAQ, click ―start recording‖ prior to clicking ―start test‖. 
11. Once the test is completed, click ―stop recording‖. 
12. Either repeat the testing, or shut down the machine by closing the V2 and start 1st 
applications. 
 
Testing tips 
1. Decrease the platen height by 0.5 mm until a substantial change in load is observed, to 
ascertain contact with the sample.  Once contact is made, then offset the readout of the 
encoder. 
2. Take a picture of the sample after contact has been made, with a ruler in the frame, to 
measure the starting height of the gel (and to estimate levels of strain). 
3. Prior to testing, compress the sample at 10% strain/s to about 5-10% strain before 
returning platen to original height, in order to precondition the gel. 
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4. Never strain the sample more than 15-20% strain, to keep within the limits of 
infinitesimal strain assumption. 
 
Analysis 
1. Convert the ―encoder‖ column to a ―strain‖ column using the change in height divided by 
the original height. 
2. Convert the ―load‖ column to a ―stress‖ column by calculating the cross-sectional area of 
the sample (from the digital image used to determine height), and changing grams force 
to Newtons (multiply by 0.00981). 
3. Plot the stress versus strain and take the slope in a linear region near 10% strain. 
 
6.1.2.  Quantitative reverse transcription PCR 
Materials needed 
 
 TRIzol reagent 
 1.5 mL microcentrifuge tubes 
 Chloroform 
 Isopropanol 
 75% ethanol 
 DNAse free water 
 Temperature-controlled microcentrifuge  
 Hotplate 
 Nanodrop, or some method to quantify nucleic acid 
 
RNA isolation 
 
1. Add 0.2 μL of TRIzol to a 1 mL gel in a 1.5 mL microcentrifuge tube 
2. Manually homogenize the gel until collagen gel fragments transition from white to 
reddish in color 
3. Pipette the solution up and down 5 times until fragments are nearly invisible. 
4. Add 0.8 μL of TRIzol to the solution, and let incubate at room temperature for 5 minutes. 
5. Either place in -80 C freezer or use in the next step. 
6. Add 0.2 μL of chloroform, and shake vigorously by hand for 15 seconds. 
7. Incubate at room temperature for 2.5 to 3 minutes. 
8. Centrifuge at 12 g at 4 C for 15 minutes. 
9. Remove the clear portion in the top layer, and add to 0.5 μL of isopropanol. 
10. Incubate for 10 minutes at room temperature, then centrifuge at 12 g, 4 C for 10 minutes. 
11. Remove the supernatant, and replace with 1 mL of the 75% ethanol solution. 
12. Vortex for 15 seconds.  There should be a white RNA pellet visible during vortexing. 
13. Centrifuge at 7.5 g at 4 C for 5 minutes. 
14. Remove supernatant, and let incubate with the cap open for 7.5-10 minutes. 
15. Add 26 μL of RNAse free water, and incubate at 55 C for 10 minutes. 
16. Quantify the RNA using the nanodrop. 
17. (optional) dilute samples to create a uniform RNA quantity prior to qRT-PCR. 
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Reverse Transcription and PCR 
 
1. Follow the instructions on the reverse transcription (RT) kit to create the correct mixture. 
2. Add 25 μL of the RNA solution to 25 μL of the RT cocktail. 
3. Run the ―cDNA‖ program in Limin‘s file directory in the thermal cycler (~2.5 hrs in 
length). 
4. Create dilutions of the selected primers, and dilutions of the cDNA mixtures according to 
the Excel worksheet entitled ―Taqman RTPCR‖ in the protocols folder. 
5. Run the Applied Biosystems PCR program, following the instruction manual for setup 
and operation.  It is important to change the second temperature step from 20 seconds to 
2 minutes. 
 
6.1.3.  Immunofluorescence 
 
Materials needed 
 
 Triton X-100 
 3.7% paraformaldehyde 
 Normal goat serum 
 Primary antibodies 
 Secondary antibodies 
 PBS 
 
Fixing  
 
1. Wash sample 3x in PBS 
2. Add 1 mL of paraformaldehyde for each 1 mL of collagen gel 
3. Incubate on the shaker for 10-20 minutes 
4. Repeat step 1 
5. Either store the sample at 37 C and 5% CO2, or begin the blocking step immediately 
 
Blocking/Permeabilizing 
 
1. Add 1 mL of PBS containing 0.1% X-100 and 5% NGS for each 1 mL of collagen gel 
2. Incubate at 37 C and 5% CO2 for 30 minutes. 
3. Wash sample 3x in PBS 
 
Primary/secondary staining 
 
1. Make a PBS cocktail containing 0.1% X-100 and 2% NGS in addition to primary 
antibodies in the correct dilutions. 
2. Incubate at 37 C and 5% CO2 for 45 minutes, or at 4 C for up to two days. 
3. Wash sample 3x in PBS, in consecutive 10 minute steps. 
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4. If using monoclonal antibodies derived from the same species, incubate sample with Fab 
fragments at 37 C and 5% CO2 for 30-45 minutes, followed by 3x washes in PBS. 
5. Incubate with correct secondary antibodies at 37 C and 5% CO2 for 30-45 minutes. 
6. Wash 3x in PBS and visualize with the confocal microscope. 
 
 
6.1.4  Western blotting 
 
Materials needed  (Westfall lab, except antibodies) 
 
 
 Pyrex dishes   
 Saran wrap     
 Transfer apparatus 
 Running apparatus 
 TBS 
 Methanol 
 Ethanol 
Trizma base 
Glycine 
 TBS-T 
 Dry milk 
 Polyacrylimide gel 
 PVDF transfer membrane 
 Primary/secondary antibodies 
 
Sample preparation 
 
1. Homogenize the gel in Garner buffer, with phosphatase inhibitors added for 
phosphorylation studies, into gel fragments 
2. Vortex samples, and continue manual homogenization with a pestle. 
3. Spin down the samples at 2 g for 20 seconds, in order to separate the large collagen 
fragments from the lighter cellular protein. 
4. Centrifuge the supernatant at 12 g for 15 minutes, and then dissolve in sample buffer. 
5. Boil the samples for 3 minutes, and then sonicate them for 10 minutes. 
 
Running the gel 
  
1. Create a polyacrylimide gel of desired PA percentage, or purchase a BioRad gel. 
2. Wash the gel lanes with DI water, and aspirate after soaking at room temperature for 5 
minutes. 
3. Fill the lanes with samples, dissolved in sample buffer. 
4. Run the gel at 200 V and 25 mA for 2-3 hours, depending on the molecular weight of the 
protein. 
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Transfer the gel 
 
1. Remove the gel from the running apparatus (and its cassette if using a BioRad gel). 
2. Soak the gel in transfer buffer for 15 minutes. 
3. Cut a piece of transfer membrane that fits the gel, and soak in methanol for 15 seconds. 
4. Remove the membrane from the methanol, and wash in ddH2O for 10 minutes. 
5. Soak the membrane in transfer buffer for an additional 10 minutes. 
6. Create a sandwich of the gel, the transfer membrane, and chromatography paper (in that 
order), and place in the transfer apparatus. 
7. Run the transfer apparatus at 50 V and 500 mA overnight. 
 
Staining the membrane 
 
1. To normalize protein loading, the blot can be stained for GAPDH or another 
housekeeping protein, or the gel can be silver stained (see silver staining protocol). 
2. Wash blot 3x in TBS. 
3. Block the blot in TBS containing 5% dry milk in TBS-T for 45 minutes. 
4. Wash blot 3x in TBS-T. 
5. Incubate in TBS-T, 5% dry milk mixture containing primary antibodies in the correct 
dilutions at room temperature for an hour or at 4 C overnight. 
6. Wash blot 3x in TBS-T. 
7. Incubate in TBS-T, 5% dry milk mixture containing secondary antibodies for an hour at 
room temperature. 
8. Wash blot 2x in TBS-T 
9. Wash blot once in TBS 
 
Visualizing the blot using chemiluminescence  
 
1. Place the blot in Pierce substrate for 15 seconds. 
2. Use undeveloped film to visualize the gel 
 
6.1.5  Lentiviral delivery 
 
Materials needed 
 Lentiviral particles 
 Polybrene 
 Puromycin 
 Culture media 
 Tissue culture plates 
 PBS 
 
Preparation 
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1. First, determine the lowest concentration of puromycin able to kill 99% of the cells on the 
tissue culture plastic.  For neonatal cardiac fibroblasts and rat-derived MSC, this is about 
2.5 mg/mL. 
2. Second, determine the highest concentration of polybrene that does not affect cell 
viability. 
3. Find an estimate of cell proliferation after plating.  For example, count the cells 12, 24, 
48 hours after plating to get an idea of how many cells there will be a day or two after 
plating. 
4. From this number, calculate the number of particles needed for the desired MOI. It is 
recommended that the infection be made at 60-70% confluency. 
 
Infection 
 
1. At time of infection, remove media and wash 3x with PBS. 
2. Replace with media containing polybrene in the predetermined concentration. 
3. Use a pipette to add the lentiviral particles dropwise in different locations of the tissue 
culture plate. 
4. Incubate the cells and the lentiviral particles for 12-16 hours at 37 C and 5% CO2. 
5. After incubation, aspirate particle-containing media and wash 3x in PBS. 
 
Cell Isolation 
 
1. To isolate infected cells, add culture media containing puromycin 
2. After 48 hours, wash the plate thoroughly and replace with non-puromycin media 
3. Monitor the cells for a day or two to assure normal cell growth 
4. Split the cells and freeze to store or use them immediately. 
 
 
6.1.6  Operation of flow/strain wells 
 
Materials needed 
 
 Acrylic chamber 
 Inlet tubing and luer inlets 
 PDMS wells 
 HEPES buffer 
 Culture medium 
 Nylon grips 
 Stainless steel fittings 
 Forceps 
 
Preparation 
 
1. Autoclave all pieces of the apparatus, including tubing, luers, and gripping apparatus. 
2. Prepare HEPES containing media by adding 15 mM HEPES. 
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3. Sterilize the acrylic chamber by filling it with 50% bleach, sealing it, and incubating it at 
room temperature overnight. Prior to use, wash in ddH2O 10-15 times. 
 
Setup 
 
1. Attach the lower fitting to the acrylic bath, and fill about ¼ way with HEPES-containing 
media. 
2. Fit the PDMS well into the grip, using the bottom fitting to attach the grip to the bath. 
3. Fill the media past the PDMS wells, to assure the samples don‘t dry out, and to submerge 
the inlet dowels for flow experiments. 
4. Remove the dowels, and use forceps to insert the inlet tube into the PDMS well inlets. 
5. For flow-only experiments, cover the top of the acrylic chamber with parafilm, with a 
0.22 μm hole fixed on top of punctured holes to allow sufficient respiration. 
6. For strain experiments, affix the top grip to the PDMS chamber and use parafilm to create 
a pseudo cap on the acrylic chamber. 
 
Operation 
 
1. Place the assembly into the large water bath underneath the mechanical testing platen. 
2. Attach the stainless fittings to the top platen and the bottom surface of the bath. 
3. Refer to the mechanical testing protocol to set cyclic strain parameters. 
4. For flow, attach the inlet tubes to a syringe, placed in a syringe pump with a specified 
volume flow rate. 
 
6.1.7  Stem cell injection into collagen hydrogels 
 
Materials needed 
 Micro-manipulator (Mayer lab) 
 25 gauge needle, 1 ½ ― in length 
  
 
1. Set the position of the micro-manipulator to determine the angle of injection (this can be 
done using a protractor or ruler with a digital camera and ImageJ. 
2. Determine the penetration distance, using the knobs to specify the exact distance. 
3. Dilute the stem cells in a high concentration, to minimize the amount of fluid needed for 
injection. 
4. When injecting, move the manipulator quickly using the joystick.  At slower penetration 
speed, the gel is not punctured correctly, and the cells do not enter the collagen gel. 
5. To assure successful injection, the stereoscope can be used to indicate the injection cone 
and the presence of any cells within the gel. 
6. Incubate for an hour at 37 C and 5% CO2 for two hours to allow for cell attachment. 
7. Add culture media to the gels after 2 hours. 
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6.2 Adult cardiomyocyte response to substrates of varying stiffness 
Introduction: 
 Substrates with tunable stiffness provide crucial information about how cells sense and 
respond to the mechanics of their environment. This tool has been used with substantial success 
for controlling stem cell fate [1], discerning the contractility of smooth muscle cells and other 
mesenchymal cell types [2,3], and observing the response of neonatal cardiomyocytes to the 
stiffness environment of the developing heart [4,5,6]. However, few studies have observed the 
effect of substrate stiffness on adult cardiomyocytes. In vivo, the cells secrete a basement 
membrane containing laminin and collagen IV that allows for integration with the myocardial 
extracellular matrix. An exciting field of research is emerging to understand how the 
extracellular microenvironment, especially its mechanical aspect, affects cardiomyocyte 
function. The goal of such research is to identify the mechanisms by which this cell-matrix 
interaction malfunctions in pathology, so that treatments can be developed to impede heart 
failure. The present study uses tunable stiffness substrates to study the effect of extracellular 
compliance on sarcomere and costamere organization and cardiomyocyte contraction dynamics. 
 The question of how cardiomyocytes sense strain is crucial for understanding how these 
cells regulate their contraction/relaxation dynamics during systole and diastole, and multiple 
studies have identified proteins associated with a ―stretch sensor‖ mechanism [7,8]. But it is 
intuitive that cardiomyocytes would also have a ―stress sensor‖, considering the changes in 
myocardial stiffness that occur as a result of pathology (myocardial infarction, hypertrophic 
cardiomyopathies, etc.) as well as aging. Atomic force microscopy measurements of fibrotic 
myocardium elastic moduli have found values between 20 and 55 kPa [9,10], compared to 2 and 
8 kPa for the non-fibrotic myocardium as determined by MRI [11]. Though it is often difficult to 
quantitatively compare elastic moduli measured by different methods [12], fibrotic tissue is 
characterized by increased extracellular matrix that facilitates a stiffer environment. A recent 
study indicated that substrate stiffness resembling a fibrotic scar inhibited beating of embryonic 
cardiomyocytes [13].  
 Proteins involved in the mechanism of sensing stretch have been identified in both the 
sarcomere and the costamere complex [7]. The function of the costamere is to couple the z disk 
to the basement membrane, so that force generated by the sarcomere can be translated to the 
surrounding extracellular matrix. The costamere complex encompasses membrane receptors 
including integrins β1 and α7 [14]. Integrin β1 is an important surface receptor in 
cardiomyocytes, regulating cell matrix interactions [15] and even playing a role in cytoprotection 
[16]. Integrins are anchored to the z-disk by structural proteins including vinculin, talin, desmin, 
and zyxin [8]. The z-disk complex is a complicated array of proteins that also includes 
candidates for the stretch sensing mechanism, with α-actinin forming the backbone of the 
structure. Recent studies have indicated that the z-disk is among the initial targets for 
deterioration during isoproterenol-induced adult cardiomyocyte apoptosis [17], suggesting that z-
disk integrity is a crucial indicator of cardiomyocyte function.  
 In the present study, components of both costamere and sarcomere structure and function 
in culture are analyzed in response to substrate stiffness. Adult cardiomyocytes in culture beat 
spontaneously and undergo a slow dedifferentiation process, which involves changes in the 
cytoskeleton and t-tubule structure [18,19]. The calcium handling in these cells also changes 
with time, possibly due to influx through protein kinase A-activated L-type Ca
2+
 channels [20]. 
To determine how the stiffness of the extracellular environment affects these properties, isolated 
125 
 
cardiomyocytes are plated on different stiffness substrates coated with laminin and cultured for 
48 hours. The organization of α-actinin and integrin β1 is observed with immunofluoresence, and 
message levels of proteins associated with the sarcomere and costamere are measured using 
quantitative reverse transcription PCR. Calyculin A, a general phosphotase inhibitor, is used to 
determine if the effects are related to some proteolytic activity. Finally, cells are paced at three 
different time points to determine how the changes in cell structure affect the function of the 
cardiomyocytes, as well as to identify any time-dependence in the cell response. 
 
Methods: 
Cell Isolation and Culture: Adult rat ventricular cardiomyocytes were isolated as previously 
described [21]. Hearts from Sprague–Dawley rats were enzymatically digested in a modified 
Langendorff perfusion apparatus to isolate the cardiomyocytes.  The protocol was approved by 
The University of Michigan University Committee on Use and Care of Animals (UCUCA) in 
accordance with university guidelines. 2.0 x 10
4
 cells were plated on PDMS coated with 40 
μg/mL of laminin in M199 supplemented with 5% fetal bovine serum, 50 U/mL penicillin, and 
50 μg/mL streptomycin for 2 hours. After that period, the media was replaced with M199 
supplemented with 10 mM HEPES, 0.2 mg/ml bovine serum albumin, 10 mM glutathione, and 
the same concentrations of penicillin and streptomycin. For experiments involving calyculin A, 
0.5 μg/mL of the phosphotase inhibitor was added to the media. 
 
PDMS Substrate Fabrication and Validation: The base and curing agent of Sylgard 184 were 
mixed in ratios of 10:1, 20:1, 30:1, and 50:1 by weight, and 1 mL of the elastomer was cured in 6 
well polystyrene plates, creating approximately 1 mm thick slabs. For experiments that required 
electric field stimulation, blocks of the elastomer were cut out of the 6 well plate and bonded to 
glass coverslips. Prior to coating with laminin, the PDMS was etched with 5 M sulfuric acid for 
60-90 minutes, washed thoroughly in distilled water, and sterilized using a UV lamp for 30 
minutes. To determine elastic modulus, the elastomer was molded in a rectangular mold with 
defined width and length. A uniaxial mechanical testing system was used to apply a 20% total 
strain at a rate of 10%/s. The elastic modulus was calculated by taking the slope of the 
stress/strain curve at approximately 10% strain, in order to keep within the limits of linear strain 
theory. PDMS mixed in ratios of 10:1, 20:1, 30:1, and 50:1 produced mean moduli of 255 kPa, 
117 kPa, 27 kPa, and 7 kPa respectively. 
 
Immunofluoresence: After 48 hours in culture, cells were fixed, permeabilized, and stained using 
previously described protocols [3].  Immunostains included fluorescent DAPI (1:50 dilution), 
phalloidin (1:50) conjugated to Alexa Fluor 488, and monoclonal mouse antibodies for α-actinin 
(1:500) and integrin β1 (1:50). A secondary Texas Red-tagged anti-mouse antibody was used to 
visualize these proteins. Cells were visualized using confocal microscopy. Projection image Z-
stacks of approximately 10 μm were collected using a confocal microscope.  
 
Immunoblotting:  After 48 hours in culture, cells were lysed in ice cold sample buffer(24.77% 
glycerol, 1.63% SDS, 0.1 M Trizma stacking buffer, 3.31% Bromophenol Blue stock solution, 
24.88 mM DTT, 1.78 mM leupeptin), and then stored at -20C. In preparation for protein 
separation, samples were boiled for 3 min, sonicated for 10 min. Protein separation was 
performed as previously described [21] using 12% or 4-12% gradient SDS-polyacrylimide 12 
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well gels (Bio-Rad), and then transferred onto a PVDF membrane overnight.  The PVDF 
membrane was then blocked in either 5% dry nonfat milk or BSA, washed in Tris buffered saline 
(TBS), and incubated overnight at 4
oC with either a mouse monoclonal antibody against α-
actinin (1:5000) The next day, blots were rinsed with TBS and incubated for 45 minutes at room 
temperature with HRP-linked anti-mouse secondary antibodies (1:2000). Gels were silver stained 
and a representative protein band was used to normalize for protein loading on the blot. 
Immunodetection was visualized with chemiluminescence using Pierce ECL Western Blotting 
substrate (Thermo-Fisher). 
 
 
qRT-PCR: A guanidium thiocyanate-phenol-chloroform extraction protocol (TRIzol) was  used 
to isolate mRNA from the cells after 48 hours in culture. Briefly, cells were dissolved in TRIzol, 
buffer, and reverse  transcription of mRNA was performed with a high-capacity cDNA Archive 
Kit and a C-1000 Thermocycler. The quantitative PCR protocol is described in a previous 
publication [3]. 
 
Cell Shortening Assay: At 2, 24, and 48 hours, PDMS coverslips were transferred to a 
stimulation chamber mounted on a Nikon microscope stage. A video-based detection system 
(Ionoptix) was used to determine sarcomere shortening in response to 40V, 0.2 Hz electrical 
shortening.  
 
Calcium Transient Assay: At 2, 24, and 48 hours, cells on PDMS coverslips were loaded with 5 
μM Fura-2 AM for 4.5 minutes at 37C followed by a 4 minute wash in media without Fura-2 
AM for de-esterification. Coverslips were again transferred to a stimulation chamber and paced 
using 40V amplitude at 0.2 Hz frequency. Calcium transients were measured by taking the ratio 
of emission at 510 nm from excitations at 360 nm and 380 nm. 
 
Statistical Analysis: Data was expressed as mean+SE. For comparisons of immunoblotting and 
message levels, an unpaired Student's t test was used to determine statistical significance for 
comparisons between two groups, with p<0.05 considered significantly different. For grouped 
comparisons of the contractility and calcium transients, a two-way analysis of variance 
(ANOVA) followed by Bonferroni‘s multiple comparison test (P<.05) was used to compare 
multiple groups using GraphPad Prism 5 software. 
 
Results: 
Effect of substrate stiffness on α-actinin and integrin β1 organization  
To assess the structural changes in response to substrate stiffness, α-actinin and integrin 
β1 were visualized using immunofluorescence. As Figure 1 indicates, the organization of α-
actinin into uniform, periodic z-disks is substantially affected by substrate stiffness.  Despite the 
changes to z-disk integrity, the morphology of all the cells appears to be uniform, with 
predominantly binucleated, rod-shaped cells on the substrates. At 255 kPa and 7 kPa (Fig. 1A, 
1D), the α-actinin staining produces a clearly defined sarcomeric pattern that is not clearly 
apparent for cells seeded on substrate stiffnesses of 117 kPa (Fig. 1B) and completely absent for 
cells on 27 kPa substrates (Fig. 1C). Nonetheless, at these intermediate stiffnesses, the antibody 
does produce positive staining. This indicates that α-actinin, or at least an immunoreactive 
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degradation product, is still present in the cytoplasm. Immunoblotting was used to quantify the 
amount of α-actinin present within the cells, and to determine if any immunoreactive degradation 
products were being produced by the cells seeded on substrates with stiffness values of 117 and 
27 kPa. As Figure 2 indicates, the blot does not indicate the presence of any degradation 
products.  Rather, the amount of α-actinin within cells appears to be constant for all the substrate 
stiffness values tested, even though Figure 1 indicates a substantial affect on α-actinin 
immunofluoresence. This result suggests that the effect of substrate stiffness on α-actinin 
organization is not due to decreased levels of the protein.  
 To determine the effect of substrate stiffness on the costamere complex, integrin β1 was 
visualized using immunofluoresence. In cells seeded on 255 kPa and 7 kPa substrates, the 
integrin β1 appears to colocalize with the z-disk of the sarcomere (Fig. 3A, 3D). As for the 
results of the α-actinin staining, this pattern disappears for cells on the 117 kPa and 27 kPa 
substrates (Fig. 3B, 3C). In cells on intermediate stiffness, the integrin β1 appears to be spread 
homogeneously throughout the cell, with small blotches of positive staining. It is impossible to 
tell if these areas of positive staining correspond to the location of z-disks. Nonetheless, in cells 
plated on the 255 kPa and 7 kPa substrates, the β1 staining nearly illuminates the entire z-disk. 
Again, the immunofluorescence images indicate that the general cell morphology is unchanged 
despite the cytoskeletal alterations. 
  
Effect of substrate stiffness on message level  
Having shown that substrate stiffness affects the organization of key proteins in the 
sarcomere and costamere complex, qRT-PCR was used to determine its effect on message levels. 
Messages of α-actinin and integrin β1 were measured because of the immunofluoresence and 
immunoblotting results. Additionally, the messages of integrin α7 and vinculin, two other 
costamere-related proteins were also measured. For cells plated on 117 kPa substrates, messages 
for integrin α7 and vinculin were significantly increased compared to the levels at 255 kPa 
(Figure 4B, 4D). For cells on 27 kPa substrates, the messages for all four proteins measured 
significantly increased (Figure 4). In contrast, no messages for cells on 7 kPa substrates had any 
significant difference to the 255 kPa levels. Hence, although cells on intermediate stiffness show 
substantial disorganization of a sarcomere-related protein (α-actinin) and a costamere-related 
protein (integrin β1), the message levels of these and other related proteins are actually 
increasing. Hence, substrate stiffness affects the cells not only at a protein level, but also at a 
transcriptional level. 
 
Addition of calyculin A 
The general phosphotase inhibitor, calyculin A, was used to determine if the sarcomere 
and costamere disorganization caused by plating on intermediate stiffness involved proteolytic 
activity within the cells. The α-actinin immunofluorescence and immunoblotting assays were 
repeated for cells cultured in calyculin A-containing media. As Figure 5 indicates, cells plated on 
all substrates presented clear z-disk organization, and immunoblotting again showed no 
significant difference in α-actinin protein levels (data not shown). Interestingly, the present of 
calyculin did have a substantial effect on general cell morphology. This effect is especially 
apparent in cells on 255 kPa substrates, which display actin fibers of varying orientation and a 
loss of the usual rod-shaped morphology (Figure 5a). Cells plated on the other substrates also 
showed varying levels of actin uniformity and rod-shaped morphology. Hence, the presence of 
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calyculin A is affecting various cell processes in addition to blocking the degradation of the 
sarcomere and costamere structure at intermediate stiffness substrates.  
 
Cell contractility assays   
Cardiomyocytes were paced at different times in culture to understand how the described 
changes in sarcomere and costamere organization affected cross bridge cycling at different time 
points in culture. Moreover, these tests were used to demonstrate that varying substrate stiffness 
was not solely determining cell stretch and consequently the preload on the cardiomyocytes. For 
instance, if cardiomyocytes exerted the same level of force regardless of substrate stiffness, the 
cells on softer substrates would always have higher levels of strain and the observed changes 
could be caused solely by levels of stretch. Rather, the results of the contraction assay indicate 
that after 2 hours, all the cells contract roughly the same amount (Figure 6).  At 24 hours, cells 
on the intermediate stiffness (24 kPa) actually contract the most, even higher than cells plated on 
the 7 kPa substrates. These results indicate that the varying substrate stiffness is affecting the 
stress generated within the cardiomyocytes, not just the levels of strain. These transient results 
also indicate that the cell response is an adaptive, time-dependent process. 
For cells plated on the stiffest substrate, 255 kPa, shortening amplitude decreased 
significantly at the 24 hour time point, but recovered by the 48 hour time point. This recovery in 
amplitude was not mirrored in departure or return velocities, which were significantly less at 
both the 24 and 48 hour time points. Cells on the 27 kPa substrates followed a similar trend, with 
significantly less shortening amplitude and velocities at 48 hours. However, in contrast to cells 
on the stiff substrate, shortening amplitude in these cells increased significantly between the 2 
and 24 hour time points. Cells on the 7 kPa substrate exhibited significant increases in shortening 
amplitude and velocities at 48 hours. Hence, even though cells plated on 255 kPa and 7 kPa 
substrates both exhibited normal α-actinin and integrin β1 organization, their shortening 
dynamics follow nearly opposite trends over the 48 hours in culture. 
 
Calcium transient assays 
Having shown that the shortening trends produced by substrate stiffness is an adaptive 
response, the calcium transients were measured to determine if the sarcomere degradation at the 
intermediate stiffness was caused by increases in calcium signaling. Previous studies have 
postulated that increased calcium transients, either by PKA activation of L-type channels or 
inositol trisphosphate (which facilitates calcium release from the sarcoplasmic reticulum), are 
associated with negative cardiomyocyte function [17]. Moreover, the calcium transient is often 
an indicator of force generation in the cardiomyocyte, and should be closely tied to the 
shortening response of the cells. However, the calcium transient of cells plated on the 27 kPa 
substrate significantly decreases at the 24 hour time point (Fig. 7), even though the shortening 
for this data point is significantly increased (Fig. 6). This result indicates that the adaptive 
response of cardiomyocytes is not mediated solely through calcium signaling. 
In cells plated on 255 kPa substrates, the amplitude and velocity of the calcium transient 
does not significantly change over the 48 hour testing period. Cells plated on 7 kPa substrates 
also have relatively constant calcium transients over the testing period. There was no significant 
difference between cells on the two substrates, with the lone exception being the departure 
velocity of the calcium transient at the 48 hour time point. As mentioned, the calcium transient in 
cells plated at 27 kPa significantly decreased at the 24 hour time point. These cells had transient 
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amplitudes and velocities significantly less than cells plated at 255 kPa at the 24 hour time point. 
The return velocity was also significantly less compared to cells on 255 kPa substrates at the 48 
hour time point. Hence, even though higher calcium gradients are often associated with negative 
cell effects, the cells displaying the sarcomere and costamere degradation had a significant drop 
in calcium signaling at the 24 hour time point. 
 
Discussion: 
 The results of this study provide further evidence that cardiomyocytes are affected by the 
mechanical stiffness of their extracellular environment, and that the stress sensor in 
cardiomyocytes may be sensitive to a specific range of substrate stiffness. Although the present 
paper does not attempt to identify a specific mechanism by which cardiomyocytes transduce 
mechanical information from the extracellular environment beyond blocking phosphotase 
activity, it suggests that the myocyte mechanotransduction mechanism exhibits nonlinear 
behavior. For many other cell types, there is a specific range of substrate stiffness that produces 
normal cell function. The results described in this study suggest there is a range of substrate 
stiffness that instigates degradation of a crucial structure in the myocyte. This finding has 
obvious implications for the study of scar growth following myocardial infarction, as well as the 
appropriateness of culturing these cells on laminin-coated glass and plastic substrates. 
 Using PDMS substrates with defined stiffness values, immunofluoresence indicated that 
for substrates between 27 and 117 kPa, α-actinin is not organized in discrete z-disk structures, 
and integrin β1 doesn‘t colocalize to the z-disk. Immunoblotting showed that there are still equal 
amounts of α-actinin within the cells plated on different substrates, but qRT-PCR showed that 
cells upregulated expression of α-actinin as well as integrins β1 and α7 and vinculin. This change 
in transcription indicates that information about the structure disorientation might be signaled 
back to the nucleus in a feedback loop. Moreover, because immunoblotting indicates equal 
amounts of protein within the cell despite message upregulation, these results suggest that there 
may be some level of proteolytic activity occurring in the cells. Interestingly, the detrimental 
effects of the intermediate stiffness substrates were attenuated by the phosphotase inhibitor, 
calyculin A. Assays for cardiomyocyte contractility and calcium transients indicated that even 
though cells on 255 kPa and 7 kPa substrates both retain their sarcomere and costamere structure, 
their dynamics under pacing can be quite different. Sarcomere shortening significantly increased 
by the 48 hour time point in cells on 7 kPa, whereas cells on 255 kPa exhibited significantly less 
shortening at that time.  
 Moreover, the fact that cardiomyocytes on soft substrates did not sustain larger 
contractions demonstrates that the cardiomyocyte can be modeled as a dynamically controlled 
system with some element of sensing, actuating, and feedback. If the cardiomyocyte were an 
open loop system, it would exert the same amount of force despite the substrate stiffness. 
Instead, the contractility and calcium transient data indicates a complex, time-dependent 
response to the stiffness of the extracellular substrate that suggests there is a stress sensor located 
in the sarcomere and/or costamere. Additionally, the results of the message levels provide 
evidence of some feedback to the nucleus of the structural changes occurring in the myocyte 
cytoskeleton. Considering the differences between the trends in calcium transients and 
contractility, it is clear that these mechanisms cannot be explained solely by changes in calcium 
handling. 
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 As mentioned, the results of this study have clear clinical implications. Although the 
majority of cardiomyocytes in a fibrotic scar following infarction die immediately due to 
ischemia, the cardiomyocytes in the border zone eventually die off. This facilitates scar growth 
and eventual heart failure. The stiffness in and surrounding the scar is increased due to 
augmented matrix deposition, and it is possible that the tissue reaches stiffness values that 
promote the structural deformations described in the present study. If the mechanism by which 
these cells sense extracellular stiffness can be discerned, then perhaps the pathways responsible 
for the malfunction can be blocked to create a cytoprotective effect. Hence, future work will 
focus on identifying that mechanism, for which there are plenty of candidates from all the studies 
seeking the cardiomyocyte stretch sensor.  
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Figure 1:  Immunofluorescence images of z-disk organization after 48 hours in culture on 
different substrate stiffnesses. Actin is stained by a conjugated phalloidin-FITC antibody, cell 
nuclei with DAPI, and α-actinin of the z-disk with a monoclonal antibody.  Images are 150 x 150 
μm. 
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Figure 2:  Immunoblot of cell homogenates from cardiomyocytes seeded on substrates with 
elastic moduli ranging from 255 kPa to 7 kPa for 48 hours. The blot in (A) shows representative 
lanes for three of the stiffnesses and (B) displays the quantification of the immunoblots. 
 
134 
 
Figure 3  Immunofluorescence images of integrin β1 colocalization with the Z disk after 48 hours 
in culture on different substrate stiffnesses. Actin is stained by a conjugated phalloidin-FITC 
antibody, cell nuclei with DAPI, and integrin β1 with a monoclonal antibody. 
 
 
 
 
 
135 
 
Figure 4:  Message levels of four proteins associated with the sarcomere (α-actinin) and 
costamere complex (integrin α7, integrin β1, and vinculin) for cells seeded on substrates of four 
different elastic moduli at 48 hours. Significance from the 255 kPa message is denoted with a *, 
indicating p < 0.05.   
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Figure 5:  Immunofluorescence images of z-disk organization after 48 hours in culture on 
different substrate stiffnesses with the addition of 0.5 μg/mL of calyculin A. Actin is stained by a 
conjugated phalloidin-FITC antibody, cell nuclei with DAPI, and α-actinin of the z-disk with a 
monoclonal antibody. 
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Figure 6:  Contractility tests of cardiomyocytes plated for 2, 24, and 48 hours on substrates with 
elastic moduli of 255, 27, and 7 kPa.  The left column shows averaged traces of sarcomere 
shortening at 2, 24, and 48 hours during electrical stimulation.  The right column displays 
quantification of total shortening amplitude, departure velocity, and return velocity.  A + 
denotes significance (p < 0.05) compared to the 2 hour time point for each stiffness value, and a 
* denotes significance (p < 0.05) compared to the 255 kPa stiffness value for each time point, as 
determined by Bonferroni posttests following a two-way ANOVA. 
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Figure 7:  Intracellular calcium flux for cardiomyocytes plated for 2, 24, and 48 hours on 
substrates with elastic moduli of 255, 27, and 7 kPa.  The left column shows averaged traces of 
the calcium transients of cells electrically stimulated at 2, 24, and 48 hours.  The right column 
displays quantification of total shortening amplitude, departure velocity, and return velocity.  A 
+ denotes significance (p < 0.05) compared to the 2 hour time point for each stiffness value, and 
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a * denotes significance (p < 0.05) compared to the 255 kPa stiffness value for each time point, 
as determined by Bonferroni posttests following a two-way ANOVA. 
 
6.3 Statistical Analysis 
6.3.1 Serum and matrix effects on fibroblast phenotype 
Compaction of released gels, Figure 4.1 
Welch Two Sample t-test – null hypothesis comparisons not included. 
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1.  data:  M199 6 hours 
t = -8.0481, df = 2.906, p-value = 0.004493 
alternative hypothesis: true difference in means is not equal to 0  
95 percent confidence interval: 
 -0.18455874 -0.07858126  
sample estimates: 
mean of x mean of y  
0.2782667 0.4098367 
 
2.  data:  M199 24 hours  
t = -3.8999, df = 3.199, p-value = 0.02662 
alternative hypothesis: true difference in means is not equal to 0  
95 percent confidence interval: 
 -0.12430591 -0.01473859  
sample estimates: 
mean of x mean of y  
0.2341000 0.3036222 
 
3.  data:  M199 48 hours 
t = -6.1346, df = 4.942, p-value = 0.001742 
alternative hypothesis: true difference in means is not equal to 0  
95 percent confidence interval: 
 -0.13300863 -0.05425837  
sample estimates: 
mean of x mean of y  
0.1367590 0.2303925  
 
4.  data:  M199 120 hours 
t = -5.0726, df = 2.666, p-value = 0.01958 
alternative hypothesis: true difference in means is not equal to 0  
95 percent confidence interval: 
 -0.08613980 -0.01675636  
sample estimates: 
 mean of x  mean of y  
0.08133867 0.13278675 
 
5.  data:  DMEM 6 hours 
t = -4.2184, df = 2.327, p-value = 0.03955 
alternative hypothesis: true difference in means is not equal to 0  
95 percent confidence interval: 
 -0.076791803 -0.004288197  
sample estimates: 
mean of x mean of y  
  0.32630   0.36684 
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6.  data:  DMEM 24 hours  
t = -8.8441, df = 3.995, p-value = 0.0009071 
alternative hypothesis: true difference in means is not equal to 0  
95 percent confidence interval: 
 -0.06230362 -0.03252172  
sample estimates: 
mean of x mean of y  
0.2544707 0.3018833 
 
7.  data:  DMEM 48 hours 
t = -2.6051, df = 5.318, p-value = 0.0452 
alternative hypothesis: true difference in means is not equal to 0  
95 percent confidence interval: 
 -0.070397705 -0.001099228  
sample estimates: 
mean of x mean of y  
0.1950313 0.2307798 
 
8.  data:  DMEM 120 hours 
t = -2.4967, df = 7, p-value = 0.04119 
alternative hypothesis: true difference in means is not equal to 0  
95 percent confidence interval: 
 -0.050762698 -0.001378702  
sample estimates: 
mean of x mean of y  
0.1797965 0.2058672 
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Released gel message levels (1: 5%,6hrs, 2: 10%,6hrs, 3: 5%,24hrs, 4: 10%,24hrs, etc.), 
Figures 4.4-4.5 
 
Post-hoc Tukey tests after one way ANOVAs 
M199, col1a1  
 
>col1a1=c(0.532,0.613,0.6058,0.773,0.902,0.787,0.7699,0.538,0.563,0.561,0.772,0.719,0.440,0.
364,0.3453,0.316,0.456,0.457,0.531,0.387,0.542,0.466,0.47,0.389,0.4514,0.404,0.314,0.429,0.42
4,0.56,0.393,0.416); 
> time=c(rep(1,3),rep(2,4),rep(3,3),rep(4,3),rep(5,3),rep(6,6),rep(7,5),rep(8,5)); 
> time=as.factor(time); 
> TukeyHSD(aov(col1a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = col1a1 ~ time) 
 
$time 
           diff         lwr           upr     p adj 
2-1  0.22437500  0.03845962  0.4102903816 0.0105553 
3-1 -0.02960000 -0.22835190  0.1691519031 0.9995910 
4-1  0.06006667 -0.13868524  0.2588185698 0.9698324 
5-1 -0.24183333 -0.44058524 -0.0430814302 0.0097694 
6-1 -0.11043333 -0.28255753  0.0616908638 0.4281169 
7-1 -0.17792000 -0.35568911 -0.0001508936 0.0496976 
8-1 -0.13920000 -0.31696911  0.0385691064 0.2065699 
3-2 -0.25397500 -0.43989038 -0.0680596184 0.0029801 
4-2 -0.16430833 -0.35022371  0.0216070483 0.1108789 
5-2 -0.46620833 -0.65212371 -0.2802929517 0.0000004 
6-2 -0.33480833 -0.49193551 -0.1776811575 0.0000067 
7-2 -0.40229500 -0.56558635 -0.2390036490 0.0000006 
8-2 -0.36357500 -0.52686635 -0.2002836490 0.0000032 
4-3  0.08966667 -0.10908524  0.2884185698 0.8030440 
5-3 -0.21223333 -0.41098524 -0.0134814302 0.0304991 
6-3 -0.08083333 -0.25295753  0.0912908638 0.7706533 
7-3 -0.14832000 -0.32608911  0.0294491064 0.1518542 
8-3 -0.10960000 -0.28736911  0.0681691064 0.4768342 
5-4 -0.30190000 -0.50065190 -0.1031480969 0.0008649 
6-4 -0.17050000 -0.34262420  0.0016241972 0.0534772 
7-4 -0.23798667 -0.41575577 -0.0602175602 0.0037118 
8-4 -0.19926667 -0.37703577 -0.0214975602 0.0204707 
6-5  0.13140000 -0.04072420  0.3035241972 0.2311043 
7-5  0.06391333 -0.11385577  0.2416824398 0.9268929 
8-5  0.10263333 -0.07513577  0.2804024398 0.5562325 
7-6 -0.06748667 -0.21488502  0.0799116897 0.7915290 
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8-6 -0.02876667 -0.17616502  0.1186316897 0.9976788 
8-7  0.03872000 -0.11523256  0.1926725622 0.9892190 
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DMEM, col1a1  
 
>col1a1=c(1.393,1.282691,1.1718,1.382,1.004,1.363,1.227,0.7402,0.9257,0.862,0.731,0.8346,0.
665,0.865,0.5835,0.7074,0.4811,0.577,0.46,0.5999,0.733,0.597,0.289,0.304,0.3477,0.40244,0.67
4,0.382,0.386,0.3914,0.346,0.394,0.316,0.471,0.1888,0.3697,0.32213,0.296); 
> time=c(rep(1,3),rep(2,4),rep(3,5),rep(4,5),rep(5,5),rep(6,4),rep(7,6),rep(8,6)); 
> time=as.factor(time); 
> TukeyHSD(aov(col1a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = col1a1 ~ time) 
 
$time 
            diff        lwr          upr     p adj 
2-1 -0.038497000 -0.3207109  0.243716945 0.9998072 
3-1 -0.463797000 -0.7336451 -0.193948855 0.0001077 
4-1 -0.622097000 -0.8919451 -0.352248855 0.0000006 
5-1 -0.689117000 -0.9589651 -0.419268855 0.0000001 
6-1 -0.946712000 -1.2289259 -0.664498055 0.0000000 
7-1 -0.853597000 -1.1148763 -0.592317657 0.0000000 
8-1 -0.955225333 -1.2165047 -0.693945990 0.0000000 
3-2 -0.425300000 -0.6731713 -0.177428651 0.0001105 
4-2 -0.583600000 -0.8314713 -0.335728651 0.0000004 
5-2 -0.650620000 -0.8984913 -0.402748651 0.0000000 
6-2 -0.908215000 -1.1694943 -0.646935657 0.0000000 
7-2 -0.815100000 -1.0536143 -0.576585683 0.0000000 
8-2 -0.916728333 -1.1552426 -0.678214017 0.0000000 
4-3 -0.158300000 -0.3919953  0.075395349 0.3776352 
5-3 -0.225320000 -0.4590153  0.008375349 0.0650503 
6-3 -0.482915000 -0.7307863 -0.235043651 0.0000138 
7-3 -0.389800000 -0.6135463 -0.166053738 0.0000872 
8-3 -0.491428333 -0.7151746 -0.267682071 0.0000016 
5-4 -0.067020000 -0.3007153  0.166675349 0.9801132 
6-4 -0.324615000 -0.5724863 -0.076743651 0.0040583 
7-4 -0.231500000 -0.4552463 -0.007753738 0.0385035 
8-4 -0.333128333 -0.5568746 -0.109382071 0.0008437 
6-5 -0.257595000 -0.5054663 -0.009723651 0.0371807 
7-5 -0.164480000 -0.3882263  0.059266262 0.2813424 
8-5 -0.266108333 -0.4898546 -0.042362071 0.0112132 
7-6  0.093115000 -0.1453993  0.331629317 0.9026563 
8-6 -0.008513333 -0.2470276  0.230000983 1.0000000 
8-7 -0.101628333 -0.3149620  0.111705357 0.7746776 
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M199, col3a1   
 
>col3a1=c(0.532,0.452,0.613,0.8899,0.5249,0.7802,0.9014,0.521,0.606,0.4892,0.644,0.68,0.449
,0.616,0.844,0.352,0.274,0.437,0.432,0.4252,0.719,0.783,0.941,0.9477,1.122,0.620,0.634,0.762,
0.8055,0.7427,0.7481,1.237,1.437,1.439,1.4822,0.932,0.845,1.437,1.581,1.627); 
> time=c(rep(1,3),rep(2,4),rep(3,6),rep(4,7),rep(5,4),rep(6,7),rep(7,4),rep(8,5)); 
> time=as.factor(time); 
> TukeyHSD(aov(col3a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = col3a1 ~ time) 
 
$time 
            diff         lwr        upr     p adj 
2-1  0.241766667 -0.22778111 0.71131444 0.7067279 
3-1  0.032533333 -0.40218344 0.46725010 0.9999969 
4-1 -0.049447619 -0.47368775 0.37479251 0.9999358 
5-1  0.315341667 -0.15420611 0.78488944 0.3921213 
6-1  0.243995238 -0.18024489 0.66823537 0.5843787 
7-1  0.866466667  0.39691889 1.33601444 0.0000293 
8-1  0.752066667  0.30309312 1.20104022 0.0001417 
3-2 -0.209233333 -0.60607364 0.18760697 0.6823008 
4-2 -0.291214286 -0.67654952 0.09412095 0.2537574 
5-2  0.073575000 -0.36114177 0.50829177 0.9992370 
6-2  0.002228571 -0.38310666 0.38756380 1.0000000 
7-2  0.624700000  0.18998323 1.05941677 0.0012546 
8-2  0.510300000  0.09789146 0.92270854 0.0073079 
4-3 -0.081980952 -0.42401428 0.26005237 0.9932361 
5-3  0.282808333 -0.11403197 0.67964864 0.3201178 
6-3  0.211461905 -0.13057142 0.55349523 0.4958051 
7-3  0.833933333  0.43709303 1.23077364 0.0000028 
8-3  0.719533333  0.34726413 1.09180253 0.0000131 
5-4  0.364789286 -0.02054595 0.75012452 0.0740278 
6-4  0.293442857 -0.03517213 0.62205785 0.1078272 
7-4  0.915914286  0.53057905 1.30124952 0.0000002 
8-4  0.801514286  0.44153460 1.16149397 0.0000009 
6-5 -0.071346429 -0.45668166 0.31398880 0.9986396 
7-5  0.551125000  0.11640823 0.98584177 0.0056231 
8-5  0.436725000  0.02431646 0.84913354 0.0317741 
7-6  0.622471429  0.23713620 1.00780666 0.0002459 
8-6  0.508071429  0.14809174 0.86805111 0.0015806 
8-7 -0.114400000 -0.52680854 0.29800854 0.9840733 
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DMEM, col3a1  
 
>col3a1=c(0.835,0.9108,0.9833,0.451,0.669,0.7899,0.6,0.626,0.791,0.526,0.824,1.288,0.439,0.3
73,0.434,0.343,0.397,1.201,1.288,1.521,1.534,0.563,0.753,0.817,0.917,0.861,1.07,1.663,1.711,1.
4923,1.24,1.46,2.33,2.21,2.193); 
>  time=c(rep(1,3),rep(2,4),rep(3,5),rep(4,5),rep(5,4),rep(6,6),rep(7,3),rep(8,5)); 
> time=as.factor(time); 
>  TukeyHSD(aov(col3a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = col3a1 ~ time) 
 
$time 
           diff         lwr         upr     p adj 
2-1 -0.28222500 -0.90518996  0.34073996 0.8081382 
3-1 -0.09870000 -0.69436844  0.49696844 0.9992531 
4-1 -0.51250000 -1.10816844  0.08316844 0.1311537 
5-1  0.47630000 -0.14666496  1.09926496 0.2347101 
6-1 -0.07953333 -0.65628682  0.49722015 0.9997762 
7-1  0.71240000  0.04642244  1.37837756 0.0296937 
8-1  0.97690000  0.38123156  1.57256844 0.0002622 
3-2  0.18352500 -0.36363140  0.73068140 0.9512860 
4-2 -0.23027500 -0.77743140  0.31688140 0.8582359 
5-2  0.75852500  0.18177152  1.33527848 0.0041390 
6-2  0.20269167 -0.32380982  0.72919316 0.9046333 
7-2  0.99462500  0.37166004  1.61758996 0.0003803 
8-2  1.25912500  0.71196860  1.80628140 0.0000010 
4-3 -0.41380000 -0.92966400  0.10206400 0.1884983 
5-3  0.57500000  0.02784360  1.12215640 0.0342531 
6-3  0.01916667 -0.47473551  0.51306884 1.0000000 
7-3  0.81110000  0.21543156  1.40676844 0.0028054 
8-3  1.07560000  0.55973600  1.59146400 0.0000061 
5-4  0.98880000  0.44164360  1.53595640 0.0000628 
6-4  0.43296667 -0.06093551  0.92686884 0.1179899 
7-4  1.22490000  0.62923156  1.82056844 0.0000077 
8-4  1.48940000  0.97353600  2.00526400 0.0000000 
6-5 -0.55583333 -1.08233482 -0.02933184 0.0330265 
7-5  0.23610000 -0.38686496  0.85906496 0.9113407 
8-5  0.50060000 -0.04655640  1.04775640 0.0912985 
7-6  0.79193333  0.21517985  1.36868682 0.0025485 
8-6  1.05643333  0.56253116  1.55033551 0.0000039 
8-7  0.26450000 -0.33116844  0.86016844 0.8228921 
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M199, TGF-beta  
>tgfbeta=c(1,1.206,1.4748,1.169,1.2014,1.174,1.727,2.7933,2.402,2.0718,1.349,1.717,1.536,1.5
36,1.037,1.156,1.198,1.145,0.7609,0.749,0.707562,0.987,0.79,1.107,0.743,1.070,0.8814); 
> time=c(rep(1,4),rep(2,3),rep(3,3),rep(4,4),rep(5,3),rep(6,3),rep(7,3),rep(8,4)); 
> time=as.factor(time); 
> TukeyHSD(aov(tgfbeta~time),conf.level=0.95); 
Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = tgfbeta ~ time) 
 
$time  
           diff        lwr         upr     p adj 
2-1  0.15501667 -0.4028744  0.71290769 0.9774046 
3-1  1.20991667  0.6520256  1.76780769 0.0000134 
4-1  0.32205000 -0.1944567  0.83855672 0.4409338 
5-1 -0.08211667 -0.6400077  0.47577435 0.9995276 
6-1 -0.32748333 -0.8853744  0.23040769 0.5126691 
7-1 -0.38426267 -0.9421537  0.17362835 0.3255497 
8-1 -0.26210000 -0.7786067  0.25440672 0.6753356 
3-2  1.05490000  0.4584894  1.65131059 0.0002016 
4-2  0.16703333 -0.3908577  0.72492435 0.9662738 
5-2 -0.23713333 -0.8335439  0.35927725 0.8689342 
6-2 -0.48250000 -1.0789106  0.11391059 0.1691658 
7-2 -0.53927933 -1.1356899  0.05713125 0.0941385 
8-2 -0.41711667 -0.9750077  0.14077435 0.2395410 
4-3 -0.88786667 -1.4457577 -0.32997565 0.0007129 
5-3 -1.29203333 -1.8884439 -0.69562275 0.0000136 
6-3 -1.53740000 -2.1338106 -0.94098941 0.0000011 
7-3 -1.59417933 -2.1905899 -0.99776875 0.0000006 
8-3 -1.47201667 -2.0299077 -0.91412565 0.0000007 
5-4 -0.40416667 -0.9620577  0.15372435 0.2712610 
6-4 -0.64953333 -1.2074244 -0.09164231 0.0158470 
7-4 -0.70631267 -1.2642037 -0.14842165 0.0076021 
8-4 -0.58415000 -1.1006567 -0.06764328 0.0200958 
6-5 -0.24536667 -0.8417773  0.35104392 0.8488078 
7-5 -0.30214600 -0.8985566  0.29426459 0.6770272 
8-5 -0.17998333 -0.7378744  0.37790769 0.9504772 
7-6 -0.05677933 -0.6531899  0.53963125 0.9999743 
8-6  0.06538333 -0.4925077  0.62327435 0.9998954 
8-7  0.12216267 -0.4357284  0.68005369 0.9942532 
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DMEM, TGF-beta  
>tgfbeta=c(1.20144,1.5686,1.511,1.544,1.129,0.989,2.304,2.426,2.3835,1.397,2.124,1.639,1.383
,1.499,1.544,2.155,2.378,1.73,1.358,1.529,1.708,1.114212,1.1119,0.75585,1.0684,1.574,1.828,1.
292,1.876,1.342,2.193); 
> time=c(rep(1,3),rep(2,3),rep(3,3),rep(4,3),rep(5,4),rep(6,5),rep(7,4),rep(8,6)); 
> time=as.factor(time); 
> TukeyHSD(aov(tgfbeta~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = tgfbeta ~ time) 
 
$time 
           diff         lwr         upr     p adj 
2-1 -0.20634667 -1.04091430  0.62822096 0.9899351 
3-1  0.94415333  0.10958570  1.77872096 0.0191074 
4-1  0.29298667 -0.54158096  1.12755430 0.9333296 
5-1  0.21823667 -0.56242987  0.99890320 0.9797350 
6-1  0.31358667 -0.43287331  1.06004665 0.8496339 
7-1 -0.41442283 -1.19508937  0.36624370 0.6478160 
8-1  0.25715333 -0.46560344  0.97991010 0.9288632 
3-2  1.15050000  0.31593237  1.98506763 0.0028000 
4-2  0.49933333 -0.33523430  1.33390096 0.5094483 
5-2  0.42458333 -0.35608320  1.20524987 0.6211529 
6-2  0.51993333 -0.22652665  1.26639331 0.3272109 
7-2 -0.20807617 -0.98874270  0.57259037 0.9844922 
8-2  0.46350000 -0.25925677  1.18625677 0.4251161 
4-3 -0.65116667 -1.48573430  0.18340096 0.2081928 
5-3 -0.72591667 -1.50658320  0.05474987 0.0812501 
6-3 -0.63056667 -1.37702665  0.11589331 0.1413358 
7-3 -1.35857617 -2.13924270 -0.57790963 0.0001587 
8-3 -0.68700000 -1.40975677  0.03575677 0.0705968 
5-4 -0.07475000 -0.85541653  0.70591653 0.9999780 
6-4  0.02060000 -0.72585998  0.76705998 1.0000000 
7-4 -0.70740950 -1.48807603  0.07325703 0.0952030 
8-4 -0.03583333 -0.75859010  0.68692344 0.9999998 
6-5  0.09535000 -0.59031728  0.78101728 0.9997297 
7-5 -0.63265950 -1.35541627  0.09009727 0.1164212 
8-5  0.03891667 -0.62086698  0.69870031 0.9999992 
7-6 -0.72800950 -1.41367678 -0.04234222 0.0320400 
8-6 -0.05643333 -0.67536525  0.56249859 0.9999842 
8-7  0.67157617  0.01179252  1.33135981 0.0440244 
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M199, alpha-sma  
>Malphsma=c(1,0.8827,0.8062,0.7435,0.499,0.4503,0.4124,0.3578,0.249,0.2300,0.213009,0.07
1,0.134,0.294,0.2208,0.271,0.5432,0.2037,0.089,0.105,0.419,0.345,0.402,0.378,0.417,0.656861,
0.5491,0.491,0.3781,0.3978,0.4233); 
> time=c(rep(1,4),rep(2,4),rep(3,3),rep(4,4),rep(5,3),rep(6,6),rep(7,3),rep(8,4)); 
> time=as.factor(time); 
> TukeyHSD(aov(Malphsma~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = Malphsma ~ time) 
 
$time 
           diff          lwr         upr     p adj 
2-1 -0.42822500 -0.693077060 -0.16337294 0.0004211 
3-1 -0.62743033 -0.913503254 -0.34135741 0.0000050 
4-1 -0.67815000 -0.943002060 -0.41329794 0.0000004 
5-1 -0.51880000 -0.804872921 -0.23272708 0.0000894 
6-1 -0.56843333 -0.810209080 -0.32665759 0.0000016 
7-1 -0.31711300 -0.603185921 -0.03104008 0.0226723 
8-1 -0.43555000 -0.700402060 -0.17069794 0.0003382 
3-2 -0.19920533 -0.485278254  0.08686759 0.3275188 
4-2 -0.24992500 -0.514777060  0.01492706 0.0740012 
5-2 -0.09057500 -0.376647921  0.19549792 0.9603848 
6-2 -0.14020833 -0.381984080  0.10156741 0.5469328 
7-2  0.11111200 -0.174960921  0.39718492 0.8929647 
8-2 -0.00732500 -0.272177060  0.25752706 1.0000000 
4-3 -0.05071967 -0.336792588  0.23535325 0.9986898 
5-3  0.10863033 -0.197194483  0.41445515 0.9294310 
6-3  0.05899700 -0.205855060  0.32384906 0.9945847 
7-3  0.31031733  0.004492517  0.61614215 0.0450382 
8-3  0.19188033 -0.094192588  0.47795325 0.3711982 
5-4  0.15935000 -0.126722921  0.44542292 0.5940537 
6-4  0.10971667 -0.132059080  0.35149241 0.7952409 
7-4  0.36103700  0.074964079  0.64710992 0.0070021 
8-4  0.24260000 -0.022252060  0.50745206 0.0891862 
6-5 -0.04963333 -0.314485394  0.21521873 0.9981382 
7-5  0.20168700 -0.104137817  0.50751182 0.3913691 
8-5  0.08325000 -0.202822921  0.36932292 0.9747241 
7-6  0.25132033 -0.013531727  0.51617239 0.0713842 
8-6  0.13288333 -0.108892413  0.37465908 0.6093353 
8-7 -0.11843700 -0.404509921  0.16763592 0.8585796 
150 
 
 
DMEM, alpha-sma  
 
>Dasma=c(0.556,0.5456,0.60155,0.39,0.4354,0.3556,0.223,0.0138,0.007558,0.009328,0.035,0.0
34644,0.03255,0.017,0.0161,0.0184,0.009,0.0147,0.017,0.23,0.2255,0.2375,0.1357,0.02,0.036,0.
045,0.044,0.484,0.526605,0.45172,0.4329,0.41063,0.1546,0.15597,0.1654,0.1446,0.208); 
> time=c(rep(1,3),rep(2,4),rep(3,6),rep(4,6),rep(5,4),rep(6,4),rep(7,5),rep(8,5)); 
> time=as.factor(time); 
> TukeyHSD(aov(Dasma~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = Dasma ~ time) 
 
$time 
           diff         lwr         upr     p adj 
2-1 -0.21671667 -0.31564773 -0.11778560 0.0000019 
3-1 -0.54557000 -0.63716237 -0.45397763 0.0000000 
4-1 -0.55235000 -0.64394237 -0.46075763 0.0000000 
5-1 -0.36054167 -0.45947273 -0.26161060 0.0000000 
6-1 -0.53146667 -0.63039773 -0.43253560 0.0000000 
7-1 -0.10654567 -0.20114186 -0.01194947 0.0188806 
8-1 -0.40200267 -0.49659886 -0.30740647 0.0000000 
3-2 -0.32885333 -0.41246535 -0.24524132 0.0000000 
4-2 -0.33563333 -0.41924535 -0.25202132 0.0000000 
5-2 -0.14382500 -0.23541737 -0.05223263 0.0004287 
6-2 -0.31475000 -0.40634237 -0.22315763 0.0000000 
7-2  0.11017100  0.02327885  0.19706315 0.0058985 
8-2 -0.18528600 -0.27217815 -0.09839385 0.0000031 
4-3 -0.00678000 -0.08156486  0.06800486 0.9999875 
5-3  0.18502833  0.10141632  0.26864035 0.0000016 
6-3  0.01410333 -0.06950868  0.09771535 0.9992035 
7-3  0.43902433  0.36058931  0.51745935 0.0000000 
8-3  0.14356733  0.06513231  0.22200235 0.0000430 
5-4  0.19180833  0.10819632  0.27542035 0.0000008 
6-4  0.02088333 -0.06272868  0.10449535 0.9908490 
7-4  0.44580433  0.36736931  0.52423935 0.0000000 
8-4  0.15034733  0.07191231  0.22878235 0.0000201 
6-5 -0.17092500 -0.26251737 -0.07933263 0.0000314 
7-5  0.25399600  0.16710385  0.34088815 0.0000000 
8-5 -0.04146100 -0.12835315  0.04543115 0.7710476 
7-6  0.42492100  0.33802885  0.51181315 0.0000000 
8-6  0.12946400  0.04257185  0.21635615 0.0008693 
8-7 -0.29545700 -0.37737971 -0.21353429 0.0000000 
 
151 
 
 
 
 
Mechanical testing of released gels, Figure 4.6 
Welch Two Sample t-test – null hypothesis comparisons not included. 
 
1.  data: M199, 6hrs, elastic modulus, 5% vs. 10%  
t = -3.6019, df = 3.448, p-value = 0.02917 
alternative hypothesis: true difference in means is not equal to 0  
95 percent confidence interval: 
 -6622.3472  -646.9862  
sample estimates: 
mean of x mean of y  
 18290.00  21924.67 
 
2.  data:  M199, 6hrs, phase angle, 5% vs. 10%  
t = -22.5061, df = 3.935, p-value = 2.636e-05 
alternative hypothesis: true difference in means is not equal to 0  
95 percent confidence interval: 
 -21.17529 -16.49737  
sample estimates: 
mean of x mean of y  
 18.29033  37.12667 
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6.3.2 Mechanical and biochemical stimulation of fibroblasts 
Control conditions (1: initial, 2: 48hr, 3: 72hr), Figure 4.14 
 
Post-hoc Tukey tests after one way ANOVAs 
Col1a1 
 
>Mcol1=c(1,1.082,1.4075,1,1.1578,1,0.684,1.494,1,1.017,1.7566,1.631,1.3775,1.118,0.966,0.89
7,1.188,1.218,1.166,1.338,1.535,2.542,2.541,2.225,1.795,1.796); 
> time=c(rep(1,10),rep(2,11),rep(3,5)); 
> time=as.factor(time); 
> TukeyHSD(aov(Mcol1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = Mcol1 ~ time) 
 
$time 
       diff        lwr       upr     p adj 
2-1 0.20587 -0.0962987 0.5080387 0.2243602 
3-1 1.09557  0.7167815 1.4743585 0.0000007 
3-2 0.88970  0.5166949 1.2627051 0.0000125  
 
 
Col3a1 
 
>col3a1=c(1,0.972,1.017,0.767,1,0.955,1,0.811,1.234,1,0.843,2.027,1.552,1.419,1.8883,1.009,1.
416,1.347,2.818,3.095,3.99,4.492); 
> time=c(rep(1,11),rep(2,7),rep(3,4)); 
> time=as.factor(time); 
> TukeyHSD(aov(col3a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = col3a1 ~ time) 
 
$time 
         diff        lwr      upr    p adj 
2-1 0.5590688 0.09793706 1.020201 1.62e-02 
3-1 2.6352045 2.07833503 3.192074 0.00e+00 
3-2 2.0761357 1.47834181 2.673930 1.00e-07 
 
TGF-beta 
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>tgfbeta=c(1,1.004,1.059,0.613,1,1.0798,1,0.745,1.096,1,0.735,0.245,0.525,0.333,0.385,0.5501,
0.667,0.626,0.404,0.3008,0.462,0.4402); 
> time=c(rep(1,11),rep(2,7),rep(3,5)); 
> time=as.factor(time); 
> TukeyHSD(aov(tgfbeta~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = tgfbeta ~ time) 
 
$time 
          diff        lwr         upr     p adj 
2-1 -0.3470688 -0.5346775 -0.15946013 0.0004054 
3-1 -0.4926545 -0.7019408 -0.28336827 0.0000230 
3-2 -0.1455857 -0.3727911  0.08161971 0.2601283 
 
alpha-SMA 
 
>alphasma=c(1,1.0613,1.2332,0.84556,1,1.465,1,0.6114,0.8978,1,0.712,3.24,2.965,2.993,3.552,
4.50,3.722); 
> time=c(rep(1,11),rep(2,3),rep(3,3)); 
> time=as.factor(time); 
> TukeyHSD(aov(alphasma~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = alphasma ~ time) 
 
$time 
         diff       lwr      upr     p adj 
2-1 2.0817945 1.6046771 2.558912 0.0000001 
3-1 2.9404612 2.4633437 3.417579 0.0000000 
3-2 0.8586667 0.2605682 1.456765 0.0056287 
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Flow/Strain/Hypoxia (1: initial, 2: control, 3: flow, 4: strain, 5: flow+strain, 6: hypoxia), 
Figure 4.15 
 
Post-hoc Tukey tests after one way ANOVAs 
Col1a1 
 
>Mcol1=c(1,1.082,1.4075,1,1.1578,1,0.684,1.494,1,1.017,1.7566,1.631,1.3775,1.118,0.966,0.89
7,1.188,1.218,1.166,1.338,1.535,1.172,1.244,1.3402,1.608,1.6704,1.093765,0.8942,0.855258,1.0
8533,0.97,0.873,1.44593,1.25576,1.534882,0.828,0.96,1.266,1.103); 
> time=c(rep(1,10),rep(2,11),rep(3,5),rep(4,6),rep(5,3),rep(6,4)); 
> time=as.factor(time); 
> TukeyHSD(aov(Mcol1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = Mcol1 ~ time) 
 
$time 
            diff         lwr         upr     p adj 
2-1  0.205870000 -0.08452120  0.49626120 0.2909117 
3-1  0.322690000 -0.04133463  0.68671463 0.1065743 
4-1 -0.122304500 -0.46551021  0.22090121 0.8867898 
5-1  0.327960667 -0.10954249  0.76546383 0.2363029 
6-1 -0.044980000 -0.43817154  0.34821154 0.9992833 
3-2  0.116820000 -0.24164668  0.47528668 0.9193709 
4-2 -0.328174500 -0.66547939  0.00913039 0.0602980 
5-2  0.122090667 -0.31079897  0.55498031 0.9549126 
6-2 -0.250850000 -0.63890156  0.13720156 0.3889342 
4-3 -0.444994500 -0.84743887 -0.04255013 0.0232199 
5-3  0.005270667 -0.48009551  0.49063684 1.0000000 
6-3 -0.367670000 -0.81350730  0.07816730 0.1553525 
5-4  0.450265167 -0.01968861  0.92021895 0.0666955 
6-4  0.077324500 -0.35168264  0.50633164 0.9937711 
6-5 -0.372940667 -0.88054876  0.13466743 0.2554467 
 
Col3a1 
 
>col3a1=c(1,0.972,1.017,0.767,1,0.955,1,0.811,1.234,1,0.843,2.027,1.552,1.419,1.8883,1.009,1.
416,1.347,2.668,2.191,2.686,1.829,1.797,1.958,2.29,1.94,1.328,2.874,2.628,2.883,2.553,2.337,3.
191,2.617); 
>  time=c(rep(1,11),rep(2,7),rep(3,3),rep(4,6),rep(5,3),rep(6,4)); 
> time=as.factor(time); 
>  TukeyHSD(aov(col3a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
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Fit: aov(formula = col3a1 ~ time) 
 
$time 
          diff        lwr        upr     p adj 
2-1  0.5590688  0.1690900  0.9490476 0.0018925 
3-1  1.5514545  1.0260943  2.0768148 0.0000000 
4-1  0.8934545  0.4840972  1.3028119 0.0000043 
5-1  1.8314545  1.3060943  2.3568148 0.0000000 
6-1  1.7109545  1.2400104  2.1818987 0.0000000 
3-2  0.9923857  0.4357892  1.5489822 0.0001098 
4-2  0.3343857 -0.1143567  0.7831282 0.2366612 
5-2  1.2723857  0.7157892  1.8289822 0.0000019 
6-2  1.1518857  0.6463318  1.6574396 0.0000020 
4-3 -0.6580000 -1.2283417 -0.0876583 0.0166656 
5-3  0.2800000 -0.3785739  0.9385739 0.7829304 
6-3  0.1595000 -0.4565394  0.7755394 0.9667357 
5-4  0.9380000  0.3676583  1.5083417 0.0003411 
6-4  0.8175000  0.2968516  1.3381484 0.0006265 
6-5 -0.1205000 -0.7365394  0.4955394 0.9903398 
 
 
TGF-beta 
 
>tgfbeta=c(1,1.004,1.059,0.613,1,1.0798,1,0.745,1.096,1,0.735,0.245,0.525,0.333,0.385,0.5501,
0.667,0.784,0.6824,1.107,0.793,0.973,0.85,0.587,0.75778,0.502,0.445,0.241,0.348,0.548,0.336,0
.518,0.4035,0.9699,0.7066,0.722,0.305,0.341,0.422,0.3755); 
>  time=c(rep(1,11),rep(2,6),rep(3,8),rep(4,8),rep(5,3),rep(6,4)); 
> time=as.factor(time); 
>  TukeyHSD(aov(tgfbeta~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = tgfbeta ~ time) 
 
$time 
          diff         lwr         upr     p adj 
2-1 -0.4884045 -0.70833678 -0.26847231 0.0000015 
3-1 -0.1224820 -0.32384142  0.07887733 0.4574023 
4-1 -0.5215670 -0.72292642 -0.32020767 0.0000001 
5-1 -0.1397545 -0.42201072  0.14250163 0.6699822 
6-1 -0.5783795 -0.83140003 -0.32535906 0.0000009 
3-2  0.3659225  0.13188805  0.59995695 0.0005275 
4-2 -0.0331625 -0.26719695  0.20087195 0.9980146 
5-2  0.3486500  0.04222697  0.65507303 0.0181286 
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6-2 -0.0899750 -0.36969967  0.18974967 0.9239981 
4-3 -0.3990850 -0.61575880 -0.18241120 0.0000448 
5-3 -0.0172725 -0.31065021  0.27610521 0.9999730 
6-3 -0.4558975 -0.72126763 -0.19052737 0.0001351 
5-4  0.3818125  0.08843479  0.67519021 0.0049207 
6-4 -0.0568125 -0.32218263  0.20855763 0.9864718 
6-5 -0.4386250 -0.76959970 -0.10765030 0.0040418 
 
 
 
Alpha-SMA 
 
>alphasma=c(1,1.0613,1.2332,0.84556,1,1.465,1,0.6114,0.8978,1,0.712,3.24,2.965,2.993,9.91,8.
119,10.802,1.13,0.899,1.507,0.938,0.909,3.022,2.8597,2.727,3.944,4.138,3.554); 
>  time=c(rep(1,11),rep(2,3),rep(3,3),rep(4,3),rep(5,5),rep(6,3)); 
> time=as.factor(time); 
>  TukeyHSD(aov(alphasma~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = alphasma ~ time) 
 
$time 
          diff         lwr        upr     p adj 
2-1  2.0817945   0.7644552  3.3991339 0.0007959 
3-1  8.6261279   7.3087885  9.9434673 0.0000000 
4-1  0.1944612  -1.1228782  1.5118006 0.9970660 
5-1  1.1069345   0.0160739  2.1977952 0.0453819 
6-1  2.8944612   1.5771218  4.2118006 0.0000096 
3-2  6.5443333   4.8929610  8.1957057 0.0000000 
4-2 -1.8873333  -3.5387057 -0.2359610 0.0189847 
5-2 -0.9748600  -2.4518923  0.5021723 0.3448547 
6-2  0.8126667  -0.8387057  2.4640390 0.6478785 
4-3 -8.4316667 -10.0830390 -6.7802943 0.0000000 
5-3 -7.5191933  -8.9962256 -6.0421610 0.0000000 
6-3 -5.7316667  -7.3830390 -4.0802943 0.0000000 
5-4  0.9124733  -0.5645590  2.3895056 0.4144502 
6-4  2.7000000   1.0486277  4.3513723 0.0005324 
6-5  1.7875267   0.3104944  3.2645590 0.0118167 
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Anti-TGFb and losartan (1: initial, 2: control, 3: ctrl+antiTGFb, 4: flow+antiTGFb, 5: 
ctrl+los., 6:flow+los.)- Figure 4.18 
 
Post-hoc Tukey tests after one way ANOVAs 
Col1a1 
 
>col1a1=c(1,1.082,1.4075,1,1.1578,1,0.684,1.494,1,1.017,1.7566,1.631,1.3775,1.118,0.966,0.89
7,1.188,1.218,1.166,1.338,1.535,1.07,1.26,1.105,1.365,1.302,0.937,0.959,1.002,0.856,1.123,1.14
8,1.492,0.851,1.7966,1.748); 
> time=c(rep(1,10),rep(2,11),rep(3,6),rep(4,3),rep(5,3),rep(6,3)); 
> time=as.factor(time); 
> TukeyHSD(aov(col1a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = col1a1 ~ time) 
 
$time 
           diff        lwr       upr     p adj 
2-1  0.20587000 -0.1364277 0.5481677 0.4631918 
3-1  0.08893667 -0.3156159 0.4934893 0.9840868 
4-1 -0.14523000 -0.6609354 0.3704754 0.9538280 
5-1  0.17010333 -0.3456021 0.6858087 0.9132110 
6-1  0.38097000 -0.1347354 0.8966754 0.2470904 
3-2 -0.11693333 -0.5145304 0.2806637 0.9448545 
4-2 -0.35110000 -0.8613672 0.1591672 0.3178621 
5-2 -0.03576667 -0.5460339 0.4745006 0.9999325 
6-2  0.17510000 -0.3351672 0.6853672 0.8991278 
4-3 -0.23416667 -0.7881231 0.3197898 0.7902696 
5-3  0.08116667 -0.4727898 0.6351231 0.9975566 
6-3  0.29203333 -0.2619231 0.8459898 0.6027020 
5-4  0.31533333 -0.3243205 0.9549872 0.6672107 
6-4  0.52620000 -0.1134538 1.1658538 0.1555334 
6-5  0.21086667 -0.4287872 0.8505205 0.9134015 
 
 
Col3a1 
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>col3a1=c(1,0.972,1.017,0.767,1,0.955,1,0.811,1.234,1,0.843,2.027,1.552,1.419,1.8883,1.009,1.
416,1.347,2.334,2.09,1.106,1.365,1.3016,2.01,1.271,1.502,1.588,1.36,1.239,1.529,1.322,1.319,1.
544,1.351,1.7,0.882); 
> time=c(rep(1,7),rep(2,11),rep(3,5),rep(4,4),rep(5,6),rep(6,3)); 
> time=as.factor(time); 
> TukeyHSD(aov(col3a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = col3a1 ~ time) 
 
$time 
           diff         lwr       upr     p adj 
2-1  0.36367662 -0.13815626 0.8655095 0.2655349 
3-1  0.68060571  0.07285591 1.2883555 0.0211618 
4-1  0.63403571 -0.01652158 1.2845930 0.0594788 
5-1  0.42678571 -0.15066544 1.0042369 0.2466426 
6-1  0.35228571 -0.36395429 1.0685257 0.6692948 
3-2  0.31692909 -0.24288893 0.8767471 0.5287183 
4-2  0.27035909 -0.33566169 0.8763799 0.7513685 
5-2  0.06310909 -0.46366053 0.5898787 0.9990689 
6-2 -0.01139091 -0.68743539 0.6646536 0.9999999 
4-3 -0.04657000 -0.74283487 0.6496949 0.9999464 
5-3 -0.25382000 -0.88231806 0.3746781 0.8196059 
6-3 -0.32832000 -1.08631718 0.4296772 0.7732598 
5-4 -0.20725000 -0.87723118 0.4627312 0.9324613 
6-4 -0.28175000 -1.07448242 0.5109824 0.8850483 
6-5 -0.07450000 -0.80842761 0.6594276 0.9995836 
 
Tgf-beta 
 
>tgfbeta=c(1,1.004,1.059,0.613,1,1.0798,1,0.745,1.096,1,0.735,0.245,0.525,0.333,0.385,0.5501,
0.667,0.6,0.474,0.427,0.4167,0.4526,0.417,0.549,0.510,0.672,0.689,0.45,0.516,0.685,0.72,0.527,
0.391,0.6,0.339); 
> time=c(rep(1,11),rep(2,6),rep(3,6),rep(4,6),rep(5,3),rep(6,3)); 
> time=as.factor(time); 
> TukeyHSD(aov(tgfbeta~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = tgfbeta ~ time) 
 
$time 
            diff         lwr         upr     p adj 
2-1 -0.488404545 -0.69473410 -0.28207499 0.0000009 
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3-1 -0.474704545 -0.68103410 -0.26837499 0.0000015 
4-1 -0.374921212 -0.58125076 -0.16859166 0.0000771 
5-1 -0.295254545 -0.56005333 -0.03045576 0.0220452 
6-1 -0.495921212 -0.76072000 -0.23112243 0.0000485 
3-2  0.013700000 -0.22101904  0.24841904 0.9999723 
4-2  0.113483333 -0.12123570  0.34820237 0.6828164 
5-2  0.193150000 -0.09432093  0.48062093 0.3412577 
6-2 -0.007516667 -0.29498760  0.27995427 0.9999995 
4-3  0.099783333 -0.13493570  0.33450237 0.7847610 
5-3  0.179450000 -0.10802093  0.46692093 0.4205840 
6-3 -0.021216667 -0.30868760  0.26625427 0.9999116 
5-4  0.079666667 -0.20780427  0.36713760 0.9563017 
6-4 -0.121000000 -0.40847093  0.16647093 0.7915500 
6-5 -0.200666667 -0.53260951  0.13127618 0.4556610 
 
 
Alpha-SMA 
 
>alphasma=c(1,1.0613,1.2332,0.84556,1,1.465,1,0.6114,0.8978,1,0.712,3.24,2.965,2.993,1.477,
0.97,1.311,1.701,1.3171,1.06,1.371,1.626,1.3601,2.632,3.2268,2.764,3.4373,3.118,3.3771,4.07); 
> time=c(rep(1,11),rep(2,3),rep(3,5),rep(4,4),rep(5,4),rep(6,3)); 
> time=as.factor(time); 
> TukeyHSD(aov(alphasma~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = alphasma ~ time) 
 
$time 
          diff        lwr        upr     p adj 
2-1  2.0817945  1.5077428  2.6558463 0.0000000 
3-1  0.3710145 -0.1043455  0.8463746 0.1913497 
4-1  0.3700695 -0.1445228  0.8846619 0.2639715 
5-1  2.0308195  1.5162272  2.5454119 0.0000000 
6-1  2.5374945  1.9634428  3.1115463 0.0000000 
3-2 -1.7107800 -2.3544205 -1.0671395 0.0000003 
4-2 -1.7117250 -2.3848604 -1.0385896 0.0000006 
5-2 -0.0509750 -0.7241104  0.6221604 0.9998898 
6-2  0.4557000 -0.2639120  1.1753120 0.3938583 
4-3 -0.0009450 -0.5921666  0.5902766 1.0000000 
5-3  1.6598050  1.0685834  2.2510266 0.0000001 
6-3  2.1664800  1.5228395  2.8101205 0.0000000 
5-4  1.6607500  1.0375478  2.2839522 0.0000003 
6-4  2.1674250  1.4942896  2.8405604 0.0000000 
6-5  0.5066750 -0.1664604  1.1798104 0.2221292 
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shRNA  (1: initial, 2: control+scmb, 3: flow+scmb, 4: control+AT1R, 5: flow+AT1R)- 
Figure 4.19 
 
Post-hoc Tukey tests after one way ANOVAs 
col1a1 
 
>col1a1=c(1.043,1,0.821,1.664,1.9667,1.628,0.852,1.919,1.157,2.33,1.875,1.9225,1.132,1.851,1
.5852,1.375); 
> time=c(rep(1,3),rep(2,3),rep(3,3),rep(4,3),rep(5,4)); 
> time=as.factor(time); 
> TukeyHSD(aov(col1a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = col1a1 ~ time) 
 
$time 
          diff         lwr       upr     p adj 
2-1  0.7982333 -0.03936654 1.6358332 0.0640082 
3-1  0.3546667 -0.48293320 1.1922665 0.6574672 
4-1  1.0878333  0.25023346 1.9254332 0.0103489 
5-1  0.5311333 -0.25236960 1.3146363 0.2512748 
3-2 -0.4435667 -1.28116654 0.3940332 0.4650808 
4-2  0.2896000 -0.54799987 1.1271999 0.7941475 
5-2 -0.2671000 -1.05060293 0.5164029 0.8019700 
4-3  0.7331667 -0.10443320 1.5707665 0.0957855 
5-3  0.1764667 -0.60703627 0.9599696 0.9453213 
5-4 -0.5567000 -1.34020293 0.2268029 0.2161338 
 
Col3a1 
 
>col3a1=c(1,1.107,1.186,1,1,1,0.837,2.723,3.071,4.208,1.209,2.70997,3.332,2.69,2.62,3.467,2.4
29,3.209,3.0357); 
> time=c(rep(1,7),rep(2,3),rep(3,2),rep(4,3),rep(5,4)); 
> time=as.factor(time); 
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> TukeyHSD(aov(col3a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = col3a1 ~ time) 
 
$time 
          diff        lwr         upr     p adj 
2-1  2.3154286  1.2722608 3.358596392 0.0000597 
3-1  0.9409136 -0.2711379 2.152965050 0.1670378 
4-1  1.8620952  0.8189274 2.905263059 0.0005656 
5-1  2.0166036  1.0690993 2.964107798 0.0000940 
3-2 -1.3745150 -2.7544963 0.005466314 0.0511313 
4-2 -0.4533333 -1.6876261 0.780959477 0.7810724 
5-2 -0.2988250 -1.4534002 0.855750203 0.9243292 
4-3  0.9211817 -0.4587996 2.301162981 0.2811910 
5-3  1.0756900 -0.2334752 2.384855225 0.1323739 
5-4  0.1545083 -1.0000669 1.309083536 0.9929367 
 
 
TGFb 
 
>tgfbeta=c(1,1.14,1,1.214,1,1,1.081,0.652,0.769,0.4353,0.8105,0.569,0.523,0.576,0.871,1.084,0.
599,0.559,0.505,0.56,0.539,0.469,0.668,0.568); 
> time=c(rep(1,7),rep(2,7),rep(3,2),rep(4,4),rep(5,4)); 
> time=as.factor(time); 
> TukeyHSD(aov(tgfbeta~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = tgfbeta ~ time) 
 
$time 
           diff        lwr        upr     p adj 
2-1 -0.44288571 -0.6078453 -0.2779261 0.0000013 
3-1 -0.08464286 -0.3320822  0.1627965 0.8390401 
4-1 -0.50639286 -0.6998251 -0.3129606 0.0000019 
5-1 -0.50114286 -0.6945751 -0.3077106 0.0000023 
3-2  0.35824286  0.1108035  0.6056822 0.0027911 
4-2 -0.06350714 -0.2569394  0.1299251 0.8577177 
5-2 -0.05825714 -0.2516894  0.1351751 0.8911913 
4-3 -0.42175000 -0.6890151 -0.1544849 0.0011790 
5-3 -0.41650000 -0.6837651 -0.1492349 0.0013424 
5-4  0.00525000 -0.2129710  0.2234710 0.9999932 
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Alpha-SMA 
 
>alphasma=c(1,1,1.2877,1,1,0.977,4.87,4.34,4.356,3.711,4.216,7.24,8.853,4.34,4.216,3.711,3.79
97,3.3975); 
> time=c(rep(1,6),rep(2,5),rep(3,2),rep(4,3),rep(5,2)); 
> time=as.factor(time); 
> TukeyHSD(aov(alphasma~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = alphasma ~ time) 
 
$time 
         diff       lwr        upr     p adj 
2-1  3.254483  2.442294  4.0666725 0.0000001 
3-1  7.002383  5.907228  8.0975389 0.0000000 
4-1  3.044883  2.096451  3.9933159 0.0000013 
5-1  2.554483  1.459328  3.6496389 0.0000464 
3-2  3.747900  2.625699  4.8701005 0.0000009 
4-2 -0.209600 -1.189137  0.7699369 0.9587248 
5-2 -0.700000 -1.822201  0.4222005 0.3343491 
4-3 -3.957500 -5.181921 -2.7330788 0.0000012 
5-3 -4.447900 -5.789186 -3.1066138 0.0000009 
5-4 -0.490400 -1.714821  0.7340212 0.7178401 
 
 
6.3.3 Effect of MSC injection on fibroblast phenotype 
 
Message levels of adjacent fibroblasts (1: initial, 2: control, 3: hypoxia, 4: flow, 5: strain) 
 
Post-hoc Tukey tests after one way ANOVAs 
Col1a1 
 
>col1a1=c(1,1,1,1.163,1,0.897,1,1.184,0.5256,0.543,0.578,0.336,0.32255,0.218,0.3568,0.541,0.
7046,0.238,0.2246,0.1495,0.4215,0.218,0.278,0.204,0.172,0.227,0.148,0.2155,0.328,0.197,0.403
,0.438,0.443,0.225); 
> time=c(rep(1,8),rep(2,7),rep(3,7),rep(4,6),rep(5,6)); 
> time=as.factor(time); 
> TukeyHSD(aov(col1a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = col1a1 ~ time) 
 
$time 
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           diff         lwr          upr     p adj 
2-1 -0.61907857 -0.81598620 -0.422170945 0.0000000 
3-1 -0.67375714 -0.87066477 -0.476849516 0.0000000 
4-1 -0.82308333 -1.02855612 -0.617610542 0.0000000 
5-1 -0.69150000 -0.89697279 -0.486027209 0.0000000 
3-2 -0.05467857 -0.25804389  0.148686751 0.9339089 
4-2 -0.20400476 -0.41567410  0.007664577 0.0630851 
5-2 -0.07242143 -0.28409077  0.139247910 0.8556250 
4-3 -0.14932619 -0.36099553  0.062343148 0.2683644 
5-3 -0.01774286 -0.22941220  0.193926481 0.9991727 
5-4  0.13158333 -0.08807632  0.351242987 0.4257841 
 
Col3a1 
 
>col3a1=c(1,1,1,1.054,1,1.027,1,1.069,0.74,0.755,0.4804,0.7778,0.48,0.676,0.308,0.45051,0.29
5,0.166,0.242,0.5134,0.122,0.3195,0.544,0.3174,0.428,0.35,0.367,0.889971); 
> time=c(rep(1,8),rep(2,4),rep(3,4),rep(4,6),rep(5,6)); 
> time=as.factor(time); 
> TukeyHSD(aov(col3a1~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = col3a1 ~ time) 
 
$time 
          diff         lwr         upr     p adj 
2-1 -0.3304500 -0.58626351 -0.07463649 0.0071135 
3-1 -0.5401225 -0.79593601 -0.28430899 0.0000209 
4-1 -0.7424333 -0.96803964 -0.51682702 0.0000000 
5-1 -0.5360215 -0.76162781 -0.31041519 0.0000035 
3-2 -0.2096725 -0.50506050  0.08571550 0.2546024 
4-2 -0.4119833 -0.68163445 -0.14233222 0.0013299 
5-2 -0.2055715 -0.47522262  0.06407962 0.1962204 
4-3 -0.2023108 -0.47196195  0.06734028 0.2086726 
5-3  0.0041010 -0.26555012  0.27375212 0.9999990 
5-4  0.2064118 -0.03477146  0.44759512 0.1184695 
 
TGF-beta 
 
>tgfbeta=c(1,1,1,1,0.965,1.005,1,1.087,0.395,0.548,0.537,0.478,1.005,0.54,0.505,0.373,0.562,0.
224,0.203,0.135,0.144,0.0924,0.2135,0.14412,0.447,0.478,0.574,0.488,0.419,0.387,0.4872,0.421
3); 
> time=c(rep(1,8),rep(2,9),rep(3,7),rep(4,4),rep(5,4)); 
> time=as.factor(time); 
> TukeyHSD(aov(tgfbeta~time),conf.level=0.95); 
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  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = tgfbeta ~ time) 
 
$time 
           diff         lwr         upr     p adj 
2-1 -0.45790278 -0.60921423 -0.30659133 0.0000000 
3-1 -0.84197929 -1.00314223 -0.68081634 0.0000000 
4-1 -0.51037500 -0.70106557 -0.31968443 0.0000002 
5-1 -0.57850000 -0.76919057 -0.38780943 0.0000000 
3-2 -0.38407651 -0.54100554 -0.22714747 0.0000010 
4-2 -0.05247222 -0.23959817  0.13465372 0.9224597 
5-2 -0.12059722 -0.30772317  0.06652872 0.3504739 
4-3  0.33160429  0.13642626  0.52678231 0.0003030 
5-3  0.26347929  0.06830126  0.45865731 0.0043122 
5-4 -0.06812500 -0.28831550  0.15206550 0.8929961 
 
Alpha-SMA 
 
 
 
> 
alphasma=c(1,1,1,1,1.011,1.423,1,1.0404,0.8,0.932,0.627,0.613,0.8677,0.606,0.698,0.755,0.133,
0.496224,1.165,0.7,1.2485,0.75868,0.898,0.7466,0.493); 
> time=c(rep(1,8),rep(2,6),rep(3,4),rep(4,4),rep(5,3)); 
> time=as.factor(time); 
> TukeyHSD(aov(alphasma~time),conf.level=0.95); 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = alphasma ~ time) 
 
$time 
           diff         lwr          upr     p adj 
2-1 -0.31835000 -0.64363614  0.006936138 0.0569316 
3-1 -0.53874400 -0.90758381 -0.169904189 0.0024427 
4-1 -0.09125500 -0.46009481  0.277584811 0.9442807 
5-1 -0.34676667 -0.75453442  0.061001087 0.1200690 
3-2 -0.22039400 -0.60918530  0.168397298 0.4582253 
4-2  0.22709500 -0.16169630  0.615886298 0.4292398 
5-2 -0.02841667 -0.45431619  0.397482861 0.9996127 
4-3  0.44748900  0.02158947  0.873388528 0.0365239 
5-3  0.19197733 -0.26804673  0.652001401 0.7238910 
5-4 -0.25551167 -0.71553573  0.204512401 0.4778841 
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